A Portable Low-power Electronic Adherence Monitoring System for Cystic Fibrosis by HE, Fei
A Portable Low-power Electronic
Adherence Monitoring System for
Cystic Fibrosis
Fei HE
Department of Electronic & Electrical Engineering
University of Sheffield
This thesis is submitted for the degree of
Doctor of Philosophy
October 2019
To my parents and your unconditional love.
Acknowledgements
I would like to acknowledge the help and supervision of Dr Mohammed Benaissa for his
superb guidance, support, and understanding during my PhD studies. I would like to express
my sincere appreciation to him for the great opportunity to study in this research and the
enhancement of my knowledge.
Also, I would like to send my genuine gratitude to Dr Tim Good for helping me building the
prototype and helping me during the entire research. Without his continuous support and
invaluable direction, achieving this work would have been impossible.
I would like to thank my lab mates, Zheng Hui and Mohammad Eissa, who have helped me
with proofreading of this thesis. Thanks for all the advice on the technology of both software
and hardware, and important information during studies.
I would also like to thank my parents, my aunt, and my uncle for their unstinting support and
love.
My special thanks go to my best friends, PX Zhang, XF Li, YX Li, SR Huang. I was fortunate
to have intelligent and diligent peers in my life.
My thanks also go to the department for their kind help during my postgraduate studies.
Abstract
In the healthcare sector, the importance of adherence monitoring has been continuously
growing in decades, with the increased need for a reliable convenient electronic system
able to detect and monitor administering routine of consumed doses during home treatment.
Patients with cystic fibrosis (CF), a severe chronic respiratory disease, require continuous
treatment to relieve symptoms. However, the adherence to medical treatment of CF is reported
low. The non-compliance may cause low utilisation of drugs, increased hospitalisation, and
progressive deterioration. A robust monitoring system becomes crucial to address adherence
to the prescribed regimen, predict exacerbation, and evaluate the efficacy of dosed medicine.
This thesis presents a developed electronic adherence monitoring system with a systematic
study of inhalation detecting using a novel low power disposable electronic sensor module
with limited memory, which shows advantages regarding computational demands and the
accuracy of detection. The selected features are proven to be reliable with high accuracy and
low computational complexity.
The designed prototype is low-power and capable to work continuously during a 28-day
treatment supplied by a thin bendable battery. The portable device can be attached to the
target dry powder inhaler and provide effective adherence monitoring with the functionality
of audio processing, motion detection, data storage, data transmitting, and a direct feedback
system. With real-time recognition and fast decision-making system, it can recognise and
record administering events, the date and time of occurrence, and the duration of inhalations
with high robustness against the noisy environment.
According to the result of user testing, the device is initially proved to be accurate on
detection and duration measurement, and the volunteers described it as convenient to use. It
shows potential to improve the quality of inhalation and adherence to medical treatment of
respiratory diseases.
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This chapter introduces a genetic respiratory disorder named cystic fibrosis and dry powder
inhalers for symptom-relieving, including an introduction of the target TOBI Podhaler. The
motivation for the research project is sequentially clarified with the aims and objectives
presented. The key contributions are then reviewed. In the final part of the chapter, the
structure of this thesis is outlined.
1.1 Background
1.1.1 The introduction of Cystic Fibrosis
As one of the most common genetically inherited disorder, cystic fibrosis (CF) is currently
affecting more than 10,800 people in the United Kingdom [1] and being a common condition
in North West European descent [2]. According to an estimation, about 1 in every 25
people in the UK are carriers of cystic fibrosis [3]. With the high mortality rate of newborn
babies, the symptoms of CF commonly start in early childhood and continuously impact
adolescents and adults. The severe condition affects mostly the respiratory system but also
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impairs pancreas, liver or kidneys. The clinical manifestations include chronic endobronchial
infection, exaggerated inflammatory response [4], sinus infections, pancreatic deficiencies
with attendant malabsorption [5], diarrhoea, frequent coughs, wheezing [3], and clubbing of
fingers and toes [6]. Associated with possible diabetes, liver disease, or bone disease, the
condition of CF may become even complicated [7].
The CF is described as an inexorable disease and will eventually deprive the health of a
patient, and it may be fatal with serious infections or losing functionality of lungs. The
reported national median age of survival was only 25 years old in 1993 [2]. With the
development of medical science and treatment technology, there are significant advances in
the management of infection and visceral insufficiency [7]. Around half of the patients with
CF have an improved life expectancy of more than 40 years, and the median survival age
was 47 years old in 2016 [1].
1.1.2 Dry powder inhalers
There is no cure for CF at the moment, whilst various palliative treatments exist for symptom-
easing, which can prevent or reduce long-term damage caused by repeated chronic infections.
Those treatments include antibiotics, physiotherapy, aspiration, and bronchodilators, which
are usually combined with regular use of an inhaled mucus-clearing agent [8].
One existing treatment to ease symptoms and relieve pain is delivering medicines directly
to the affected lung. As drug delivery devices, both nebulisers and inhalers are commonly
used in administering medication. Nebulisers are in the form of the inhaled mist or various
respiratory diseases, and medicines are broken into small aerosol droplets or mists by
compressed air or ultrasonic power [9]. Nebulisers are mostly placed in hospitals or houses
due to the equipment size, thereby bringing inconvenience by its immobility. Furthermore,
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the nebulisers have been reported to be relatively inefficient with higher power wasting and
time consumption [4].
The inhalers show their advantages compared to the conventional nebulisers, which are
handier and with wider design space. The pressurised Metered Dose Inhaler (pMDI) is the
most commonly prescribed device and the standard drug delivering mechanism with small
airways, which is low-cost, compact, easy to use, independent of inspiratory flow, and has
no contamination risk [10]. However, the usage of pMDIs requires the higher coordinating
ability of inspiration to achieve correct inhalation and proper deposition of medicine [11]. It
is reported that many patients are not using the inhalers properly even after repeated tuition
sessions [11–13]. As a result, instead of being delivered to the lungs, the aerosolised drug
may impact the back of the throat [10].
Among different types of inhalers, dry powder inhalers (DPI) require less coordination than
metered-dose inhalers. The DPIs are also more user-friendly without producing Cold Freon
effect, which is a throat reaction to the cold blast [14], as the DPIs contain no propellant
gases [11]. In the current market, a variety of DPIs have been provided and widely used in
asthma and other chronic obstructive pulmonary diseases.
1.1.3 TOBI podhaler
The target device of this research is TOBI Podhaler [15]. TOBI Podhaler capsules store the
functional powder, which is delivered through oral inhalation. An antibacterial aminogly-
coside named tobramycin is contained in the capsules. It is the first and only dry powder
inhaled antibiotic and prescription medicine for an appropriate cohort of patients with CF and
those who are affected by Pseudomonas Aeruginosa, which is a bacterium causing serious
health risks and living in the thick mucus in the lungs of patients. The chance of having
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Pseudomonas Aeruginosa in lungs increases with age, reaching its peak with around an 80%
infection rate by 25 years old [15].
Fig. 1.1 The TOBI Podhaler
Fig. 1.1 shows the structure of a Podhaler. The device comes in a two-piece case, consists of
a base piece and a lid. The inhaler itself has a removable mouthpiece, a capsule chamber,
and a button for capsule piecing [16].
TOBI Podhaler is compact and lightweight, which is portable and convenient to be carried.
It is also easier to be cleaned. The result of a clinical trial showed an improvement of lung
function measured by forced expiratory volume in 1 second (FEV1) [15], which means
the exhaled amount of air during the first second of a forced expiratory, with 64% fewer
respiratory-related hospitalisations and declined need of IV antipseudomonal antibiotics after
28 days of treatment. The measured value of FEV1 is compared to the predicted normal
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FEV1 and expressed as a percentage of it. After a full treatment, the FEV1 improved by
12.54% [15].
The device is available as three supply packages for a 28-day, 7-day, or 1-day treatment [16].
The longest treatment follows a 28-day on and 28-day off routine. One administering using
TOBI Podhaler takes from 2 to 7 minutes [15]. 4 capsules need to be consumed to receive a
full dose, and two doses will be taken each day. There will be 2 or more inhalations from
each capsule to empty it. Therefore, approximately 400 - 500 intakes will occur during a full
treatment. The price of 8 capsules is from $386.45 [17] according to the current market.
1.2 Research motivation
Chronic respiratory system diseases like CF and asthma are often under medication moni-
toring as the intensity of the symptoms varies frequently. CF patients usually need a large
number of medicines to relieve symptoms and disease progression and require continuous
treatment from an early age as CF imposes a demand for full regimens [18]. Around 50%
of CF patients are receiving pulmonary medication treatment [19], which has improved the
prognosis system significantly.
The primary factors may impact the efficacy of inhaled medications are devices, inhaling
technique and patient adherence [20], whereas patient adherence was emphasised as the vital
one. Adherence is the term for the success of a patient to follow the instructions regarding
correct therapeutic usage or treatment. It is defined as the voluntary and collaborative
involvement of patients in the mutually acceptance of behaviour to bring about a preventative
or therapeutic result [21], which is similar to patient compliance and demonstrates the
progress of pulmonary therapeutic treatment to achieve better management of CF [22].
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Poor adherence or non-adherence of treatment has been considered to be a main factor of
exacerbation [23], whereas the knowledge of the efficacy of adherence is still limited. Remote
monitoring devices can acquire relevant objective information during home treatment [23].
To analyse medication intakes, address medication adherence to the prescribed regimen,
predict exacerbation, and evaluate the efficacy of selected medicine, an improved adherence
monitoring system, which can detect, identify and measure inhalation, is still in need.
Furthermore, additional factors of adherence, including the time and date of administering
medications, can improve the predictive accuracy and effect of treatment [22–24]. The
system needs to be implemented with a big population of CF patients. For CF, the data of
inhalation duration length may provide indispensable information to the clinics. There is still
a lack of self-evaluation or feedback system to allow the patients to hone in the new sensing
device, especially in nascent periods of usage.
The designed electronic sensing system aims to detect and demarcate inhalation, measure
intake duration, record usage frequency, and save the information of adherence, which
provides the clinical information of consumed doses. The recorded data should be stored
in the device and transmitted to computers or mobiles for onward assessments. Therefore,
the device may aid in regulating the using of inhalers and furthermore providing a fitted
treatment regimen to individuals.
This work builds upon the knowledge of sound recognition, motion detection, real-time
processing, and low-power hardware system. The sound recognition system is selected for
inhalation detection and duration measurement. The traditional microphones that have been
used in speech analysis or speaker identification system are good-quality high-performance
products with inner filters, whereas their financial cost and power consumption are higher.
With the development of Micro-Electro-Mechanical Systems (MEMS) devices, sound sensors
are getting smaller in size with lower power consumption. Similar to respiratory measure-
ments, the developed sound detecting system focuses on inhalation, not the estimated result
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from intake movements or unconsumed doses, thus provides more accurate information of
administering. Filtering and transformations are vital in pre-processing and identification
stage for detecting inhalation from a mixed background sound. Building up a model consists
of feature threshold value helps to compose fast and accurate identification.
1.3 Research aim and objectives
The hypothesis of this thesis was: would a technology-based approach to measuring adher-
ence to CF treatment via dry powder inhaler lead to improved health outcomes, quality of life
and reduced cost? The aim of this research is to design a low-cost, low-power, lightweight,
small-size reliable electronic device to detect and measure inhalation precisely and achieve
an efficient adherence monitoring of a CF long-term home treatment, which is only the first
monitoring detector of a dry powder inhaler.
The technology is developed to assist in administering, monitoring and help the patient in
maintaining the required dosage regime using dry powder inhalers. The ideal inhalation
detector should feature efficient detection, accurate measurement, optimised data processing
and transmission, high portability, and low energy consumption. It also benefits if the
users receive direct feedback of inhalation evaluation or usage guide from the system. The
challenges of the research include pre-processing collected data, analysing feature candidates,
identifying features which can discriminate proper or improper usages, building up the
prototype system to provide the technological underpinnings for a clinical investigation and
more involved future work.
The main aims and objectives of this thesis include:
1. Discuss the importance and the existing technologies of adherence monitoring.
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2. Review the conventional sound processing technologies and widely-used features of
sound detection and recognition.
3. Analyse the collected inhaling data with further feature extraction, comparison, and
selection.
4. Describe and explore an accurate sound detecting method with duration measurement
based on simple time-domain features.
5. Construct a portable prototype for a demonstration of the proposed methodology with
selected algorithms.
6. Design a complete monitoring system with a motion-detecting wake-up system and a
light-emitting diode (LED) direct feedback system.
7. Perform a relative evaluation of the constructed system to explore its accuracy and
reliability on inhalation detection and adherence monitoring compared to existing
technologies.
8. Organise initial user testing experiments with volunteers who have restricted lung
functions and have been using inhalers.
9. Incorporate recommendations for a future design for a powered clinical trial.
1.4 Key contributions
1) A low processor-memory solution
In terms of audio processing, the difficulty of real-time inhalation identification under a noisy
environment with a limited-sized random-access memory (RAM) is one main challenge in the
research. A novel real-time audio processing architecture with a challenging 1 kibibyte (KiB)
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processing random-access memory (RAM) is composed. The methodology of abandoning
processed raw audio signal from a MEMS microphone reduces the size needed for data
storage. Comparing to the frequency-domain counterparts, the calculation of time-domain
features requires less memory with higher speed [25, 26]. The reduced processing memory
enables the real-time detection and classification system to be implemented on the selected
simple low-end processors with good performance.
2) A detection system against noisy environment
Comparing to the existing time-domain approaches based on the zero-crossing rate (ZCR)
and energy, the composed novel inhalation detection system is more resistant to the noisy
environment. The optimal feature-set has been selected from the candidates based on their
performances to present inhalation, the robustness against noises, the orthogonality between
features, the computational complexity, and the needed memory space for matrix calculation.
The system is capable to detect inhalation from noisy environment of 10 dB signal-to-noise
ratio (SNR) or at even higher noise levels. White noise shares high similarity with the target
inhalation in both frequency-domain and time-domain as they are both low-volume broadband
signals. A novel simple time-domain feature, the Short-Time Magnitude Difference (STMD)
is used instead of energy to reduce interference from white noise. The size of the processing
window and the abandoning criteria enable an efficient extraction from the contamination of
loud sound impulse.
3) An accurate duration length measurement
The study accomplishes an accurate measurement of inhalation duration length as an improve-
ment of the existing event detection. The novel rapid decision-making system recognises
inhalation in milliseconds and starts counting samples for a later time-length calculation.
Instead of measuring the time gap between the opening and closing gestures of container
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cover and estimating time length of usage, the duration of actual administering is measured
by sound detection, and the duration difference has been declined.
4) Motion detection for the wake-up system
Motion recognition has been introduced into the system for power saving. The simple
hand gestures are detected and recognised through a 3-axis accelerometer to trigger the
microphone, and the system stays in the sleep mode until specific motion and gesture are
detected, as MEMS microphones are costing much more energy than accelerometers. The
wake-up system is two-phase, and horizontal alignment of the inhaler is detected in the
second phase.
5) Storing capability
The system is capable to store and transmit the information of adherence of a full treatment
course. To avoid data loss caused by unexpected instability of power supply, the result of
inhalation detection and measurement is stored in the 0.5 KiB non-volatile Ferroelectric RAM
(FeRAM) of the near-field communication (NFC) chip. The non-volatile random-access
memory (NVRAM) has been used to store pre-set threshold values, parameters, variables,
and constant numbers, which contribute to the implementation. The adherence information
within a treatment, such as a short treatment of 7 days or a long treatment of 28 days, can be
fitted into the limited memory with developed highly-compressed storing solutions. The new
simple fast coding algorithms are employed before data storing. A C# PC application has
been developed for data transmitting from the device to a PC via an NFC/RFID contactless
reader, and the encoding process is conducted after data reading.
6) A low-power portable hardware prototype
A low-power finger-tip hardware prototype to achieve audio and movement processing is
constructed in this study. The applied power supply is an internal 43-mAh flat flexible
rechargeable Li-Ion battery. To extend the period of use, the power consumption is kept
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low during processing and stays in the extra-low mode when it is sleeping or being idle.
The average working current is less than 30 uA, allowing a 20-mAh battery operating for a
month, which also necessitates a low operational duty cycle less than 1:100 and single-digit
micro-amp standby current.
7) A direct feedback system
A direct feedback system is present with the potential to improve the quality of medicine
intakes. An attached red/green light-emitting diode (LED) can be observed externally
through the shell. The sign of detected inhalation allows the patients to have an early and
fast evaluation of their inhaling quality. The transitions between different working modes
are also informed through the lights. Single red light flashing, double flashing, long-period
flashing or other flashing modes are endowed with different meanings and providing multiple
feedback to users.
1.5 Thesis outline
The first chapter of the thesis introduces the cystic fibrosis and its main symptoms. It also
describes the popular conventional symptom-easing equipment, including nebulisers and
various inhalers. It emphasises the TOBI Podhaler as it is the target DPI. After a brief
introduction of adherence to CF, the motivation to build a low-power portable real-time
detection and identification device for inhalation is presented. The aim and objectives are
stated sequentially with key contributions of the project outlined.
The second chapter of the thesis reviews the importance of adherence monitoring for the
treatment of CF. With a literature review of existing adherence or healthcare monitoring
system, it emphasises electronic monitoring technology as it is the state-of-art method and has
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played an important role in the modern health care system. It describes various technologies
that have contributed to adherence monitoring.
The third chapter introduces different sound feature extraction algorithms, including time-
domain features, frequency-domain features, and wavelet extraction. The advantages and
disadvantages of each extraction method have been discussed and compared. Sequentially,
it presents the knowledge of the audio collection, pre-processing, analysis of recorded
inhalation, and the filtering algorithm, followed by the feature extraction of target inhalation
and the evaluation of the environment. The feature selection for the real-time device also
has been discussed in this chapter. The optimal feature set consists of three features, which
are easy to be calculated by a limited-sized processor and have the capability to distinguish
inhalation exclusively from the surrounding noises. The efficacy of each acoustic feature is
analysed separately.
In the fourth chapter, the NFC chip used for data storing and transmission have been
considered for data storage and transmission. Instead of the original 16-bit inhalation length,
two highly-compressing methodologies are developed to store information of hundreds of
inhaling events in the limited-size non-volatile memory safely.
The sixth chapter discusses the experiments of inhalation detection and the result compre-
hensively. An observed two-phase initial user testing study has been completed with two
groups of volunteers to evaluate the performance of the prototype monitoring system. The
participants used an inert inhaler without drug delivery. The findings indicate that the device
is easy to use with more than 90% accuracy as a self-evaluation system.
The conclusions and major contributions of the thesis are outlined in chapter seven. The
suggestion of future work is then proposed.
1.6 Research Publications 13
1.6 Research Publications
The following publications to be submitted based on the research in this thesis is presented
below:
1. The portable low-power electronic adherence monitoring system for cystic fibrosis,
IEEE Transactions on Biomedical Engineering.
2. Design of low-power real-time audio processing system of monitoring devices for
respiratory disease, IEEE Transactions on Biomedical Circuits and Systems.
Chapter 2
The Adherence Monitoring in the
Healthcare System
With an introduction of medication adherence for cystic fibrosis, the chapter emphasises
the importance of adherence monitoring during a long-term treatment and reviews existing
monitoring technologies. Electronic monitoring technology is the state-of-art method and
has played an important role in the health care system. Different technologies of adherence
monitoring have also been introduced in this chapter.
2.1 The importance of adherence monitoring
Adherence to the treatment plan is one of the recognised common issues among patients with
cystic fibrosis (CF). The inappropriate inhaler usage and poor adherence normally result in
lower utilisation of drugs, inefficient disease control, and higher consumption of powder [27].
The consequences also include progressive deterioration, excessive prescription of drugs to
achieve enough potency, extended duration and the increased cost of hospitalisation [27],
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increased outpatient visits, the erroneous conclusion about the efficacy [2], weaken baseline
lung function [19], and even a failed treatment [7].
The mean adherence is reported low for long-term regimens and treatments. Notwithstanding
that patient and clinics make efforts on the adherence to the treatment, the reinforcement is
limited to individual pulmonary medication among patients with cystic fibrosis [7]. The Na-
tional Health Service (NHS) spends around £30 million annually on inhaled therapy whereas
the shown median adherence is only 36% [28]. Inadequate collection of less than 50% of the
medication during inhalation may increase the possibility of unscheduled emergency care
and additional hospital admission, thus cost the healthcare system significantly compared to
those who collect 80% or above [24].
The inefficient inhaling technique is considered one of the inadequacies of daily medical
treatment and the main causes of incorrect medicine delivery, alongside with incorrect priming
the powder and slow inspiration [12]. The usages of seven inhaler devices, including the
Easi-Breathe (Allen & Hanburys), the Autohaler (3M Healthcare), and the most commonly
prescribed pMDI, have been recorded and analysed among 100 instructed users by Lenney,
Innes, and Crompton in 2000. Some users have used the inhalers effectively, whereas the
rest failed to follow expert instruction and the rate of valid drug delivery dropped among
them. Only 79% usages of the conventional pMDIs were effective. This assessment graded
poor techniques indicating the scant drug delivery with partial, little or no powder received
by users. Poor co-ordination, triggering at the wrong stage of inspiration, nose inspiration,
induced coughing, incorrect priming or no priming, and other faulty behaviours would lead
to a failed inhalation [12]. Besides inaccurate inhaler operating, the inhaling quality also
affects the delivery of powder. Also, inspiratory flow, tidal capacity, and breathing rate differ
from patient to patient [29]. An inadequate inhalation indisposes treatment quality due to the
reduced amount of committed dose. As a consequence of low inspiratory rate, few portions
of prescribed medication could finally act on the target organ.
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Without quantifiable information of actual usage profile, the medical team is unable to
accurately assess adherence and thus may be uncertain in prescribing changes. Consequently,
the treatment may be compromised with the inevitable increases in financial burden. To
address the problem of incorrect inhalation, adherence monitoring has been introduced to
demonstrate whether the users are receiving the correct amount of medicine as advised thus
reduces drug abuse or waste.
The reason for measuring failure includes the lack of valid and reliable adherence measure-
ment, no clear delimitation between adherence and non-adherence, and the varied adherence
due to the different regimen of each individual [18]. The situation varies between each patient
as their age, personality, gender, knowledge of the disease, the frequency of clinic visits, the
severity of symptoms, family, or social environment is different [2, 18]. Without a reliable
measurement of adherence, there is not enough accurate information about the prevalence
of incomplete adherence, therefore the consensus about the importance of each treatment
method is still absent among the health care researchers.
Proper measurement of inhalation adherence is imperative in the study of CF, whereas non-
compliance is difficult to be recognised without a detailed demonstration against the varieties
of patterns. The reasons for non-compliance might be complicated. When the patients
dose themselves in the home environment, their adherence may vary over time [30]. The
patient may not be aware of the importance of adherence, especially when the symptomatic
relief fails to occur immediately and lead to a decline in the belief and confidence in the
treatment. The complexity, demands, and duration of a long-term treatment also dispel
the belief of patients [18]. The emotional resistance may affect adherence when a patient
with depression or anxiety refuses daily doses. The accessibility of medical device is also
considered important, the doses may not be taken continuously if the device is difficult to
operate.
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For adult patients, the forgetfulness is cited as a frequent reason for poor adherence [30].
The patient may miss regular doses during the busy daily life and have not been aware of
the negligence. The strong concerns about potential adverse effect may hinder the progress
of adherence [7]. Only when the patients are worrying about the disease and believing that
the treatment is beneficial and provides positive reinforcement, the adherence is managed
successfully [2].
Children suffering from CF require special medical care to maintain health, and their adher-
ence was recorded to be notably higher than older patient groups [22]. The parents may start
to transfer treatment responsibility to children with the growth of their age and independence
ability. Thus, the adherence of older children, teenagers, and young adults are declined in
this transitional period due to the difference of beliefs about treatments between adults and
adolescents [31]. With the increased complexity of administering treatment, even adults may
find it challenging to understand the efficacy and importance of their own regimen. The
uncertainty may transfer from parents to children during an explanation of adherence [7].
2.2 Adherence monitoring technologies
2.2.1 Traditional health diaries and direct measurements
The use of health diaries became a common adherence monitoring method in the early days.
The patients were asked to take records of their diary medical regimens, the remaining
amount of medicine, and how the symptoms vary during treatment. Health diaries provide a
comprehensive view of the patient’s condition [32] and make early detection of worsening
trends to introduce therapeutic measures in time [33]. To record, assess and properly control
CF inhaler adherence, self-report or daily diaries are utilised by the clinicians in existing
cases. The University of Minnesota CF Centre aimed to develop a home monitoring model
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based on home-monitoring data to evaluate the therapeutic process [34] and implement it
into an expert system shell in 1989 [32]. The considered parameters in the program included
respiratory rate, vital capacity, resting pulse, and weight. The project introduced the idea that
the specific parameters could represent the health condition of patients and had demonstrated
an example of a computer-based prototype system.
The novel monitoring and direct measurement of adherence based on self-reported health
diaries, including the retrospective analysis of therapeutic response, the usage of tracer
substance, and inspection of blood, urinary excretion, or body metabolites [7] have been
developed. With a higher requirement of equipment and more human actions involved, the
frequent tests may increase both the financial and time cost and be considered as impractical.
Self-report adherence is known to be higher than the measured adherence through electronic
monitoring devices, as the former may introduce positive measurement bias [35] or insertional
manipulation. The complexity of interpreting a large amount of time-based data increases
the difficulty of further analysis and the uncertainty of human-recorded data may lead
the statistical errors in the final evaluation [36]. According to statistics, self-reports by
independently monitored patients showed low accuracy and low reliability without precise
information on usage times or duration for a long study period. Daily diary report from
the clinician side showed objectivity, which was considered more promising and accurate,
whereas the cost and time consumption would also increase as long-term treatment progressed.
The usage of questionnaires can also collect direct or subjective information from the patients
[37].
The communication between the patients and the healthcare teams benefits the treatment
especially when frequent conversations can be achieved. Despite the important perceived
information from patients, physicians may still make a misguided assumption about how good
the patient will comply with the adherence following the instructions [7]. As a consequence,
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the patients and the clinicians might not be aware of the non-compliance and incorrect usages,
causing exacerbation of symptoms eventually.
2.2.2 Electronic adherence monitoring technologies
Electronic monitors are considered as one of two primary objective adherence measurement
alongside with pharmacy refill records [19]. Automatic electronic monitoring through
dedicated devices is regarded as the optimum method with lower cost, higher accuracy [8],
and the capability of providing a date/time stamp of medication administering [19]. The
integrated monitored devices measure and record relevant information of usage rather than
depend on self-reporting, without placing a time or financial burden on the clinicians. By
sensing the correct usage and storing accurate records electronically, the system provides
supporting information to demonstrate treatment progress more effectively.
The cost of each plastic inhaler is relatively low comparing to the price of medicine, which
costs around $386.45 for 8 capsules [17], thus inhaler can be replaced frequently once it is
not in the good condition. The target monitoring device should be designed to be low-cost
with an approximate cost lower than 10 pounds. In this way, the electronic device can be
replaced and deposed frequently with the used inhaler.
To sense, monitor, and diagnose CF, diverse electronic technologies have been developed in
recent years. Comparing to the traditional monitoring methods with more human activities
involved, the electronic methods are more objective and independent alongside with the
following advantages:
• The electronic methodology has higher accuracy and reliability [38].
• The devices are non-invasive [7] and relatively safer to the human body.
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• It reduces the frequency of clinic visiting with continuous data collected in the relatively
long-period treatment.
The electronic monitoring for CF and other diseases can be based on various technologies,
such as the respiratory measurement, motion detecting, sound detection or perspiration detec-
tion [39]. With the development of smartphones, healthcare mobile applications capture the
market and become an emerging technology for adherence monitoring. Existing applications
include the function of self-report dairies, medication reminders [40] or condition monitors
have been used for diseases like diabetes and high blood pressure, which need daily monitor-
ing. Without extra devices, the patients can download applications into their own phones. The
time of administering training might be reduced by recorded demonstration audios, animation
or videos. The functional processor implanted in smartphones can provide advanced signal
processing and solve the transmission issue with Wi-Fi or Bluetooth technologies. As the
current applications are more dependent on the action of patients, the accuracy and reliability
of reported data are declined as the recorded data are varied by their own medical briefs,
which is similar to the situation of self-reports.
Electronic monitoring devices for respiratory diseases can be attached to the nebulisers,
aerosol dispensers, and inhalers to measure and record the adherence. Developed electronic
technologies include:
1. Ingestible sensors
Besides extracorporeal monitoring methods, ingestible integrated micro-sensors with in-vivo
communication system has been designed, optimised, and embedded inside medication
for daily adherence monitoring. The functional sensing circuit can be developed in food-
particle millimetre-size. The contacting with gastric fluid activates and powers the integrated
circuit, providing the electrolytic solution without additional batteries [41]. The adherence
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information, alongside with other possible measured properties, can be transmitted from the
sensor to an outside receiver, such as an electronic patch [42], a compliant cloud-based web
server [43], or a mobile application. An efficient signal processing including channel sensing,
frame synchronisation with decimation, auto-correlation and frequency estimation may be
introduced and implemented on a low-power platform for further data analysis [42].
The ingestible integrated sensors are small in size, low in power consumption and financial
cost and safe to the human body. Direct information about adherence and non-adherence
will be detected and recorded with less recall bias or distortion. The identification and
transmission system can provide real-time processing with feedback, which can guide the
users in nascent periods of treatment to adapt the therapy.
In the case of a monitoring system for inhalation, ingestible sensors are not suitable as the
powder will not be through the digestive system and they are not considered in this research.
2. Motion detection
Motion detection is one main approach for adherence monitoring as accelerometers have been
embedded in most smart-phones, smart watches or other emerging electronic devices. The
signal from real-time movements directly responses to the action with high sensibility. To
detect and identify the movements of adherence, the accelerometers sensors can be attached
to the pill containers, mobile phones or the human body.
Existing research studies attach importance to upper-limb movements as it can present the
action of the medicine administering after proper data training. Zhang and Xu attached 3D
accelerometers to a wrist strap and the information of upper-limb movement was collected
and processed to detect real-time human motions by normalisation and interpolation [44].
The data were transmitted to a PC for processing through a USB interface.
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A research group from Washington State University has developed a learning-based method-
ology to detect the medicine-taking action of patients. Wrist motions were detected and
collected by a wearable sensor on a wristband device. The collected data were transmitted to a
computer for signal segmentation, feature extraction, model training and final execution [45].
The accuracy rate of detection achieved 78.3% by a single sensor. Another detection system
to recognise a hand-to-mouth gesture has been developed for cigarette-intake identification
[46]. The specific gesture is similar to medicine intakes and can inspire adherence monitoring
technology of inhalers.
The duration of inhalation can be estimated by the movements of patients. AdhereTech [47]
is built in the same size as a pill bottle. It can collect adherence information and obtain
valuable insights. A battery-powered tablet-dispenser to monitor the preventive therapy for
tuberculosis is developed in 1999 [38]. Instead of measuring the inhalation, the lid of the
container is monitored by an electromagnetic detecting system. The date and time, and the
duration of the removal of the lid will be detected and recorded into the memory. An interface
box is used for data transmission from the memory to a computer. The battery and memory
have the capability to continue for years.
In 2014, a new adherence monitoring attached electronic device SmartTurbo, which is
designed for a dry powder inhaler named Turbuhaler, is developed [48]. The evaluation
stimulated the movements of actual usages. The opposite rotations of the inhaler are detected
to identify inhalation. A USB cable connection is used for data transmission from the device
to a web-based database.
3. Vision recognition
Medication intakes can be monitoring by a computer vision system with multi-level hierar-
chical approaches. Instead of tracking the pill itself, the human activities are detected and
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tracked remotely for the home-care system. Based on proximity and occlusions [49], the
occurred interactions between hands or pill bottles are captured by a camera-based system
and recognised by further image processing. Face identification has been introduced to make
sure the right user is under monitoring. The face region can be detected and constrained,
and the face will be recognised and tracked by template matching with assumptions. Hand
localisation [50] based on greyscale sharpness is developed to track the hands, and the orien-
tation of fingers are detected to recognise the movements of opening or closing a medication
bottle [51]. The duration, the actual date and time of an event, and the gaps between two
intakes are recorded into the electronic system. A high-performance camera may present
the information to measure the dosage amount. With a previous advanced training stage, the
quality of administering can be estimated to grade normal and abnormal intakes.
Building an entire vision recognising system may lead to a higher cost of time and money. For
people with dementia, the research group from Fukuoka University [52] developed a Kinect-
based medication adherence monitoring system. The depth-image analysis technology was
provided by Kinect, which is an existing motion-sensing line that was produced by Microsoft
for video game consoles and PCs.
4. Sound recognition
Acoustic analysis has been introduced in the health care system especially for those diseases
with specific sounds, such as breathing and snoring sounds. The functionality of microphones
has been improved whereas their size shrinks. Sound detection plays an important role in
state-of-art monitoring and other healthcare systems, such as pre-diagnosis of heart disease
[53], sleep quality diagnosis [54], environmental sound detection for hearing-impaired people
[55], sleep apnea detection [56], coronary artery disease [57], and electronic auscultation of
lung sound detection [58].
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As the acoustic features of inhalation relate to the expiratory volume [59], sound processing
has been introduced into respiratory adherence monitoring. Martin S Holmes indicated
clinical implications on measuring whether the patients reach the peak inspiratory flow rate
as it presented the feasibility of using acoustics to detect a dry-powder inhalation objectively
[20]. Temporal acoustic detection of asthma inhalation was firstly introduced in 2012 [60],
presenting empirical evidence to an asthma medication regimen. Raw audio signals which
contained inhalation were recorded by a Micro-electro-mechanical (MEMS) microphone and
were saved in a Secure Digital (SD) card. The inhalation was detected and demarcated by
a developed algorithm after the signals were downloaded to the analysing platform. Faulty
usages, including low flow rate and multiple blisters, would be identified by the system. The
result of the clinical investigation was published in 2016, showing that the remote monitoring
device excluded incorrect usages to acquire objective information. As a clinical decision-
support tool, it might also predict exacerbation, aid preventative strategies, detect adverse
events, report the efficacy of medication dosing [23], find out the causes of low-adherence
behaviours, and leverage findings with targeted interventions [47].
A novel medical wheezing detection technology was developed in 2017 [61]. Instead of a
single microphone, an analogue microphone array was fabricated on an insulator to detect
asthma attacks. The new algorithm reduced power consumption and computing complexity
of acoustic detection and recognition. The Bluetooth Low-Energy (BLE) technology was
introduced as the transmitting method.
Another research in 2016 introduced a new system for intake detection [62], with recognising
the individual sounds of inhaling, exhaling, inhaler actuation, and background sounds. A
wireless microphone was attached to the inhaler and the data were transmitted in a smartphone
through Bluetooth for processing. With the functional processor in the smartphone, complex
frequency-domain calculation and distinct algorithmic approaches were achieved with 96%
as the highest accuracy.
2.2 Adherence monitoring technologies 25
5. Respiratory measurement
Respiratory measurement has been used for health monitoring of pulmonary diseases like
CF and asthma. Pressure and air-flow are measured during the research studies [63]. The
existing respiratory measurement for CF are usually not in portable size, and the respiratory
sensors in use might be costly. An online speaking detection system based on respiratory
measurements was developed in 2011 and presented the idea of building a respiratory
inductive plethysmograph chest band [64]. The duration data of inhalation and exhalation
was detected and collected. The device captured respiration information rapidly whereas the
samples would be analysed and recorded by a smartphone. The chest bands provided a more
portable respiratory measurement which can be introduced for CF inhalation measurements.
A battery-powered portable electronic I-neb Adaptive Aerosol Delivery system was developed
for CF treatment [4], which is capable to release aerosol adapting to the breathing pattern of
users with monitoring. A measurement of an inhaled dose has been achieved by placing an
absolute viral/bacterial inspiratory filter between the system and breath simulator. As the
liquid drug was nebulised during usage, the system is not suitable for dry-powder inhalers. A
single piece of this highly-priced system costs hundreds of dollars [65] and being relatively
expensive.
2.2.3 The comparison of presented technologies
The electronic components for sensing, signal processing, data storage, and power supply may
increase the financial cost in both research period and production stage. The inconvenience
of usages may also cause frustration or even abandonment of the device. Some devices
demand additional training time for patients or clinical staffs. The developed system should
consider the accuracy of detection, the portability, the financial cost, the durability and the
power supply, the return and transmission of data, and the presentation and analysis of data.
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1. The accuracy of adherence detection
The accuracy of motion detection stays uncertain in terms of whether the patient has com-
pleted efficacious medicine administrations. The electromagnetic tablet-dispenser [38] and
AdhereTech [47] detect whether the container is opened and record the date and time of
the lid openings. There is no accurate information of whether the patients have taken the
medicine or not and there is a possibility that the patient forgets to put the lid back on the
container. SmartTurbo [48] shows a similar problem, which uses single-wrist motions to
simulate inhalations. There is no evidence for ensuring the inhalation has occurred properly
and effectively.
The visual detection [49–51] is proven to be reliable as a large amount of information
being recorded and considered. With a high-quality static camera, the technologies of face
detection, template matching, and hand localisation have been used for recognition of in-take
movements, ensuring the right user is taking a correct dose of the right medication within the
required time period.
The researches that detect and demarcate inhalation sound from audio recordings show an
advantage on accuracy with a sensitivity of 95% and a specificity of 94% comparing the
effort from human raters. With an effective sound demarcation and inhalation recognition, the
duration of each inhalation can be measured and the average difference of duration between
the system and human raters is around or less than 0.1 seconds [60].
2. The portability
The portability of the device affects the convenience of usages and acceptance by patients.
High-performance visual recognition usually requires high-quality cameras and a functional
processing system. Therefore, they are usually settled and cannot be moved. The user needs
to stand in front of the camera during every consumption of medicine to make sure their faces,
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hands, or pill bottles are captured clearly by the camera. In some studies, the sensing and
recognition system was bulky with a size that bigger than inhalers and declined the mobility.
The accelerometers and MEMS microphones are in smaller scales and capable to fit into
portable devices. The AdhereTech [47] and the acoustic detection system for asthma [60]
were both attached to the medical equipment without affecting normal usages. However, when
a real-time evaluation system based on a high-performance processor, such as a smartphone
application or a PC data-receiving interface, is involved, the device needs to be connected to
the terminal through wireless communication or a cable. The real-time data transmission
requires extra human actions, which might cause inconvenience and be forgotten or avoided
intentionally by the users.
3. The financial cost
The Podhaler device and storage case are disposable and should be replaced when they are not
in good condition. The price of each device needs to stay low to fit the short-term usage and
to be disposable with the device. The financial cost to develop an electronic device base on
the price of components and the technology of manufacture. The essential components for an
adherence monitoring system include a microprocessor, sensors, solid-state memory storage,
data transmitting system, and a power supply for portable devices. Additional components,
such as LEDs and speakers, also increase the total cost.
Building a visual detection system is believed to be expensive as cameras are needed for video
capturing. The acceleration sensors and sound sensors are more affordable and been widely
used in current healthcare applications based on the development of MEMS technology. A
solid-state memory chip is usually priced based on its size of storage, and a high-capacity
micro SD card may cost several pounds. According to the given information from existing
research studies, however, the price per device is considerable high. The electromagnetic
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tablet-dispenser were at a cost 500 Australian dollars in 1999 [38]. It is reported that
AdhereTech bottles would cost $1,000 per year per patient according to estimation [47].
4. The durability
The durability of an adherence monitoring device should consider: 1) whether the detection
can stay accurate during a long period, 2) whether the functionality can continue on one
charge of the battery, 3) whether the data can be successfully stored during the whole
treatment, which is crucial for portable devices.
For most of the portable devices, power is only consumed when the device has been woken
up by defined triggering signals from sensors and turned to the working mode. For example,
the electronic detecting system can be turned on by the removal of the lids from containers
or inhalers, which has been widely used and avoid unnecessary power consumption when the
system is being idle. Supplied by a normal battery that can be purchased from the current
market, most of the devices can theoretically continue to function for months or even years
[38, 60, 47].
5. The return and transmission of data
For developed technologies, there are two main methods to return the data of adherence.
With higher portability, raw data from activities of medication administration can be detected
by the system and stored into memory [60]. The data will later be read from the memory card
and received by clinics, hospitals, or pharmacies for further analysis after a treatment period.
The second method declines the portability to achieve a fast or even real-time evaluation.
The system is connected directly to a PC or a phone during medicine in-takes [62] and the
information can be returned to clinics immediately. For the first method, the patient cannot
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receive feedback in time, whereas the second method requires more coordination from users
as the connection between the device and a terminal is prerequisite.
A terminal that can communicate with a database is presented for adherence evaluation. The
data are usually transmitted to a PC [38, 44, 45, 60], a mobile phone [62, 64], or both of
them [48]. The transmission can be through a USB cable [48, 44], a built interface box [38],
or any wirelesses communication, such as Bluetooth [34, 62] or Wi-Fi.
6. Data presentation and analysis
The information of event occurrence is time-stamped. During the data analysing stage, the
adherence is presented in chronological order with the date and time of recordings.
For adherence estimation based on motion detection, as there is no recorded information of
accurate time length to consume a daily dose, the test protocol to present adapted patient
behaviours by the researchers. In the case of SmartTurbo, each event was tagged as low-use
or high-use based on the frequency of usages during the same period [48]. The monitored
adherence was an estimated result with limited information about powder delivery.
For the audio recording method, the evaluation was delayed until the data were read from the
memory. The audio inhalation identification of asthma inhaler recordings defined the correct
using procedure of the Seretide Diskus inhaler, including mouthpiece revealing, medication
releasing, an event of inhalation, 10-second breath holding, and turning off the device. The
sound clips of different events were recorded previously for a training procedure [60]. Based
on the subsequent evaluation, the common technique error during treatment was detected
and revealed, such as exhaling into the mouthpiece, no inhalation, low inspiratory flow rate,
and multiple inhalations [23]. Adherence to medicine was acquired over 3 months in the
later clinical trial (NCT01529697), it was proven that the remotely monitored adherence
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holds important clinical information. However, during the 3-month treatment, the users had
received no feedback of their technique error until the trial finished [23].
Discussion
With the importance of monitored adherence has been indicated, it was also claimed that
the limitation of electronic monitoring exists despite high accuracy and objectivity, and a
robust adherence measurement is still in the absence. The comprehensive review of existing
technologies lists the strength and weakness of each monitoring method.
It is believed that the visual recognising system is able to collect important information
for identification, whereas the construction may lead to high financial cost, high power
consumption, bulky equipment, or even low acceptance by users. Comparing to the visual
capturing system, the acceleration sensors and sound sensors are manufactured in a smaller
size with lower price and lower power consumption. For motion detection, the adherence
is estimated from human movements during usages, including lid-removal and rotations
of inhalers. The information of whether medicine has been consumed and whether it was
delivered properly stays insufficient, which declines its accuracy for inhalation monitoring.
Sound detection based on a high-performance processing system is proven to be more
accurate in terms of medicine delivery, as the extracted features from acoustic analysis relate
to respiratory rate.
A self-evaluation tool is still in need as the adherence and information of inhalation are only
recorded and stored without any feedback given in most cases. The users receive limited
knowledge about whether their adherence has been recorded correctly.
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2.3 Summary
The solution of adherence monitoring has been developing in many med ical fields and
the methods based on traditional diaries and electronic system have been proposed in the
literature for detecting, recording, and analysing administering of medicine. The electronic
devices are recommended as the advanced technologies for medical monitoring thanks to
their objectivity, accuracy, and the possibility of employing a fast-reacted evaluation system.
In this chapter, the existing popular monitoring solutions have been classified and described
briefly.
The technologies of sound detection, motion detection, and vision detection have been
discussed. Due to the characteristic of respiratory diseases, the quality of inhalation is the
main target for detection, therefore the sound detection is selected with the assistance of a
motion detecting system. The motion detection has been used to switch the device from the
low-power idle mode to the full-power working mode and thus achieve power saving. The
acoustic analysis and detection of inhalation are presented and evaluated in the next chapter,




This chapter briefly introduces different technologies of sound recognition with a further
comparison of their performance and computational complexity. It reviews time-domain,
frequency-domain, wavelet, envelope, and deep-learning analysis of sound from human
activities, especially from the respiratory system, the feasibility of using sound detection to
achieve adherence monitoring has been discussed. It presents a comprehensive acoustic
analysis of inhalation with a further environment evaluation. A soundproof room has been
used for data collection in the early stage.
According to the performance of different features, a combination of three features, including
the ZCR, a new feature named short-time Magnitude Difference (STMD), and the pulse
length (PL), have been selected to fit the real-time processing. This novel combination has
high accuracy in terms of detected rate and duration measurement with low computational
complexity and memory requirement, which can fit into a small-scale electronic system with
only 1 KiB RAM. The duration difference between the measured duration and reference can
be limited to milliseconds based on the fitted threshold value of selected features.
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3.1 Introduction
Acoustic recognition has been widely applied in healthcare engineering as a non-intrusive
monitoring technology [54, 58]. Especially, for respiratory disease, as the sound of inhalation
is related to the quality of medicine administering, acoustic recognition has been successfully
established to detect and evaluate medical treatment remotely and is proven to be cost-
effective and accurate in its performance [60, 62]. It is proven to be able to identify inhalation,
exhalation, and the pulse between the events by analysing extracted acoustic features, thus
providing an evaluation of correct inhaler usage. Considered CF as the target disease, acoustic
recognition is selected.
The main processing target of the research is to recognise inhaling sounds during medicine
administering and measure the duration of inhaling events using the limited 1 KiB random
memory to handle data buffers derived from the audio stream. The differences between
inhalation and non-inhalation demarcate a sound clip of actual administering. The sound of
inhalation is considered to be stationary and continuous during time-limited frames, which
is similar to miscellaneous common broadband environmental sounds, such as white noise.
With the acoustic complexity of the environment, it is always challenging to discriminate
target sound from background noise and locate boundaries of segments on audio files. When
the inhalation cannot reach a certain amplitude, especially for users with restricted lung
functions or aged patients that cannot inhale strong enough, the sound of inhaling is easier to
be affected by surrounding broadband noises.
The duration of inhalation will be measured by detecting the discontinuities of inhalation
and locating its endpoints. Endpoint detection is an early stage of sound identification. It
contributes to healthcare monitoring and the pre-processing of audio processing technologies
like speaker identification and word recognition, which has been widely used to identify
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acoustic changes. It plays an essential role in sound recognising and removing mute segments
before speech processing with the potential to demarcate inhalation.
For a portable device, low-power computing can contribute to saving energy and extending
battery life for a duration-fixed treatment. Alongside with dynamic power management
and server virtualisation, improving the efficiency of the algorithm is one of the general
approaches to reduce power consumption [66], which can save electrical power by reducing
the number of computing cycles and the required hardware storage for calculation. The
selection of features needs to consider computational complexity and it may aid to decrease
the needed number of coefficients and increase the efficiency of the algorithm.
3.2 Feature extraction and deep-learning methods
3.2.1 Time domain features
The very early version of endpoint detection was proposed for locating endpoints of an
utterance processing in 1975 [67], based on two parametrical controlled spectral analysis
systems [68, 69], which is inherently capable of performing correctly in any reasonable
acoustic environment. The simple efficient processing was considered as one goal of endpoint
detection alongside with the reliable locating capability and the adaptability to various
environment sounds [67]. The algorithm was based on two features: short-time energy (STE)
[70] and zero-crossing rate (ZCR), which are fast to calculate and the most commonly applied
feature to form temporal feature sets in endpoint detection [71, 72]. In the early 80s, the
improved endpoint detection for isolated word recognition [73] was proposed and composed
a concept of the explicit, implicit and a comprehensive combination hybrid endpoint detector,
depending on whether the endpoint locating was separated from and prior to the recognition
and decision stage. With only the equalised energy was used as the key feature, an energy
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pulse detection and the pulse endpoint ordering system was introduced. It also pointed out
that in the real-time identification, the start point of the target sound must be detected before
it ended in order to use a smaller processing buffer[73].
When the signal is presented as x(n), n means the nth frame and N means the total frame shift
number or the length of the signal, the equations of different features are described below:
1. Amplitude-based features
The most common and easy-implemented features in the time domain are the mean value
and the peak value. The mean of signal values over the sample length. When µ is the mean








The peak value represents the maximum amplitude of a signal, it can achieve a rough sound
estimation or change detection. The peaks above a certain threshold can also be counted to
roughly present the volume of a signal. Peak values are very sensitive to random impulses
and become less promising for endpoint detection, which requires an averaging process.
2. Energy-based features
Energy has always been a key factor in endpoint detection. For the audio signals, E(n)






where L is window length of the processing window w[N-n].
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The root mean square (RMS) value is a simple measure of energy content for signal detection










The ZCR is the rate of sign-changes along a set of sample data, calculating how many times
the signal changes from negative to positive or conversely. It has been used widely in the
existing audio process, including speech recognition, audio information retrieval, and music
analysis, being a key and basic factor to identify percussive or continuous sounds in this way
[75].





|sgn(x[n])− sgn(x[n−1])|w[N −n] (3.4)
where
sgn[(n)] =
 = 1, x(n)≥ 0=−1, x(n)< 0




2L , 0 ≤ n ≤ L−1
= 0, otherwise
As a time-domain feature, the ZCR also presents signal characteristics in the frequency
domain and is used commonly to frequency or period measuring, especially for periodic
signals [76]. A theorem was introduced to show the relationship between the ZCR and
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Fourier Coefficients for signals in a limited range [77, 78]. The ZCR also contributes to
pitch detection alongside with Autocorrelation Function (ACF) for fundamental frequency
characteristic extraction, whereas the lack of its detecting accurateness for noisy signals and
harmonic signals has been mentioned [79].
Based on the zero-crossing detection, other zero-based features, such as the sign-turning
points, and the duration between zeros, have presented time-varying signals [80]. A coding
concept Time-Encoded Signal Processing and Recognition (TESPAR) was generated in 1999
[81] with the original data being divided into small segments by zero-crossings. It is coded
based on the duration and the wave shape between real zeros. It has been widely used in
specific simple and steady sound recognition technology. The CARCODE was developed for
real-time condition monitoring of a pressure control system on the basis of TESPAR with the
peak amplitude and the turning points involved [80].
The peak to peak period detection can also be used to extract fundamental frequency charac-
teristics. The direct time domain fundamental frequency estimation (DFE) [82] provides the
classification criterion with the adaptive peak to peak detection after a pre-processed spectral
shaping, which needs lower computation complexity and fits especially in a real-time sound
identification system.
4. Variation-based features
Variation-based features are common statistical time-domain feature extractions, and the
most widely-used variation-based feature is the variance. The variance of a signal is the
expected value of the squared deviation from its mean µ . For a random variable x[n], var is
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For further measurement of the rule how samples change, deviation of the variation is









Skewness is asymmetry in a statistical distribution by measuring the third order cumulative.








Kurtosis is in a similar way to skewness, which is another descriptor of the shape of the
probability distribution of a real-valued variable by measuring its fourth order cumulative.
kurtosis characterises the flatness of distribution and has been successfully applied in auto-
mated identification of respiratory sounds [83] and lung sounds [84]. Combined to ensemble
empirical mode decomposition, it can be used for sound segmentation and extraction in the








ACF and Cross-Correlation Function (CCF) have been proved to be comparatively robust in
pitch detection against noise. Correlation analysis is a common wave-analyse method in time
domain. Considering deterministic discrete-time signals x[n] and τ as the lag index number,





x(n) · x(n+ τ) (3.9)
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Average Magnitude Difference Function (AMDF) was introduced in 1974 as a variation of
ACF for pitch detection in speech recognition [86] and was usually weighted and combined
with ACF for advanced robust pitch detection [87]. In later researches, the falling trend
of AMDF is avoided to compose the high-resolution AMDF (HRAMDF) [88], the circular
AMDF (CAMDF) [89], the aligned AMDF [90] and the Extended AMDF Extended AMDF
(EAMDF) [91], which efficiently reduce detection errors and increase precision. The multi-
plication of ACF and AMDF in addition to a functional bandpass filter [92] are presented to
form a high-resolution pitch detection.
The original AMDF is defined as [86]:
D(τ) =
1




|x(n)− x(n+ τ)| (3.10)
Inspired by the concept of AMDF and mean absolute difference, which measures statistical
dispersion between two independent variables drawn from a probability distribution by
calculating the average absolute difference between them, this thesis introduces the short-
time Magnitude Difference (STMD). STMD measures the difference between two continuous








3.2.2 Frequency domain features
With the development of frequency-domain feature extraction, more sophisticated processing
technologies have been composed in decades. Frequency domain features can demonstrate
more detailed characteristics, whereas the calculation complexity may also increase especially
when the matrix is extended.
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There are various methods to extract frequency domain characteristics. The traditional fast
Fourier transform (FFT) uses periodic signals in the individual frequencies to present the
target signal, which shows an iconic insight and majorly contributes to transforming the time-
domain signals into its spectrum representation. The spectral features were less susceptible
to be affected by the changing environment noise.
Despite that the information of signals that varies with time will be lost, short-time Fourier
transform (STFT) is defined for improving time-frequency analysis. It usually presents
or plots the changing spectra against time and shows how the frequency characteristics
change linearly. Instantaneous frequency (IF) [93] obtained from the STFT spectrum with a
time-warping method and presents sharper harmonic structures of quasiperiodic signals.
Mel-frequency cepstrum is one of the most popular methods to pick up information from
sample data based on the linear cosine transform on a nonlinear Mel-frequency scale [94]. It
is a representation of the short-term power signal spectrum. According to existing references
and progress, frequency warping using Mel-frequency cepstral coefficients (MFCC) can allow
for better representation in audio compression. The MFCC incorporates biologically inspired
characteristics and relates to human auditory habits. In 2012, new research combining basic
acoustic parameters with MFCC in the segmentation of continuous speech among resonant
or obstruent environment [95], with some acoustic parameter could not balance robustness
to noise with intrinsic stability. With the compensation of channel distortion, MFCC is
proved to be one of those successful features in sound recognition. The original signal is
pre-emphasised, framed, added windows to give out information in the time domain, and then
leaves through the discrete Fourier transform its discrete spectrum [96]. The Gammatone
Frequency Cepstral Coefficients (GFCC) [97] also shows promising performance in sound
recognition.
Linear predictive coding (LPC) is an encoding method to represent the spectral envelope
from the target signal, which extracts information from the previous samples and determines
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a model of weighted coefficients to make a forward linear prediction [98]. To achieve better
extraction of acoustic parameters, the prediction error filter needs to be minimised and the
target LPC coefficients could be found by using Levinson-Durbin recursion [99]. The LPC is
usually used as an autoregressive process in audio processing for sound synthesis, speaker
verification, word recognition, and other sound detection technology. Line Spectral Pair
(LSP) frequencies are uncorrelated pairs derived from LPC, which have optimal theoretical
statistical properties for scalar and vector quantisation [100]. The LSP is proved to be more
explicit for sound classification and more robust in a noisy environment [101]. The Perceptual
Linear Predictive (PLP) [102] was described in 1989 as a development of linear predictive
analysis with engineering approximations of resolution curves and auditory relations to be
more consistent with the human hearing habit.
Conventionally delta and double-delta cepstral features are appended in current automatic
speech recognition (ASR) systems [103]. Delta-cepstral features were proposed to add dy-
namic information to existing static frequency features, which can also improve identification
accuracy. Delta cepstrum may improve characterisation quality of temporal dependencies to
the Hidden Markov Model (HMM) frames, which are assumed statistically independent.
On the basis of the spectral analysis, features with simple logic contribute to the transformed
signal. Spectrogram row self-correlation [104] is constructed on spatial frequency based on
the knowledge of image processing. The sub-band spectral selection method provides a more





pm log pm (3.12)
pm presents the corresponding probability density. N counts the quantity of frequency
components from FFT. The spectral entropy-based algorithm is related to the energy variation
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instead of the amount. As the spectral entropy is more reliable under non-stationary noises
like mechanical sounds than pure energy-based detection, but it shows deficiency under
babble noise and melodic noise, the entropy and energy are unusually combined to form a
more tolerable feature for detection under different noises [106].
In most cases, the change rate or difference of spectrum energy between sub-bands are
measured and analysed. The concept of discrimination information replaces the traditional
probability distribution with sub-band energy distribution improves system efficiency [107].
3.2.3 Wavelet transform
The STFT presents both time-domain and frequency-domain characteristics in terms of sine
and cosine functions, whereas the time interval is fixed [74]. The wavelet transform can
be understood as a complement to the conventional Fourier decomposition and suits better
to non-periodic broadband signals even with sinusoidal or impulse transients [108, 109].
Wavelet transform introduces the varied-sized processing window for providing detailed
decomposition and reconstruction information [110] with more capability for the extraction
of transient features. Wavelets are a widely-used statistical method and contribute in different
areas, including signal processing, data compression, DNA analysis, and speech recognition
[108].
It can be described as an oscillation which decays by the time [108] and expresses over
the entire spectrum of various scales. For the detection and analysis of abrupt changes, the
wavelet transform provides simultaneous localisation in both time-domain and frequency-
domain. Wavelets have an adaptable window that fits the signal automatically and provides












where a is the scale, b is the time, and ψ(t) is the mother wavelet.
Wavelet theory has been proved to be a promising method for non-stationary signal detection
with time-width being adapted to the signal frequency [108]. Recent research studies have
described wavelets as an established investigative technique for detection and quantification
with high flexibility and relatively efficient. Wavelet packet is an extension of wavelet
transform with the approximation coefficients while details in certain levels are decomposed
to create the binary tree [74].
3.2.4 Envelope analysis
The technology of envelope extraction has been developed in early radio communication. It
can be considered as the amplitude modulation, which is a simple signal presentation in the
time domain. Envelope analysis of breathing sounds is considered as a reliable method for
feature extraction in classification and recognition of respiratory diseases. It is associated
with the pathophysiological relevance of respiratory sound [111] and contributes to healthcare
science, such as heart sound analysis. The extraction of amplitude envelope from waveform
has also been introduced into cognitive studies of speech to detect and remove breath sounds.
With a Hilbert transform and a full-wave rectification [112], the gradient between adjacent
samples of the extracted envelope is measured and compared with the gradient thresholds of
the trained speeches.
The extraction of the envelope is a perceptual equivalent to the assessment of the amplitude
modulation and can be conceived to evaluate inhaling events. The differences between the
sound waveform and converted waveform can be used to extract information of the envelope.
The coefficient of variation of the envelope is defined as the quotient between the standard
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deviation and the mean of the envelope of a signal [113], which describes the information of
the envelope profiles and ascertains the differences between them. The envelope extraction
can be analytically performed by the non-linear Hilbert-Huang Transform as an improved
solution of the original Hilbert Transform, which may be affected by high-order harmonic
with high-frequency rough glitches in the extracted result. The result of envelope extraction
depends on the carrier frequency band, which remains unknown when the processing initially
occurs. The target signal in those frequencies should be the majority. Thus, the prior analysis
of the signal before filtering is necessary to improve the envelope extraction.
To extract envelope, the signal will be pre-processed with noisy and mute clips removed first.
All the local extrema of the target sample are identified in the next stage. The local maximum
and minimum are connected by the parabola parametric spline interpolation line to obtain
the upper and lower envelope. The mean line of the sample is defined by the median value
between the maxima and the minima. The difference between samples and the mean value
is the first component h(t), which should be defined as the demand of an Intrinsic Mode
Function (IMF). h(t) should be symmetric and distributes in both positive and negative areas
across the x-axis.
As the breathing sounds were measured to be from 100 Hz to 1200 Hz [111], only the IMF
with instantaneous frequency in this range will be retained. By extracting the envelope of an
instantaneous signal by Hilbert Transform, a result with only positive frequency can be used
to express the real part of the original sample.
A simple envelope detector can be constructed by diodes or a rectifier with a fed low-pass
filter [114]. After the absolute value of the real and imaginary parts of a complex signal was
summed, a first-order low-pass IIR filter can be used to build a signal envelope detection
scheme. With the feedback coefficient α , which is valued from 0 to 1, the envelope is
proportional to the instantaneous magnitude of the original complex signal [114]. Without
squaring calculations, the computational complexity of this envelope detector stays low and
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fits into the real-time processing, which has been introduced and developed for environment
estimation in this research.
3.2.5 Machine learning models
Distance-based segmentation [115] and model-based detection [116] are two main categories
of detection approaches. Compared to the model-decoding-based detection, distance-based
segmentation defines a distance measurement initially with an endpoint detection strategy
without the basic characteristics of input contents prior to the detection.
Machine learning algorithms calculate and define the prior sets at the data training stage
[117]. The knowledge of probabilistic mathematical models is introduced to approximate
the optimum of feature combinations. At the discrimination stage, the feature sequences
are extracted from target signals and compared with the defined threshold value. Machine
learning algorithms contribute to both audio processing and healthcare monitoring technology
[56].
With the simple algorithmic structure, clear performance and high recognition accuracy, the
Gaussian Mixture Model (GMM) [118] and the HMM [119] have been widely used in sound
recognition system in decades. Feature behaviour can be described by the relative weights
and the covariance parameters of the models [120].
The Support Vector Machine (SVM) builds mostly non-probabilistic binary linear classifiers
and separates different categories with large margins. To achieve a better data implementation,
the samples in higher dimensional feature spaces can be implicitly introduced only by using
an efficient kernel mapping [121]. The learning process for constructing an SVM is more
efficient than previous learning methods, which can provide a unique optimised solution
[122]. It has been a promising learning technology for classification and widely applied in
the developed learning systems with the ability of generalisation.
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Fuzzy modelling describes the signal characteristics based on fuzzy inference rules and
is applied to represent complex nonlinear relations of the system [123]. A fuzzy neural
network (FNN) can handle the uncertainty from data and has been successfully used in signal
processing and pattern classification [124].
The boosting technology combines different classifiers to construct a more accurate solution
[121] and solves the two-class classification problem efficiently. AdaBoost, which adapts to
weak hypotheses, has been the most widely used boosting algorithm [125] and showed good
performance in inhaler medication adherence detection of a pMDI for asthma [62].
More state-of-the-art deep learning models, including the Deep Neural Network (DNN),
Recurrent Neural Network (RNN) and i-vector methods [126], have contributed to sound
labelling. The clustering and identification technologies like the k-nearest neighbours’
algorithm and the Bayesian information criterion (BIC) agglomerative clustering [127], have
been highly mentioned and widely used in audio classification.
3.3 Feature selection
Both frequency domain features and time domain features are widely used in sound detection
and identification. Simple time domain features are more popular in event detection or
segmentation, and frequency domain features show an advance performance in speaker
characterisation or further audio extraction.
To select an optimal feature-set to detect and measure inhalation, a novel detecting method
aimed to employ fewer features to represent target inhalation with high discriminative
capability and reduced computational cost [128] was built in this research. Samples of
inhalation and exhalation were collected in the soundproof room and extracted on the PC-
based sound detecting system. The relative merits of feature candidates were analysed
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in terms of their performance on signal presentation, computational load, and memory
requirements.
3.3.1 The complexity of features
Computational complexity is one of the most prominent aspects of a processing algorithm
of mathematical functions, which can be very high and unbounded for a Fourier Transform
algorithm. A high-performance signal processor allows pipelining which dedicated for certain
time-critical functions, such as multiplication and the FFT. The complexity of computing
the DFT is O(n2). An FFT factorising the DFT matrix into a product of sparse and thus
reduces the complexity to O(n logn) of the fast implementation [129]. A wavelet transform
is based on FFT with similar or even higher computation complexity. For example, the
2D Haar discrete wavelet transform matrix of calculations is similar to the 2D Fast Fourier
Transform with a complexity of O(4N2log2N) [25], which is relatively high and fits more
in a high-performance processor, such as a PC or a mobile phone. The MFCC is also more
common to be developed on a high-performance processing system.
In the execution of feature extraction or other stages in signal processing, the computing
speed of the general processor may decelerate with depleting the battery, especially when the
exhaustive features are involved. Time domain features refer to the variation of amplitude
and show the fundamental acoustic characteristic. They are temporal directly measured or
estimated from the original signal with a simple calculation, such as the basic addition or
multiplication. The time-domain features, including the ZCR, the STMD, sound volume,
deviation, the STE, and the ACF, are simple for calculation with no exponentiation or FFT
operation.
An optimal feature selection approach for wearable monitoring systems was proposed and
embodied information regarding feature selection, relevance, and redundancy [130]. To opti-
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mise the power consumption of feature extraction, the research considered the computation
complexity of the selected features, including signal amplitude, deviation, median value,
and root mean square power among time-domain features, which clarified that the start to
end value was the most low-energy feature and the median value cost most power. It also
discussed how the energy was constrained to prevent feature-set from being accounted for
during motion recognition. The practical energy consumption experiment of the feature
extraction was estimated on a Texas Instruments (TI) MSP430 microcontroller.
To measure the deviation of a signal, the mean value of the processing window needs to
be calculated as the difference between samples and the mean value will be stored in the
system, which means the data in one window needs to be processed twice with extended
calculation time. To measure the ZCR, the STMD, and the STE, each sample only needs to
be processed once. The complexity to measure STMD is lower than STE, as the STE is based
on the multiplication of two neighbouring samples and the STMD is based on the difference
between two neighbouring samples. The STMD can be fulfilled by basic subtraction of bytes.
As only two neighbouring samples are taken into account for calculating the ZCR, the STMD,
and the STE, only two integers are needed, which takes only 2 bytes. Besides, counters for
summing up the integers during a full window are needed, which will be one byte for each
feature. For deviation, one more byte will be used to record the mean value. Overall, the
simple non-multiplicative features based on neighbouring samples can be calculated using 3
to 5 bytes, which saves the memory space massively.
For algorithm development, the memory requirement is also important for processing perfor-
mance and account for the computation time. For evaluating FFT algorithms and wavelet
extractions, a large memory space is needed for matrix calculation, especially for higher
order functions [26].
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3.3.2 Acoustic analysis of inhalation and environment
To select the optimal combination of features, the frequency and time domain characteristics
of inhaling and exhaling were extracted in the analysing stage of the research. The samples
clips of usage of inhalers were collected and recorded in a soundproof room.
With similar concepts like anechoic chambers, a soundproof room was insulated from exterior
sources of noise with thickened doors and designed to absorb reflections of either sound or
electromagnetic waves. To decline unwanted noise, such as the low-frequency noise from
electronic devices or fluorescent lamps, multiple methods like acoustic quieting, physical
barriers, noise mitigation, and noise control were introduced into the soundproof systems.
The participated soundproof room for this research was a Clinical Audiometric Equipment
Calibration Room with extreme ambient performance. The ambient sound pressure level was
lower than a leaf rustling and approximately no more than 10 dBA.
During the recording phase, the inhaler was empty without inhaling any substance. Only
the sound of air-flow had been recorded. No drug delivery, powder or propellant were
involved following the consideration of health and safety. The inhaling sound with powder
delivered from the recorded video has been considered, which has similar broadband acoustic
characteristics as the inhalation without powder. The sound volume of inhalation with powder
is higher as the powder may introduce more vibration and friction, which also indicates
higher energy and higher robustness for detection.
Fig. 3.1 demonstrates the waveform and spectrum of inhalations and exhalations on a cross-
platform audio editor called Audacity [131], showing the diagrammatic characteristic of the
signal in both the time domain and frequency domain. From the spectrum, the energy of
inhalation is spread evenly in the frequency domain, which shows that the inhalation is a
broadband sound with constant power spectral density from 450 Hz, sharing similarities with
the white noise. The associated condition to generate inhalation with a dry powder inhaler
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Fig. 3.1 The waveform and spectrum of inhalations and exhalations in a medicine administer-
ing
includes the airway friction or vibration of human throat, mouth, drug powder or inhaler itself,
which also excites resonances as the signal is broadband with multiple formants. Receiving
from multiple sound sources, the volume, and energy of inhalation is distributed over a wide
frequency range at a low energy level. In contrast, the exhaling events accompanied by
airflow noises are concentrated in lower frequency around 55Hz from the spectrum analysis.
Fig. 3.2 demonstrates the zoomed-in details of inhalation in the time domain, which shows
that the signal crosses the zero line frequency with a high ZCR.
The wide distribution of energy impedes accurate detection through conventional spectrum
analysis, which may fail to locate the peak or centre frequency of the signal. And the
periodicity of a broadband signal is hard to be measured accurately. Particularly, the detection
is more difficult in the presence of any sound source that shares a similarity with white noise,
such as the mechanical sound or other vibration noises. The friction between the inhaler and
any solid surface also incurs vibration noises. These other broadband sound sources are easy
to be confused with inhalation and be tagged incorrectly.
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Fig. 3.2 (a) The zoomed-in time-domain details of inhalation; (b) The start of an inhalation
in time domain; (c) The end of an inhalation in time-domain.
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Fig. 3.3 The spectrum of the background sound in the soundproof room
The background noises have been assessed during the recording stage. The spectrum of the
environmental sound is presented in Fig. 3.3. Due to the lack of volume of inhalation, the
best samples that recorded inside the normal environment were still in inadequate quality,
with low SNR from 12 dB to 18 dB, increasing the difficulty of detection. The noise source
might be any electronic equipment in the experimental surrounding, which operated a low-
volume continuous sound. The sound samples recorded inside the soundproof room provided
better performance with lower noise, down to -66 decibels relative to full scale (dBFS) of
sound pressure level (SPL) as the RMS value. The measured SNR of the samples from the
soundproof room was 40 dB, which was also negligible for adding an exterior 10 to 20 dB
artificial noise.
The frequency response of the selected microphone INMP441 is from 60 Hz to 15 kHz
[132] and ideally, low-frequency noise will be not be recorded. Notwithstanding, from the
spectrum in Fig. 3.4 of a recorded inhalation clip from the soundproof room, it still exhibited
a significant low-frequency noise from vibration. The frequency of the artefact noise was
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Fig. 3.4 The spectrum of inhalation and the low-frequency vibration artefact
low from 1 Hz to 13 Hz, but it stays high in energy. The low-frequency error accounted for
existing single cycle deviations seen in sound traces under the possibility that the MEMS
microphone device was controlled to keep the sensing element floating, which is due to an
artefact from the control circuitry of the MEMS microphone. The low-frequency noises
could theoretically be filtered out by a high pass filter.
3.3.3 The feature extraction
In the feature extraction stage, 200 inhalations have been recorded by a MEMS microphone
and transmitted to a PC. The performance of feature candidates, including the conventional
low-complexity time-domain features, the STE and ZCR, was extracted using a developed
MATLAB system. The features without an obvious change of value around the start points
and endpoints of inhalation were considered irrelevant.
Fig. 3.5 illustrates the STE, the ZCR, and the STMD with the original waveform of the
audio clip in Fig. 3.1, which contains 2 inhalations and an exhalation. It is clarified that
inhalation has high ZCR, low energy, and high STMD, whereas exhalation has high STMD,
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Fig. 3.5 The STE, ZCR, and STMD of inhalation
high energy, and low ZCR. According to the result, the STE will be affected by high-volume
low-frequency noise, such as the exhalation sound. The STMD shows higher sensitivity to
inhalation than the STE against low-frequency noises.
Another example is presented in Fig. 3.6. The audio clip was recorded in the soundproof
room with 25-30 dB SNR. The 15-second audio file, which contained 4 clips of inhalation, 2
clips of exhalation, a whistling sound and a clip of vibration noise, was analysed to instantiate
the identification system based on individual features.
The measured value of these features is demonstrated in Table 3.1. It is presented that
the ZCR of exhalation is much lower than the inhalation while its energy is higher. The
high-frequency whistling has high ZCR and low energy. The ZCR of vibration noise is low
and its STE is similar to the inhalation, whereas its STMD value is lower and can be easily
distinguished from the target sound. With introducing the STMD, the effect of friction or
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Fig. 3.6 An audio clip with inhalation and exhalation





(J) (peak) Length (s)
Clip 1 whistling 0.002 - 0.005 0.16 - 0.42 1.2 - 1.8 0.83
Clip 2 inhalation 0.016 - 0.032 0.52 - 0.72 3.6 - 8.6 1.02
Clip 3 exhalation 0.06 - 0.74 0.028 - 0.16 1.5 - 6.7 1.19
Clip 4 inhalation 0.021 - 0.040 0.58 - 0.67 5.1 - 8.9 0.91
Clip 5 exhalation 0.047 - 0.42 0.024 - 0.084 0.93 - 2.5 1.05
Clip 6 inhalation 0.015 - 0.023 0.58 - 0.75 3.3 - 7.3 1.86
Clip 7 vibration 0.008 - 0.048 0.012 - 0.14 0.32 - 0.71 1.62
Clip 8 inhalation 0.01 - 0.032 0.59 - 0.77 2.8 - 8.7 1.05
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vibration can be reduced, which commonly occurs during the medicine administering with
impacts or scratches between a hard surface and the sound sensor.
The performance of various feature combinations is depicted with the concepts of True
Positive (TP), False Negative (FN), and False Positive (FP) [60] for further evaluation. The
TP presents the sensitivity of the indication system, clarifying whether inhalation has been
correctly detected or neglected. The NP means the number of neglected true inhalation. The
FP gauges the probability of misdetection, showing how many non-inhalations have been
falsely tagged as inhalation. In other words, the FP presents the specificity of indication.















Then, the accuracy of the system can be defined as:
Accuracy = Sensitivity×Speci f icity (3.17)
In Table 3.2, the system was built on different feature sets, the size of the feature set is from 1
to a combination of 5. 200 recorded inhalations from soundproof room have been demarcated
manually by the experimenters. The features of the cut segments have been measured, and
the value has been analysed using a normal Simulated Annealing (SA) function, which was
developed in MATLAB. The threshold value of each feature was initially defined as the
minimum of the feature array. Then the minimum value of each feature of each inhalation
has been compared and analysed. The average minimum of the feature of the inhalations
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has been defined as the threshold. For example, the average minimum of the ZCR of 200
inhalations was defined as 0.48.
During the feature selection stage, 4 simple calculated features (the ZCR, the STMD, the STE,
and the ACF) and 1 measured feature (the PL) had been tested and their performance had
been compared initially. The performance and accuracy were calculated based on the same
200 inhalations. Starting from single feature solutions, the ZCR showed 64.8% accuracy and
selected as the optimal feature. The result of segmentation contains very short clips from
several milliseconds to hundreds of milliseconds, which might be a very short sudden noise.
The measured feature PL was introduced into the system. As the PL can only be presented
when a feature has been calculated and a segment has been demarcated with a measured
duration length, it can only be added with another existing feature. The threshold value of
PL was defined as 0.6 seconds. After the PL was considered, the short noises or inhalation
could be eliminated. The sensitivity dropped to 97.5% and the specificity increased rapidly
to 84.6%. The highest accuracy of the 2-feature solution was the ZCR with the PL, with
82.5% as the accuracy.
With 3 candidates, there were 6 different combinations of features. The combination of the
ZCR, the STMD, and the PL presented the best performance with high sensitivity (97.5%),
high specificity (98.5%), and accuracy of 96%. The combination of 4 features presented
88.7% accuracy as the best performance. And with all 5 feature, the accuracy was 70.9%.
To estimate the stability of different combination of features, the 200 samples were tested
under diverse noise levels from quiet to noisy, which was quantised as SNR. The natural noise
that came from unwanted sources with sundry acoustic characteristics might exist on every
occasion of daily life. Loud music, speeches, mechanical noises, traffic noises or weather
sounds might add redundant information into inhalation and influence the identification. The
result of the optimal feature set is presented in Figure 3.7.
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Table 3.2 The accuracy against number of features
Number Features Sensitivity Specificity Accuracy
1
ZCR 99.0% 65.5% 64.8%
STMD 98.5% 63.8% 62.8%
STE 92.5% 54.3% 50.2%
ACF 82% 56.6% 46.4%
2
ZCR + PL 97.5% 84.6% 82.5%
STMD + PL 98% 73.2% 71.3%
STE + PL 92% 71.3% 65.6%
ACF + PL 78% 75.6% 59%
3
ZCR + STMD + PL 97.5% 98.5% 96%
ZCR + STE + PL 91.5% 88.7% 80.4%
STMD + STE + PL 91% 75.8% 69%
ZCR + ACF + PL 75% 86.2% 66.6%
STMD + ACF + PL 74% 84.2% 62.3%
STE + ACF + PL 73% 82.5% 60.2%
4
ZCR + STMD + STE + PL 90% 98.5% 88.7%
ZCR + STMD + ACF + PL 70.5% 98.5% 69.4%
ZCR + STE + ACF + PL 68% 90.1% 61.3%
STE + STMD + ACF + PL 69% 87.8% 60.6%
5 ZCR + STMD + STE + ACF + PL 72% 99% 71.3%
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Fig. 3.7 The accuracy against feature number in different noise levels
Based on the result, the performance of feature-set is not linearly proportional to the growth
of involved feature number. With a single feature, which was selected from ZCR, the STE, or
other conventional features, the boundary of inhalation was demarcated roughly by detecting
feature variation, especially in a quiet environment. However, the performance deteriorated
when the noise level increased. The sensitivity of the single-feature solution was high as
any sound with extracted value in the threshold range was detected, including inhalation and
non-inhalation, and thus lead to low specificity. The ZCR was the optimal feature with a high
sensitivity to inhalation and the accuracy of 64.8%.
When 2 features were involved in the detecting algorithm, the sensitivity dropped as there
were two threshold ranges from different features, whereas the specificity was significantly
improved. The accuracy of a combination of ZCR and STMD was 88.7% and it reached 96%
when the pulse length was introduced to avoid interfere from short broadband noises like
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the sound of friction between the inhaler and a hard surface. The sensitivity of the optimal
3-feature solution was 97.5% while the specificity was improved to 98.5%.
The sensitivity of the best 4-feature solution of the ZCR, STE, pulse length, and STMD
continued to decline to 90% with the accuracy of 98.5%. With more limitations from added
features, the sensitivity of the system decreased as inhalation might be too soft or too short to
fulfil the threshold requirements. Only 72% of the inhalations were correctly detected by the
5-feature solution, whereas the detected segments were 99% correct inhalation. It was also
clarified that a system based on more features was more robust under noisy environment. In
Section 5.7, a LED feedback system which can recognise the noisy environment has been
introduced.
From the result, it was presented that the accuracy of the system would not increase contin-
uously when more features were involved. A multi-feature solution showed an improved
performance from the single-feature solution, especially when the features were orthogonal
and described the original signal from different aspects. The accuracy stayed stable or even
dropped when the number of the feature was above 3 as the added features might share
similarity with old features and the orthogonality between features declines. According
to the accuracy, it is indicated that the STE and the STMD show high correlation with
similar performance, which will be discussed in the next section. An optimal feature set may
consist of 3 or 4 features to achieve high accuracy and low computational complexity. The
combination of the ZCR, pulse length, and the STMD was selected for inhalation recognition.
3.3.4 The relevance and redundancy of features
The relevance and redundancy of features were analysed at this stage. Relevance analysis is a
pre-process of feature selection, which can eliminate irrelevant features of sound recognition
and avoid the unnecessary calculation cycles [130]. With a high correlation between these
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two features, repeated or similar characteristics will be defined as redundant information.
Finding the optimal feature set can reduce the measure-complexity, storage requirements,
and training or utilisation times [133]. The feature reduction can also avoid over-fitting, resist
noise, defy the curse of dimensionality, and strengthen prediction performance [133].
In statistics, correlation, dependence or association is used to measure the relationship
between two random variables or bivariate data. The Spearman correlation and Kendall’s tau,
which belong to rank correlation coefficients, suits ordinal variables. Spearman correlation
assesses monotonic relationships while Pearson correlation assesses linear relationships.
Cramér’s V is based on the Pearson chi-squared statistic and available for nominal variables
[134].
The symmetric uncertainty is a measure of correlation between two discrete random variables
[130], which is presented as normalised information gain and suitable for non-linear features.
When H(X) and H(Y) represent the entropy of X and Y, their symmetric uncertainty is given
by:




where I(X, Y) denotes the information gain between X and Y, which is defined as:
I(X ,Y ) = H(X)−H(X |Y ) (3.19)
Another common simple measure of dependence between two quantities is the Pearson
correlation coefficient, which is also called the product moment correlation coefficient. It
simply referred to the correlation coefficient and can be obtained by dividing the covariance
of two variables by the product of their standard deviations [135]. Pearson Correlation can
be used to detect linear dependencies between two features, which may also be improved to
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fit a non-linear function [136]. Pearson correlations are only suitable for metric variables,
including dichotomous variables, and the correlation matrix is symmetric.
Pearson correlation coefficients are easy to be calculated, and the features are metric as they
are measured based on fix-sized processing window. When σX is the standard deviation of X






where cov(X,Y) is the covariance. The covariance between two random variables X and Y is
defined as the expected product of deviations from individual expected values:
ρXY = E[(X −E[X ])(Y −E[Y ])] = E[XY ]−E[X ]E[Y ]. (3.21)
where E[X] is the expected value of X and represents the average value of X, and E (Y)
represents the average value of Y. E[XY] represents the average value of the product of the
corresponding elements from X and Y.
To analyse the orthogonality between the ZCR, the STMD, and the widely-used STE, 25
multi-environment sets are estimated in Fig 3.8. Each set contained 5 audio clips under
the same recording environment. The audio clips of various background environments
contained natural noises like random music (with the periodic percussion/bass sound and
the singing voice tone), mechanical sound (broadband, loud and continuous), speeches
(aperiodic, the voice spectrum of different speakers varies massively), whistling (high-
frequency, continuous), and other common noises. The sound clips were recorded by the
target microphone through the built prototype system. The Pearson Correlation estimation
was analysed using MATLAB.
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0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
ZCR and STE 0 32% 20% 32% 8% 4% 0 4% 0 0 0
STMD and ZCR 0 0 4% 20% 36% 12% 12% 8% 4% 4% 0

























ZCR and STE STMD and ZCR STE and STMD
Fig. 3.8 The Pearson Correlation between feature pairs of multi-environment clips
The STE and STMD both partly presented sound volume and they were highly related to
each other as the Pearson Correlation coefficients were from 0.78 to 0.96. The separation
between the ZCR and STE was high and the Pearson Correlation coefficients were 0.02. The
coefficients between the ZCR and the STMD widely distributed from 0.2 to 0.8, as they
both described how two neighbouring sample differentiated whereas the STMD was more
sensitive to the peaks of the waveform.
25 inhalations were estimated in the subsequent test and presented in Fig 3.9. Each set
contained 3 inhalations, 3 exhalations and silent clips in between. The correlation coefficients
between the STMD and the STE were high and stayed above 0.8. The coefficients of STMD
and the ZCR were more concentrated and mostly from 0.2 to 0.4, which was relatively low.
The difference between two continuous samples was calculated and summed in a fixed-sized
window. From the correlation analysis and the performance estimation, the STE and the ZCR
are the most orthogonal pair whereas the ZCR and the STMD have the highest capability





0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
ZCR and STE 0 32% 44% 24% 0 0 0 0 0 0 0
STMD and ZCR 0 0 8% 56% 28% 8% 0 0 0 0 0


























ZCR and STE STMD and ZCR STE and STMD
Fig. 3.9 The Pearson Correlation between feature pairs of 25 inhalations
for inhalation identification. The conventional STE shows inferior performance in boundary
detection of inhalation in a noisy environment. Besides, the duration length of a single
inhalation is considered as the third element to get rid of the effects of short continuous
broadband signals.
As a conclusion of analysing performance and relevance, the combination of STMD and
ZCR lead to sufficient specificity and sensitivity of inhalation detection theoretically on the
basis of an effective noise reduction alongside with high discrepancy between them. As the
STMD shows a high correlation with the STE with better performance, it is selected with
the ZCR. Comparing to the STE, the STMD has higher accuracy against frequent noises
in inhalation, such as the air-flow sound. Without data multiplication, its computational
complexity is lower than the STE and fits more for a limited-sized processor.
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3.3.5 The performance of selected features
To evaluate the performance of the selected features, a system for inhalation identification
and segmentation was developed using MATLAB.
The processing window was sized as the quotient of the sampling frequency divided by 31.25,
which was 179 in the research. The samples with the STMD that above threshold ratio,
which was defined in the previous training session, were initially considered as a segment of
inhalation. The ZCR of it was measured afterwards to locate the start points and endpoints of
inhalations more precisely.
In this system, the STMD has been used to define the start points and endpoints of inhalation
initially. When a segment is detected, the ZCR of it will be measured. Only the segments
with ZCR that higher than the threshold value will be saved. The logic of this methodology
is been presented in Table 3.3.
Fig. 3.10 The inhalation detection using MATLAB based on the STMD and the ZCR
Both the STMD and the ZCR contributed to the detection successively. Fig. 3.10 shows
the result of the inhalation detection MATLAB. The boundaries of detected inhalation are
demarcated by coloured vertical lines, where the magenta lines represent the start points and
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Table 3.3 The methodology of inhalation detection using Matlab
//ZCR and STMD has been calculated and stored
//Initial segmentation based on STMD
//STMDTh is the defined threshold, which is 0.1 of the max of STMD










//Further segmentation based on the ZCR
//ZCRTh is the defined threshold, which is 0.7 of the max of ZCR
for i=1:length(inhalation),
head = inhalation(i).begin;










the green lines represent the endpoints of segments. According to the result, clip 2, 4, 6, 8
were correctly marked as inhalation and the other sound clips were neglected.
To detect exhalation, the threshold value of the ZCR is set to be 0.15 of the maximum of the
ZCR array, and only the segments with ZCR that lower than the threshold will be defined
as exhalation and stored. The exhalation detecting system is based on the same logic as the
inhalation detection.
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Fig. 3.11 The exhalation detection using MATLAB based on the STMD and the ZCR
Fig. 3.11 shows the simulated detection of exhalation on MATLAB. The segments of exha-
lation have been correctly detected and demarcated by the red vertical lines. According to
the result, clip 3 and 5 were correctly marked as exhalation and the other sound clips were
neglected.
The duration difference analysis of detection based on the weighted ZCR and STMD against
different noise levels presents its performance and focuses on the length difference between
the measured duration and the reference duration. The measured duration is the result of the
developed MATLAB system. The reference duration was recorded by another microphone,
analysed in Audacity and demarcated by a trained experimenter based on human-ear ability
and the waveform. The duration difference was calculated by reference duration minus
measured duration from on-chip storage. It can be defined as:
DurationDi f f erence = Re f erenceDuration−MeasuredDuration (3.22)
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Fig. 3.12 Duration difference against noise levels
From existing labelling of usages and acquired soundproof room data, the start and end
positions of one inhalation were converted to suitable formats to plot the duration error versus
SNR.
Fig. 3.12 shows how duration difference increases with noise level growing. The added
noise was white noise, which had high ZCR and shared similarities with inhaling sound thus
affected the recognising system. A sample set of 30 inhalations has been analysed to show
the distribution of duration errors. The white noises were added manually through MATLAB
in addition to the original noise from the recording system.
When SNR was higher than 30 dB, the maximal length of duration difference was 103
milliseconds and the average value was 46 milliseconds. When SNR dropped to 25 dB, the
duration difference was up to 163 ms while the average difference kept low at 58.5 ms. The
performance stayed acceptable when the SNR was lower than 15 dB, at which level the
average duration difference increased to 400 milliseconds.
3.4 Summary 69
The duration difference analysis focused on the detected inhalation and the length difference
between measured value and the true one, whereas the redundant detected rate calculated
how many sound clips were labelled wrongly as the target sound when they were actually
noise clips or other similar types of sound. When the SNR was higher than 20 dB, there
was no incorrect detection among more than 200 wave files. However, 23% of detected
inhalations were incorrect when SNR dropped to 15 dB. The FP rate increased to 140% with
13 dB SNR and reached 250% under 10 dB SNR.
With further analysis, the redundant detected sounds were mainly short clips which were not
in normal inhalation length. With ruling out small clips which were shorter than a defined
duration threshold value, the rate was declined and stayed stable with no incorrect detection
in 15 dB SNR, 24% in 13 dB and 67% in 10 dB, respectively. The threshold ratio was
later trained and adjusted based on the SA system. The duration difference was declined by
approximately 45% from the previous version, and the redundant rate was also cut down to
half.
Frequency-domain features were not chosen for being energy-hungry and slow to be cal-
culated for a small-size processing RAM. Considering the relatively limited information
available to present, frequency domain features are not showing advantages for recognising
the inherently broadband signals. The selection approach is aimed to pick out most orthogo-
nal pairs which letting simple features present more information when they matched together.
The insignificant characteristic in the frequency domain may lead to the futility of studying
spectrum or any spectral features of inhalation.
3.4 Summary
The technologies and methodologies of sound recognition in Healthcare device in an attempt
to improve adherence monitoring has been discussed and evaluated. Acoustic features have
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been compared in terms of performance and computational complexity. Compared to the
frequency-domain features and wavelets, the significant advances of time-domain features
include faster calculation and lower requirement of calculating RAM space. Due to the
broadband characteristic of respiratory sound in the frequency domain with low-STE in
time-domain, and the requirements to build a fast-react real-time system, it seems more
sensible to select the applicable simple time-domain features. After the analysis of various
feature-set, the combination of three features, including the ZCR, the STMD, and the PL,
has been selected for the real-time processing with a small-scale electronic system. Thus
method gives speedier calculation and processing than the conventional acoustic analysis.
The storing system and transmission system are needed after signal processing, which will
be discussed in the next chapter.
Chapter 4
Data Storage and Transmission
In this chapter, an advanced approach based on NFC technology has been considered
and developed for data storing and transmission. The duration of detection is saved as a
highly-compressed format with real-time stamping. With a new presented coding method,
the adherence of a full long-term treatment can be stored as small size data to fit the limited
storage.
4.1 The data transmission
Once the data of inhalation has been written into the system, the stored data can be extracted
and transmitted from the memory of the constructed prototype to a terminal at any time. For
the fingertip-sized device, the conventional communication modules, such as the global sys-
tem for mobile (GSM) communication, ZigBee, WiFi, and ANT+ are relatively cumbersome
with the considerable higher financial cost [137].
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4.1.1 The BLE and NFC technology
The BLE is a new version from basic Bluetooth for short burst data transmission [138]
with reduced power consumption, which firstly appeared on the market as Bluetooth v4.0.
Comparing to Bluetooth, the wireless BLE has shorter setup time [139] from around 100 ms
of the basic Bluetooth to a few milliseconds. It also shows an advantage of lower financial
cost, ultra-low peak, average and idle/sleep mode power consumption [140]. The device
stays in the sleep mode before getting activated and is enabled to run for months or even
years on limited coin-cell batteries. It has been widely used in mobile phones, wearables,
healthcare, sports, and other areas. Although it has limited ability to handle a large amount
of data, it is enough for this research as the inhalation only takes bytes for transmission.
NFC is a short-range contactless communication technology, which detects and enables
communication in close proximity [141]. A limited amount of data can be transferred
when there are a few centimetres between the devices. It operates within the unlicensed
radio frequency industrial, scientific and medical (ISM) band of 13.56 MHz [142] and
employs electromagnetic induction between loop antennas. The supported data rates of
NFC technology are 106, 212 and 424 kbit/s [142]. Evolved from established supported
radio-frequency identification (RFID) standards, including ISO/IEC 14443 and FeliCa [143],
the NFC protocols cover data exchange formats. It allows enabled devices, which are usually
smartphones, communicate with other devices containing an NFC tag [144]. NFC has been
established in electronic devices and been widely used for contactless payment systems [144].
Most Android devices offer full access to their NFC chips, whereas it is still limited to be
used for an Apple mobile device as Apple does not offer access to NFC chips for data and
information security [141].
The NFC and Bluetooth share similarities as they are both been widely used in mobile phones
and provide short-range communication. Comparing to other conventional technologies, the
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Table 4.1 Table comparison between BLE and NFC
Category BLE NFC
Price
Around £5 (from £2 to £20) Around £0.2 (from ££0.1 to £2)
Example: CC2540F128RHAT Example: M24SR02-YDW6T/2
£1.968 (for 1000+) [145] £0.2556 (for 1000+) [146]
Size
Around 6 × 6 × 1 (mm) Around 2 × 2 × 0.5 (mm)
Example: CC2540F128RHAT Example: MN63Y1213
Power
<15 mA (read and transmit)
<15mA (read)
Consumption Can be batteryless
RF frequency 2.4 GHz 13.56 MHz
Adaptability Most mobiles Most mobiles expect Apple




(Wireless personal area network)
Setup Time < 0.006 s < 0.1 s
Range ≈50 m < 20 cm
chips of the NFC and Bluetooth communication are usually built in a smaller package and
lighter in weight. Bluetooth and NFC have their own advantages and disadvantages. The
differences between the parameters are presented in Table 4.1.
According to Table 4.1, NFC operates at slower speeds with a much shorter range comparing
to BLE. On the other hand, it consumes less power and needs no pairing before transmission
[147]. The setup time of the standard Bluetooth is a few seconds (usually around 6 seconds),
whereas the communication of NFC can be established automatically in less than 0.1 seconds
and no manual configuration for identification is needed. However, the BLE can set up within
6 milliseconds, which is one of its well-known advantages.
The maximum working distance of NFC is approximately 20 cm, and its communication
is likely to be limited to 4 cm [147]. Comparing to BLE whose working distance can be
50 metres, the range of NFC is shorter but is also capable to prevent unwanted interception
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and interference caused by other devices. The close proximity makes NFC more suitable
for crowded occasions, avoiding correlated signals from other users. The maximum data
transfer rate of NFC (424 kbit/s) is slower than that of Bluetooth v2.1 (2.1 Mbit/s) and BLE
(1 Mbit/s). The power consumption of both BLE and NFC is comparatively low.
The BLE or other aforementioned technologies require the device to be powered for data
transmission, whereas NFC can be self-powered from the RF signal thus can recover data
even when the battery is discharged. There are two working modes of NFC, the passive mode
and the active mode. Typically, both the initiator device and the target device need to be
powered in the active mode as they generate their own fields. The target device in the passive
mode, on the contrary, answers by modulating the existing initiator-provided electromagnetic
carrier field and draws operating power from it. The target device works as a transponder
and achieves batteryless transmission [148]. The extra power needed by the passive tag of
NFC can only be supplied during the reading stage.
An NFC tag is usually small in size and inexpensive to deploy, whereas the configuration
and administration system, such as the reader/writer, can be bulky [142]. For a long-period
treatment, the reader will be kept in the clinics or pharmacies and used by clinicians or
clinical staffs for data transmission.
4.1.2 The NFC chip and the data reader
The MN63Y1213 [149] is a large-scale integration (LSI) for RFID, which weights 76 mg
in a 2.00 mm x 2.00 mm x 0.37 mm package and fits in lightweight small-scale devices.
The detected data can be recorded into the built-in 4-Kbit FeRAM non-volatile memory
speedily with low power consumption. The Radio Frequency (RF) interface of MN63Y1213
is constructed with the 13.56 MHz contactless IC card standards. The communication
modes include the conventional RF mode, serial mode, and tunnel mode [149], which allows
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transmission between reader/writer and the host central processing unit (CPU). However,
only the RF communication mode allows batteryless operation by getting supplied from the
antenna whereas the other two modes require power supplied to the voltage pin.
The firmware for data acquisition is hosted on the microcontroller through an NFC/RFID
contactless reader and writer SCM SCL011 [150], which is shown in Fig. 4.1. The matched
antenna coil is winding around the inhaler. The extended ring-shape antenna has been
designed to fit the cylindrical shape of the inhaler.
Fig. 4.1 The NFC reader with the extended ring-shaped antenna
Instead of mobile phone applications, a windows C# application was developed on Microsoft
Visual Studio 2013 for data-reading. With the same application, the information of patients,
such as the patient ID, the real-time clock (RTC) start time, and the storing formats, can be
written into the microcontroller and the memory of the NFC tag. The setup stage needs to be
completed before treatment and the data of adherence will be collected during the treatment.
The inhaler needs to be brought to the clinics or pharmacies when the treatment ends, and
the data will be downloaded to a terminal, which is a PC in this research. The interface of
the application is designed to be simple and easy to be used.
The interface of the downloaded result is presented in Fig. 4.2. The stored data can be
downloaded through the application with a simple evaluation presented. When the duration
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Fig. 4.2 Exported result from the NFC chip presented on the PC application
is shorter than 0.8 seconds, it will be demonstrated as ’no inhalation’. With duration from
0.8 seconds to 3 seconds, the inhalation is tagged as ’short inhalation. ’Long inhalation’ is
considered to be longer than 3 seconds. Any unexpected data will be ’indeterminate’. The




To achieve a data analysis, the data of inhalation should be stored safely in the device before
data transmission. To avoid information loss due to an unstable power supply or other faulty
factors, a non-volatile memory chip is required essentially for the system.
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In the existing adherence monitoring studies of CF, the raw audio files were saved directly
to memory accessories [60]. The formats of audio coding include the uncompressed audio
formats, such as the Waveform audio file format (WAV), and compressed audio formats, such
as the lossless compressed Free Lossless Audio Codec (FLAC) and the lossy compressed
MP3 [151]. The size of audio files is decided by the compressing method, the sampling rate,
and the bit rate. The size of a WAV file of 1 minute is usually several megabytes, and it will
also take hundreds of kilobytes for a compressed form like MP3.
The commonly-used non-volatile electronic data storage include electrically erasable pro-
grammable read-only memory (EEPROM) [152], FeRAM, resistive random-access memory
(ReRAM), erasable programmable read-only memory (EPROM), and other types of storage.
The EEPROM has been widely integrated into microcontrollers or other electronic devices
allowing individual bytes in EEPROMs to be programmed and erased. The common size of
an EEPROM is from 4 Kbit to 1 Mbit, which can store a relatively small amount of data.
As saving raw audio requires larger storage, large-capacity memory cards were introduced
in the research studies. SD cards have been commonly used [23] and size of storage can be
modified by changing memory cards in this way. Notwithstanding the big amount of raw data
that a single SD card can store, it consumes more power. A flash memory chip requires power
for reading and writing data and long-period storing, and the power consumption of memory
is related to the type and size of storage. Besides, the SD cards are considerable bulky for the
target inhalation monitoring system even with a Micro SD card, which is normally sized at
15 mm × 11 mm × 1 mm. The price of a Micro SD is also relatively high.
To achieve non-volatility and avoid potential data loss due to the erratic power supply, a
new non-volatile memory, FeRAM, has been used in this research. the FeRAM has a large
maximum read/write endurance of static random access memory (SRAM) and high stability
and reliability of flash [153]. With higher flexibility, it also requires less power consumption
and less time to be written in [154]. To shrink the size of the developed device, with no extra
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storing component has been added into the system, the accessory FeRAM of NFC chip is
used to store data.
A novel highly-compressed storing method is provided in this work. In contrast of the
existing methods which store raw audio files, the important information of adherence for
monthly usage, including the duration length of each inhalation and the date and time of
occurrence, will be stored using only a few hundred bytes of NVRAM. It is considerable
energy and cost efficient over many of the other memory intensive approaches.
4.2.2 The highly-compressed format of inhalation duration
With high writing speed, the 4-Kbit built-in FeRAM for RFID consists of 32 blocks where 5
among them are for system area [149]. The rest 27 blocks are available for data storage. Each
block contains 16 bytes. The date and time of setting, the user ID number, system encryption
key and authentication key for transmission are written through the PC application earlier
than the inhalation detection. To store the data of adherence for a full treatment, several
solutions have been developed to fit in the 432-byte (16 × 27) memory.
The original 16-bit inhalation length
The uncompressed duration data of a single event of inhalation are unsigned 16-bit integers
from 0 to 65,535. The pulse length is calculated by counting processed raw samples between
the start point and the end point of a detected event.
When Ns is the counted number of detected samples, and the sampling rate SPS, which
equals 5578, means the number of processed sample in a second, the duration length DL is






In this manner, each number represents 1 ms and the duration of inhalation is ranged from
0 to 65,535 seconds. However, a regular inhalation usually takes from 1 to 10 seconds,
depending on individuals. In a later initial user test, 115 inhalations from 15 different
volunteers were collected. A temperature sensor and a reference microphone have been
used for duration measurement. The histogram of inhalation duration collected from 15
participants is indicated in Fig. 4.3, which presents that the measured duration of inhalation
distributes from 1.5 to 8 seconds.
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Fig. 4.3 The duration distribution of collected 115 inhalations from 15 participants
From the histogram, it is clarified that inhalation distributes mostly (93%) from 2 to 6
seconds. As the value of the stored 16-bit inhalation data has a wider range than needed,
highly-compressed coding methods can be introduced into the storing system to massively
shrink the data size. An 8-bit compression and a 4-bit compression of inhalation have been
developed with different resolutions.
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8-bit coded output with 12-bits range and 5-bit resolution
An unsigned 8-bit integer is coded to present the original 16-bit integer of duration length
with a 5-bit resolution. The first 5 bits of the coded number is a right-shifted value of the
original data, and the rest 3 bits counts how many bits have been shifted. With this developed
coding method, the number of bits required to describe the duration length of each inhaling
event has been reduced.
When v presents the samples and n counts the shifted bits, the logic is presented as:
Table 4.2 The code logic of bit shifting
if (v < 128) return v; //small value
while(v>255) n++; v»=1; //right shift
if (n>7) return 0xffff; //overflow maximum value of a 3-bit integer n
return (v & 0xf8) | n; //v is stored in the first 5 bits, n is stored in the last 3 bits
In the decoding stage on the PC application, the duration is calculated as (v&0x f 8)×2n if
v is not less than 128. Otherwise, it equals to its original value. A value table is presented
in Table 4.3. The error in millisecond presents the possible difference between the original
value and the coded number.
When inhalation does not exceed 8 seconds, the resolution is limited to 32-bit following the
above coding method, which equals only 0.032 seconds. Comparing to a duration of several
seconds, a tolerance of 0.032 seconds is negligible for the following adherence analysis.
The improved 8-bit coded output
The 8-bit coded output with 12-bits range and 5-bit resolution has been presented before
and used in the preparation tests and the later user testing experiments with volunteers. This
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Table 4.3 The presented coding methods
Inhalation v n Coded Range Error (Millisecond)
0-127 v 0 0-127 1
128-255 v 0 128-248 1 - 8
256-511 v»1 1 256-496 2 - 16
512-1023 v»2 2 512-992 4 - 32
1024-2047 v»3 3 1024-1984 8 - 63
2048-4095 v»4 4 2048-3968 16 - 127
4096-8191 v»5 5 4096-7936 32 - 255
8192-16383 v»6 6 8192-15872 64 - 511
16384-32767 v»7 7 16384-31744 128 - 1023
32768-65535 0xffff 0 65535 0 - 32767
method transforms every number with the 16-bit range to a corresponding 8-bit number,
which may avoid the data loss due to a failed detection without an ending sign. However,
according to the measured in Fig. 4.3, the inhalation for a human is normally limited in 10
seconds.
An improved 8-bit coded output cuts 8 bits directly from the original 16-bit inhalation,
discarding the LSBs. The methodology, the value table, the coded range and the increment
unit are presented in Table 4.4. The error in millisecond presents the fixed difference between
the original value and the coded number.
After the data collecting stage from user testing experiments, the duration length is considered
not as long as a value that exceeded 10 seconds. Comparing to the first 8-bit method, for a
duration less than 10 seconds (10000 as an integer), the coded range is from 64 to 16383. In
the range, the error of the new methods is less than 64 milliseconds, whereas the old method
is 64 - 511 milliseconds. The revised method will be used in the later experiments, and the
7th number (bit 6) to the 14th (bit 13) will be cut from the original 16-bit inhalation to reduce
error.
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Table 4.4 The improved LSBs-cutting 8-bit coding methods
Used bits (LSB) Coded Range (Integer) Error (Millisecond))
1 to 8 1 - 255 1
2 to 9 2 - 511 2
3 to 10 4 - 1023 4
4 to 11 8 - 2047 8
5 to 12 16 - 4095 16
6 to 13 32 - 8191 32
7 to 14 64 - 16383 64
8 to 15 128 - 32767 128
9 to 16 256 - 56635 256
The highly-compressed 4-bit coded output
For a more highly compressed scale, an exponential function returns a 4-bit power number of
2 from the original data. For example, for number 32, the returned exponent is 5. However,
as an exponential value, the resolution of a sample between 4-second (4096) and 8-second
(8192) is 4 seconds (4096), which loses the accurateness of detection and measurement.
A new 4-bit coding method for compressing inhalation length has been developed and
presented in Table 4.5 based on the measured duration.
Table 4.5 The method of 4-bit coding
Original Range Calculation Coded Range Increment Unit (ms)
v<1 No 0 Short Inhalation
1000≤v<2000 1+(v-1000)/500 1-2 500
2000≤v<5000 3+(v-2000)/300 3-12 300
5000≤v<7000 11+(v-5000)/1000 13-14 1000
v>7000 No 15 Long Inhalation
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86% of recorded inhalations were from 2 to 5 seconds, and any measured duration with a
pulse length in this range has the highest resolution. From a 2-second inhalation to a 5-second
sample, the resolution is 0.3 seconds. With the possible error rate from 6% (0.3/5) to 15%
(0.3/2), the 4-bit solution is able to represent important information of duration.
Fig. 4.4 The presented interface of 4-bit solution
The interface of the 4-bit solution in Fig. 4.4 presents the exported length data of detected
inhalation. The samples of duration are abbreviated from the original duration length and
categorised by every 0.3 seconds. With a concession of duration accuracy, the length of each
inhalation still presents important information about how long effective inhalation continues
during each administering. The presented number of each range is a floor value, which means
for data between two categories, it will be categorised to the lower range. Each duration has
a possible negative increment from 0 to 0.3 seconds.
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4.2.3 The compressed method for date/time stamping
The RTC starts counting time once the information of setup date and time have been written
into the system through the PC application. The RTC needs to be powered during the entire
treatment to ensure its stability. The data of time from RTC are 16-bit unsigned integers,
which are accurate to each minute and capable to function continuously within 45 days
(64800 minutes).
Instead of recording the actual date and time of each administering event into memory, the
time differences (in minutes) between doses are stored. The length of the gap between a
detected administering event and the last event is also measured as an unsigned 16-bit integer,
which is recorded with inhalation for date/time stamping, clarifying when the adherence was
monitored and recorded.
To shrink the data size and save memory space, the integer of time difference can be
compressed to an unsigned 6-bit integer in compressed format by the progressive increment
with different resolutions. The coded result is presented in minutes. The coding method is
depicted in Table 4.6.
Table 4.6 Coded 6-bit time difference in minutes
Original Range Time Presented Resolution Calculation Coded Range
0-59 First Hour 5-minute TD/5 1-11






>3840 >64 hours Limited to 64 No Calculation 64
According to the instructions for use, doses should be inhaled twice daily with 4 capsules
for each. It is recommended that patients should take doses every 12 hours [16]. During
a normal treatment with no serious forgetfulness issue occurs, it is unlikely that the gaps
between doses are longer than 3 days.
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4.2.4 Compressed duration with stamped time
The solution with different compression will be selected based on the duration of the treatment
and the size of inner storage. As the current constructed prototype contains a 0.5 KiB FeRAM,
the discussion will base on the size of 0.5 KiB as the example. With a fixed storage size,
the highly-compressed method takes priority when the treatment is longer. As mentioned
in Section 1.1.3, 4 capsules will be consumed as a full dose, and two doses should be taken
daily. It is indicated from the user information [15] that at least 2 inhalations are needed to
empty each capsule. As a result, 400 - 500 inhalation may occur during a 28-day treatment.
The presented 8-bit solutions, including the 8-bit coded output with 12-bits range and 5-bit
resolution and the improved LSBs-cutting 8-bit coding methods, both take 8 bits (1 byte).
Regardless of the possible error, these two solutions will be discussed together as 8-bit
solutions.
Fig. 4.5 The diagram of data structure using different solutions
The diagram of data structure in Fig. 4.5 presents how the bytes have been occupied in each
solution.
a. the 16-bit solution
The 16-bit solution consists of an 8-bit unsigned integer of compressed inhalation length, a
6-bit coded unsigned integer for stamped date and time. The first 6 bits of the first byte is for
time stamping. The last 2 bits are flexible for future design. In the future version, it can be
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used to record a simple evaluation of how strong and stable the inhalations are depending
on the average value of ZCR and STMD. The second byte is used for storing duration. The
measured length data are coded into 8-bit integers in 12-bits range and 5-bit resolution.
b. the 8-bit solution
The 16-bit solution uses 6 bits to store time, whereas the 16 intakes of the same doses share the
same time stamping as a dose is likely to be taken within 5 minutes. It is worthy of combining
similar recorded time samples together to reduce data size. The 8-bit solution abandons
time updating if the latest inhalation is taken within one hour since the last inhalation, which
means the neighbouring events belong to the same dose. The time will only be updated
and recorded when the current inhalation occurs after one hour later than the stored time. It
adopts the 8-bit duration length like the 16-bit solution.
An empty byte will be stored into the memory after time-stamped inhalation to label the end
of a complete dose. The PC application detects empty bytes to demarcate a full event of
medicine administering. The new method cuts the memory size of single doses to roughly
half of the original size.
c. the 4-bit solution
The capsule will be removed and checked after two intakes following the instructions.
Although it is recommended that 2 intakes should empty a capsule, there is a possibility of an
unemptied capsule. Repeating the inhalation helps to inhale the rest of the powder, whereas
it requires extra memory to store the added data. To store information of adherence for more
than 28 days into the limited memory, a 4-bit solution with the higher resolution has been
developed.
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Each inhalation will take 4 bits using the 4-bit compressing method in Section 4.2.2. There-
fore any inhalation shorter than 1 second will be abandoned, and no 0 value will be adopted
to represent inhalation. The coded data will be from 1 to 15 and presents data from 1 second.
An empty half byte (0000) will follow the time-stamping data to label the end of a dose. The
PC application detects 4-zero binary data to demarcate a full event of medicine administering.
The discussion and context of selecting solutions
The data of original 16-bit inhalation length has been coded to 8-bit and highly-compressed
4-bit coded output with different resolutions. Combining the 6-bit data of time stamping,
the essential information of each inhalation event can be stored in the 16-bit, 8-bit, or 4-bit
compressed solutions. As the 16-bit and 8-bit solutions are based on the same data resolution
with only the time-stamping method varies, both of them have the same duration difference
against reference from 0 to 0.26 seconds for an inhaling event that is limited in 8 seconds. The
4-bit solution categorises the duration length with a maximum duration difference against the
reference of 0.3 seconds, and the data will be slightly biased with an upward data wrapping.
The storable doses can be calculated based on the available storage size and the selected
solution. The quantity of available doses is the quotient of the available 432 bytes and the
byte requirement of each dose. Assuming each capsule can be successfully consumed by the
minimum 2 inhalations, each dose requires 8 inhalations.
For the 16-bit solution, as each inhalation requires 2 bytes, at least 16 bytes need to be
occupied for one dose. The adherence information within around 10 days (13.5 days for a
minimum of 16 inhalations daily in the available 432 bytes) can be fitted into the 0.5 KiB
FeRAM memory with the aforementioned compressing method. With the limited storage,
the 16-bit solution can be selected in short treatment for less than 2 weeks.
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For the 8-bit solution, 8 inhalations cost 8 bytes for a dose, with the attached time-stamping
byte and an empty sign byte. The minimum requirement is 10 bytes. The adherence
information within 21 days for a minimum of 16 intakes daily can be fitted into the available
432 bytes. The 8-bit solution will be suitable for any treatment for around 20 days.
For the 4-bit solution, 8 inhalations cost 4 bytes for a dose, with the attached time-stamping
byte and the 0.5 empty sign byte. The minimum storing requirement of each dose is 5.5
bytes. The adherence information within 39 days for a minimum of 16 intakes daily can be
fitted into the available 432 bytes. The 4-bit solution will be suitable for a long treatment,
such as the 28-day full treatment.
Table 4.7 Storable doses for a 0.5 KiB FeRAM of different solutions
Solution Bytes per Dose (Minimum) Storable Doses Maximum Days
16-bit 16 27 13
8-bit 10 43 21
4-bit 5.5 78 39
In Table 4.7, the number of doses that can be stored in the 0.5 KiB FeRAM using the
developed coding solutions are presented. Comparing to the 8-bit solution, the 4-bit solution
is more suitable for the small size memory and long-period treatment, whereas the distortion
of duration length is considerably higher with a biased increment up to 0.3 seconds.
To keep both the high resolution and accuracy for long-period treatment, an improved NFC
replacement is required. A bigger FeRAM is required if a 28-day treatment is monitored
using the 8-bit solution. A possible replacement is MN63Y1221 [155]. The built-in FeRAM
non-volatile memory of MN63Y1221 is 8-Kbit (approximately 1 KiB), which doubles the
size of FeRAM of MN63Y1213. The accuracy of different methods will be further analysed
in Chapter 6 after the user testing experiments.
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4.3 Conclusion
The aim of the research was to design and develop a monitoring system with advanced
transmission and storing approaches. Compared to the BLE technology, NFC consumes
less power, and the device can be connected without paring stage. As one of the main
considerations is power consumption, and the NFC can be powered by the RF signal and
transmit data without battery or any other type of power supply, it shows advantages and is
more suitable for a portable long-period electronic system.
The duration of detection is saved as highly-compressed formats with real-time stamping.
The size of available FeRAM of the developed prototype, which is the storage of NFC chip to
avoid data loss and enhance the readability of data even when the battery goes flat, is limited
to 0.5 KiB. With presented 16-bit, 8-bit, and 4-bit coding methods for data compression,
the adherence of a full long-term treatment can be stored as small size data to fit the limited
storage.
Chapter 5
The Prototype System and Experimental
Procedure
The chapter introduces the new inhalation detecting prototype. A low-cost self-printed finger-
tip on-chip recognising system has been developed with a TI low-power microcontroller,
an omnidirectional microphone, a bicolour LED, a 3-axis accelerometer, and an NFC chip
for data transmission. The system has achieved accurate real-time inhalation recognition
and duration measurement based on simple time-domain features to reduce computational
complexity and memory cost. The energy-effective device was designed with low-power
working modes, which extended its durability with the capability to fit a 28-day treatment.
The data were stored in FeRAM of the NFC chip to improve the non-volatility and avoid data




The main target of the research is to design a durable digital signal processing system as the
attachment to an inhaler. The design challenges of the electronic device include:
1. The detection and duration measurement of inhalation is reliable with high accuracy
against noises.
2. Computational and memory cost of features are low to fit the limited processing RAM.
3. The device is energy-effective with power saving mode and low-power processing.
4. Data recovery with drained battery is available to prevent unexpected information loss.
5. The simplicity of use is concerned to avoid frustration or even abandonment of the
device.
To maintain stable usage during a long-period treatment, the power consumption needs
to be limited to extend the durability. Wearable or portable electronic devices are more
pervasive with increasing requirements of low-power architecture. From existing knowl-
edge, the energy-efficient signal processing can be achieved through software or hardware
implementation. Algorithms and software can be optimised for the target architecture, which
can also be developed to avoid massive shuffling of data between memory and processor.
Improving coding skills with considering strength and weakness in the developed system
saves computing clock cycles and power. The energy consumption can also be reduced with
the reduction of supply voltage and geometry with the recent improvements in semiconductor
technology [66].
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5.2 The early design: the RFduino board
In an early prototype, an RFduino board [156] had been used to develop the adherence
monitoring system with BLE communication technology. The RFduino includes a high-
performance BLE radio transceiver and an bulit-in ARM Cortex M0 microcontroller, which
is optimised for small silicon die size and used in the low price chips. The system was
programmed efficiently through the simple-to-use Arduino integrated development environ-
ment (IDE) using RFduino extensions, which can also be wirelessly communicated with iOS
Phones, iPad or Android smartphones or tablets. The size of the surface-mount technology
(SMT) module is 15 mm in length, 15 mm in width and 3.5 mm in height, which can fulfil
the transmitting and processing function requirements at the same time.
For rapid development and prototyping, the early design was built on the developed RFduino
dual in-line package (DIP) shield, which was a modular accessory that can be directly
plugged into another RFduino DIP shield. The prototype contained an RFduino module, an
RGB LED/Button Shield for direct feedback, a coin Battery shield for power supply, With
an external USB shield for programming. The size from a regular RFduino DIP shield was
around 22.86 mm × 23.37 mm × 18.4 mm, whereas the used coin battery shield was 22.86
mm × 46.99 mm × 18.3 mm. The built prototype is 22.86 mm × 46.99 mm × 41.7 mm.
The early design was too bulky as an attached electronic device and more suitable as an
external accessory device.
The accompanied RGB LED/Button board includes three different colours of flashlights,
which gives direct feedback to the users. When the green light is flashing, the time counter
is working and measuring time pulse. The idea of using LEDs to demonstrate real-time
processing has been kept in the future version.
Sound source identification based on the real-time calculation of key factors, such as over-
zero rate, variation, and deviation, has been designed with a low-cost system. A MEMS
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microphone ADMP401 was used for sound sensing. The Android application receives the
data from the RFduino board immediately when the board is active and has detected updated
identified data. The device can reject surrounding noises, such as the mechanical sound from
the traffic and vehicles, the human voice and music under different occasions.
Fig. 5.1 The Android application interface of the data receiving system
The BLE technology was used for data transmission from the sensing system to the terminal.
Compare to classic Bluetooth, BLE is more economical and widely supported by the current
generation of smartphones and tablets. Both iOS and Android application were built at the
early stage of the project. The Android application was developed to receive data information
such as the inhalation duration length and the date and time of a recorded event, which is
presented in Fig. 5.1. The data can be updated automatically when a new inhalation was
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detected with an active BLE module. The data would be analysed on a PC-based platform
and the monitored adherence could be analysed and indicated.
More than 800 inhaling events have been tested for detailed threshold adjustment. The
original threshold was defined according to the measured value using MATLAB. A yellow
LED was used to represent whether the ZCR reached the threshold, and a green LED was
used to represent whether the STMD reached the threshold. 200 samples was set as one
processing window. The threshold value was adjusted by observing the LED. If the LEDs
were flashing during inhalation, the threshold was exact or lower than needed. When the
LEDs were not flashing during inhalation, the threshold was higher than needed. The
threshold value was adjusted until the LEDs were flashing during inhalation and reach the
maximum of allowance.
An early user testing experiments estimated the accuracy of the developed detecting RFduino
system with 200 inhaling events. 96.5% of inhalations have been successfully detected and
marked as inhalation correctly, and 100% of detected inhaling events have been transmitted
to a paired phone successfully.
As an early prototype, the RFduino version with BLE was designed and developed by the
writer of the thesis, which provided an initial approach to low-cost low-complexity processing
on small-size electronics and short-distance transmission between the device and the terminal,
which proved the feasibility of the methodology. The idea of using 1 KiB RAM has been kept
in the second version on MSP-EXP430FR573x. The technology of BLE has been compared
to the later NFC version based on performance and power consumption. The option of using
BLE can still be considered as diversified design if different types of products are in need.
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5.3 The PCB based on MSP-EXP430FR573x
5.3.1 The printed prototype
The improved design considers physical size, energy consumption, the ability to store data
for a full treatment, and the data safety even with a depleted battery. A low-cost development
board with a microcontroller capable of performing digital signal processing operation
was needed. Instead of the Arduino platform, the TI MSP430FR573x family of ultra-low-
power microcontrollers [153] was selected as the main processor. The system fits both
MSP430FR5736 and MSP430FR5738, which was initially designed to fit MSP430FR5736
with MSP430FR5738 introduced in the later printed design. NFC technology has been
introduced to replace the BLE for data transmission. The idea of using a limited 1 KiB RAM
and a simple processor was decided by the writer of this thesis and The PCB was built and
developed by Dr Tim Good. The components were selected and tested together. The core
code of audio processing was programmed by the writer.
The revised prototype was a thumbnail-sized thin PCB as shown in Fig. 5.2, which contains:
• A green/red bicolour LED and a crystal
• A TI microcontroller: MSP430FR5736 [153]
• An omnidirectional microphone INMP441 with an I2S digital output [132].
• A 3-axis accelerometer LIS2DH12 with I2C/SPI digital output interface [157].
• An NFC (RFID Reader/Transponder IC) chip MN63Y1213 [149].
• External components: small battery and NFC antenna coil
The new inhalation-detector is a finger-tip medical monitoring electronic device for inhalation
detection, recording, and evaluation, which is designed to be attached to the body of an
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Fig. 5.2 The 12.5 mm × 10 mm × 1.5 mm printed circuit board
inhaler. The printed chip is 12.5 mm × 10 mm × 1.5 mm in size. During the testing stage,
the chip is sealed underneath a 3D printed plastic protective shell, which is a 22 mm wide
ring-shaped cover and fits tightly to the inhaler. The inner diameter of the ring is 26 mm
and the outside diameter is 31 mm. The shell is coloured white and not being transparent,
whereas the red/green LED can be observed externally through it to provide direct feedback.
The power supply is an ultra-thin curved flat flexible Li-polymer battery 201030. The nominal
voltage is 3.7V, and it is rechargeable. It is 2 mm × 10 mm × 30 mm in size, which fits
underneath the shell with the processing device. For a final version to be widely produced in
future, other suitable batteries may be introduced to replace the current version, considering
the price and the stability. The locations of the chip and the battery are presented in Fig. 5.3.
The TI MSP430FR573x microcontrollers feature embedded non-volatile FeRAM and 16-
bit CPU with added peripherals, including an ADC, a comparator, 3 serial channels, an
internal DMA, a hardware multiplier, an RTC, 5 timers, and digital I/Os [153, 158]. The
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(a) The protective shelf with located chip (b) The location of the bendable battery
Fig. 5.3 The printed protective shelf with the locations of the chip and battery presented
microcontrollers are capable to fit in portable sensing applications with long battery life as
being ultra-low-power, lightweight and available in various small packages. In this research,
a 4 mm × 4 mm × 1 mm package of MSP430FR5738 has been selected to suit the small-size
design of the prototype.
Fig. 5.4 The developed prototype with the programming cable and the protective shell
The developed prototype with the location of the chip and the programming cable is presented
in Fig. 5.4. The version in actual usage will exclude the programming cable.
The MSP-EXP430FR5739 Experimenter Board was used for programming and debugging
MSP430FR573x boards through a serial cable. Pairing with a PC application, it provided an
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efficient method to develop, debug, and implement prototypes. It is supported by both IAR
Embedded Workbench and Code Composer Studio (CCS). In this research, CCS 6.1.2 was
used as the programming platform. The used Experimenter Board with the serial cable is
shown in Fig. 5.5.
Fig. 5.5 MSP430FR5739 FRAM Experimenter Board with serial programming cable
5.3.2 The low-power inhalation detecting system
The system hardware block diagram for the detection-transmission solution is depicted in
Fig. 5.6.
The accelerometer stays activated when the system is being idle and deep-sleeping, and
the information of movements is collected through a multiplexer (MUX), converted by an
internal ADC, and finally be transferred through SPI. Any sudden movement occurs a signal
of interrupt and is received by the microcontroller. The signals of changing angles are
being received when the system is triggered by the waking-up motion. With an activated
microphone, the accelerometer stops to function. The analogue raw audio is converted by an
ADC and pre-filtered by anti-aliasing filters. The pre-processed signals can be transmitted
through I2S serial port of the microphone to the microcontroller using the adapted SPI MISO
(Master In Slave Out).
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Fig. 5.6 The block diagram of the system
With raw audio signal abandoned, only the duration of each inhalation is extracted, and
the system attaches the information time and date (in minutes) to each event. The result of
detection is written into the NFC chip directly through I2C serial without being stored in the
main processor.
To achieve a portable system, the size of the applied battery is limited to fit in the inner side
of the protective shell and thus restrict its electrical capacity. The selected power supply is a
43-mAh flexible rechargeable Li-Ion battery. The information of the typical working current
of each integrated component is presented in Table 5.1, according to their data sheets.
Table 5.1 Power consumption of components




Real-Time Clock 1.5 µA
Shutdown 0.32 µA
LIS2DH12 (Typical) 2 µA
INMP441 (Typical) 1.4 mA
MN63Y1213 (Typical) Batteryless RF communication
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The microphone is shown to be the most power-hungry component in the system. To reduce
power consumption, the progress of audio processing will only be activated when the user is
inhaling. The working modes of a complete inhalation detection include the sleep mode, the
gesture detection mode, the inhalation detection mode, and the data transmission mode. The
system flowchart is demonstrated in Fig. 5.7.
1) The sleep mode
To reduce energy consumption and maintain long-period functionality, the system stays in
the ultra-low-power sleep mode when it is not activated. The microphone keeps off at this
stage. The accelerometer is activated for receiving the triggering signal of preset motion and
the RTC is working after the preset of system till the data collection.
2) The gesture detection mode
A shaking motion is defined as the triggering signal from the accelerometer. The attached
LED flashes once the system is triggered, highlighting the current working status of the
system. The horizontal alignment of the inhaler is detected and measured at the gesture
detection stage.
3) The inhalation detection mode
With a horizontal position, the microphone starts to function the real-time inhalation detection.
The ZCR and STMD are calculated in parallel. As the calculations of the ZCR and STMD
are both based on neighbouring samples, the samples will only be read once, and the parallel
calculations can be achieved by using two separated integers as the accumulation of sign
differences or value differences.
The pulse length is counted by sample number when the features are within the preset
threshold range. The threshold ranges of different features have been evaluated and calculated
by a previous training system. To enhance the robustness against the noisy environment,
a concept of tolerance threshold has been introduced into the system to avoid triggering






















Fig. 5.7 The diagram of the inhalation detecting system
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the wrong end of inhalation from the random sudden noise. The tolerance threshold adds
10% - 15% increment to the original threshold, which indicates a ‘possible’ situation of
identification thus reduce instability. When the features of samples in a window are within
the inhalation range but in the tolerance range, the counter for duration length measurement
will not increase, but the counter for triggering the end of inhalation will not increase and
stays in zero.
The detailed methodology of inhalation detection will be presented and discussed in Fig. 5.16.
Inhalation will be correctly detected when the measured pulse length is longer than 0.6
second. The duration of a correct inhalation and the event time are stored into the FeRAM of
NFC chip.
4) The NFC transmission mode
When an NFC reader activates the system, the stored data can be transmitted from the FeRAM
of the NFC chip to a PC through the accessorial application. During the transmission mode,
both the accelerometer and the microphone stays off. The power for transmission is supplied
by the NFC reader without battery consumption.
During each mode, a protective module is inserted to prevent overflow, bad loops, or other
unexpected errors, and also to avoid extra power cost. The system goes back to the sleep mode
for unexpected incidents. 15 seconds without horizontal holding in the gesture detection
mode or 20 seconds without identified inhalation in the sound detection mode turns the
system back to sleep mode.
The measured power consumption of the audio detection mode is around 3 mA, and the
daily routine of intakes is shorter than 2 minutes. With the real-time clock and accelerometer
functioning, the working current in sleep mode is measured to be from 30 µA to 45 µA. With
the 43-mAh battery, the device can operate normally for more than the 30 days expected life
of an inhaler and has a pre-usage shelf life in excess of several months.
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Fig. 5.8 illustrates the procedure of adherence monitoring of a full treatment from device
setting to data analysis and the procedure of data extraction from the electronic medical
device through utilised layers to a PC terminal.
Fig. 5.8 The progress of a full treatment
The monitoring device will be preset by professional clinicians using the PC read/write
application. The ID of each patient and the date of setting as the reference of time stamping
will be stored into the hardware. The battery needs to be applied before system setting and
continues supplying the system during the home treatment. After a time-fixed treatment, the
device will be returned to the clinics or pharmacies. The wireless and battery-less operation
permits the device to be placed in a prepaid postage envelope and posted to a sorting office.
The device will be scanned and the data will be transferred into the database without needing
to remove from envelopes and the data of adherence will be extracted and analysed by
professional clinicians.
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This method saves time and cost of clinical visits, it is more economical and convenient
to both the users and the clinicians. The patients only need to handle the inhaler with the
attached chip without being involved in the troublesome system setting or data management.
And they are not responsible for data transmission and thus avoid the risk of data loss due to
forgetfulness or improper operations. The adherence is monitored and recorded automatically
with regular medicine administering, and the patient needs no extra behaviour for data saving.
For the current version of the developed prototype, the measured power consumption of the
system in audio detection mode is around 3 mA. With the real-time clock and accelerometer
functioning, the measured current in sleep mode is from 15 µA to 45 µA. The shelf current,
which is discharged before the system activates, is low as 0.3 µA. As the audio detection is
expected to continue for several minutes each day, and the device stays idle for most of the
time. The device can operate normally for more than the expected life of an inhaler and has a
pre-usage shelf life in excess of several months or even for a year.
In actual usage, the working current may vary from the measured or calculated value due
to temperature or other factors. The built prototype is proven that it has the capability to
function continuously for more than 1 thousand of inhalations base on one single charge of
battery.
5.4 The motion detecting wake-up system
Motion detection has been widely developed in add-on devices for adherence monitoring.
For a previous device, SmartTurbo [67], consecutive opposite rotations of the base of inhaler
were interpreted as inhalation. Combining the information of whether the protective cap is
removed or not, the overall accuracy of detection reaches 99.2%.
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As the developed prototype in this research is not only focusing on inhalation, but also
concerning about the duration length and the quality of inhalation, the information of
rotations is insufficient for evaluation whereas it is favourable for triggering system from
the deep sleep mode as it is proven that the rotations of inhaler can successfully indicate
actuation of inhalation. The system is designed to be auto-on/auto-off and will only be woken
up by predefined movements of inhalers to avoid unnecessary power consumption.
The selected LIS2DH is an ultra-low-power linear 3-axis accelerometer with I2C/SPI standard
output. The advantages of LIS2DH include having two independent programmable interrupt
generators and being available in small thin plastic package [157]. In the low-power mode, the
power consumption can be down to 2 µA. A two-phase motion detecting system is developed
based on LIS2DH, including the detection of interrupts to achieve full functionality of
accelerometer and the detection of position to indicate that the device is ready for detecting
inhalation.
Three operating modes are provided by LIS2DH, including high-resolution mode, normal
mode, and low-power mode, with 12-bit output, 10-bit output, and 8-bit output respectively.
The working mode can be selected by changing the value of registers. The output data rate
(ODR) may be selected from defined numbers from 1 to 5376, and the current consumption
of each operating mode varies with different data rates. For the low-power mode, as the
example, when the operating data rate is 1 Hz, the power consumption is the lowest 2 µA,
which may increase to 10 µA with 100 Hz as the data rate. For this thesis, the resolution
of an 8-bit output is adequate for detection interrupts therefore low power mode is selected
for detecting both waking up shaking movements and the angle of alignment. The data rate
can be selected between 10 Hz and 25 Hz, with 3 µA and 4 µA as the current consumption,
respectively. In the current version, 10 Hz of data rate has been developed.
The full motion detection is depicted in Fig. 5.9.
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(a) The shaking of wake up the system (b) The approximate horizontal alignment
Fig. 5.9 The two-phase motion detection before detecting inhalation
a. The detection of interrupts
During the sleep mode, the microphone is off and the accelerometer is working in the low
power mode.
In the current version, the ODR is 10 Hz with 3 µA current consumption. The threshold
value and duration of interrupts are preset to define the wake-up movement. The sensitivity
of the system can be adjusted at any time, the currently used version equals the weight of a
light shake, which is easy to be operated by users in the early stage. The threshold value of
interrupts is defined by the value of the full scale (FS) and the least significant bit (LSB). In
the current low power mode, FS is selected to be 2g (g presents the gravitational acceleration),
thus 1 LSB equals 16 mg according to the data-sheet [157]. As the value of the quantity of
LSB is set to 96, the threshold value of a pre-defined waking-up shake is 1.536g (16 mg ×
96). The threshold duration of interrupts is the minimum duration of two recognised events.
It is stored in another register and defined as 1/ODR, which is 0.1 second when ODR is
valued 10 Hz.
To avoid unnecessary power wasting due to unwanted triggering signals, especially when
inhalers are being carried on travel, the threshold value of waking sign is set high as a light
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shake in the developed version. Two continuous light shakes is defined as the waking gesture,
which is depicted in Fig. 5.9a. The shakes can be detected regardless of directions and the
rotations of the inhaler, and the system then goes automatically into the rotation-detection
mode.
b. The detection of approximate horizontal alignment
For a better medicine administering, the inhaler is required to be held horizontally during
inhalation. Instead of recognising inhalation from rotations of the inhaler, the horizontal
alignment is detected to active audio processing.
When the angle of the inhaler with respect to the ground is ±15◦ and continues for longer
than 0.2 seconds, it is defined as being held horizontally, which is illustrated in Fig. 5.9b. The
alignment detecting mode proceeds for 20 seconds, and the system goes back to sleep mode
automatically without a recognised horizontal holding when the 20-second period expires.
With a 0.2-second horizontal holding, the system turns to the audio processing mode where
the accelerometer stops to function and the SPI is used for transmitting audio signals from
the microphone.
The sensitivity of the wake-up system
The device has been tested for 500 usages, and 4 intakes occurred for each usage. For
each usage, the wake-up motion has been tested once before inhalation. 91% usages were
successfully activated by the first attempt of shaking, whereas 7% of usages were activated
by the second try and the rest 2% required the third shaking. The probability of unsuccessful
activation decreased when more shaking attempts had been done by the same person. During
the final 200 usages, there was no failed activation. It was indicated that a training session
may help the user to activate the device properly.
5.5 The sound sensing 108
During a later user testing session with volunteers, all users had successfully activated the
device following the illustrated instructions. 33% of participants did no activated it by the
first attempt of shaking, but showed the capability to adapt to the system properly during the
second attempt with a 100% successful rate (15/15).
The specificity of the wake-up system
To avoid unwanted activation, the threshold value has been set to be higher than a normal
swing from walking, whereas a sudden speed shift from transportation or a movement from
running may be recognised as the triggering signal. In a small-scale 30-minute motion
detecting experiment, the device was attached to a travel bag to test the specificity of the
system. The inhaler was located in the bag vertically. From the record, there was no redundant
activation during the 10-minute walking, whereas 3 activation pulses had occurred during the
10-minute travel on the tram. Activation could not be avoided during strenuous exercise. It
was also clarified that audio processing had not been triggered as the right angle had not been
detected if the inhaler was located vertically, and thus avoided faulty activation and power
wasting.
5.5 The sound sensing
5.5.1 The MEMS microphone
It is worth considering the size and power consumption of the voice sensor, whereas conven-
tional microphones are bulky with high energy consumption. Electret condenser microphones
have been used in miscellaneous applications, such as being built in telephones and comput-
ers to provide a high-quality recording [159]. Piezoelectric microphones are usually used as
contact microphones, sensing audio vibrations through contacted solid objects [160]. Nev-
5.5 The sound sensing 109
ertheless, the performances of traditional electret condenser and piezoelectric microphones
have been improved from the earliest version, the diameters of electret condenser are usually
around 9 millimetres with 5 millimetres as the height and piezoelectric microphones are flat
and thin with 30 millimetres as the diameter according to the current market of electronic
components. With small footprints and low power consumption, MEMS microphones can be
integrated into a package with round 4 mm as the longest side.
The first selected microphone was ADMP401 [161], an omnidirectional MEMS microphone
with bottom port and analogue output. The internal Analogue-to-Digital converter (ADC)
inside microcontroller reads the data one after another from the analogue microphone.
The appendant amplifier of the breakout board costs extra energy, and the instability and
indirectness of the analogue device may complex the processing. Besides, the size of the
ADMP401 breakout board was 1.4 square centimetres, which was over the requiring size. A
Pulse-density modulation (PDM) microphone INMP522 [162] was later introduced into the
system. The INMP522 is omnidirectional digital output MEMS with low power costing and
an impedance converter amplifier followed by a fourth-order Σ-∆ modulator. Besides having
a high SNR of 65 dBA and sensitivity of -26 dBFS, it also has an extended wide frequency
response from 75 Hz to above 20 kHz, resulting in natural sound with high intelligibility.
The usage of PDM microphone was excluded temporarily due to errors to fit the MSP430
microcontroller.
The INMP441 [132] is a high-performance low-power MEMS microphone with a digital
(Inter-IC Sound) I2S interface with high-precision 24-bit data, which is used to collect wave
files in the subsequent progress. The I2S output is a widely used digital interface for audio
converters and processors and now being integrated at the edges of systems in components
such as new MEMS microphones. The I2S microphone has similar advantages as a PDM
microphone, but its digital data are a decimated base-band audio sample rate output instead
of a high sample rate PDM output [163]. It can connect directly to a signal processor or
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microcontroller for processing with its standard interface. Its current consumption is around
1.4 mA and can be kept as 2 µA when it is powered down. With high SNR of 61 dBA, high
sensitivity of -26 dBFS, and flat frequency response from 60 Hz to 15 kHz, the INMP441
fits the requirements. It is available in a thin 4.72 mm × 3.76 mm × 1 mm surface-mount
package, slightly bigger than the previous candidates but in the acceptable range.
For an early prototype, the MEMS microphone was attached to the surface of the inhaler
body with a small piece of foam covered on the top of it to avoid the influences of airflow.
In the improved design, the integrated chip was embed and fitted to the inner side of a 3-D
printed protective shell. The sound hole in the microphone package was aligned with a
through-hole in the printed circuit boards (PCB) board, which allowed the vibration of air
in the chamber and inhaler body to be sensed through. The performance of the microphone
and the recognising system would be impeded if the through holes were obstructed partly or
completely by additional material, such as glue or tapes.
5.5.2 Audio signal filtering
An initial evaluation of breath sounds detected by the microphone was carried out in a
noisy environment with low SNR from 12 to 18 dB. In order to provide a reference, the
recording experiments were performed in the soundproof room which yielded a data set
under approximately 40 dB SNR. It was degraded by additive noise to create the training
and evaluation system to select and assess the performance of appropriate feature-extraction
algorithms.
The strong vibrational artefact at around 1 Hz from the control circuitry of the microphone
was removed by first-order infinite impulse response (IIR) high-pass filter presented in
Figure 5.10, which has been constructed in the processing c code with a simple algorithm.
The cut-off frequency of the filter was designed around 15Hz with 60dB for the vibrations.









Fig. 5.10 The IIR high-pass filter before real-time feature extraction and sound identification
The coefficients were adjusted to divisible numbers to reduce computational complexity and
fit into the real-time one-way processing. For a first-order filter, the transitions between the
cut-off region and pass region were gentle and smooth. The -3dB frequency of constructed-in-
code IIR filter, which means the ratio between the output an input was 0.707, was calculated
to be around 800 Hz with the chosen coefficients. The frequency that signal power was
attenuated by 50% was calculated to be around 463 Hz. Although there is no obvious pass-
band as the filter is simple-constructed, the performance of filtering low-frequency signal
whose frequency is lower than 100Hz has been indicated.
Fig. 5.11 depicted the filtered result of the inhalation and exhalation in Figure 3-1. The
inhalations were mostly kept, and the exhalation was restrained as the sound from air vibration
was filtered and reduced.
To be more specific, the original signal and the filtered signal are presented in the frequency
domain to demonstrate the frequency response of the first-order high-pass filter. In Fig. 5.12,
it is shown that the original sound includes the high-energy low-frequency noises from
very low frequency to around 300Hz, which is massively reduced in the filtered result. The
filtering performance is presented in logarithm in Fig. 5.13 for a detailed demonstration of
low-frequency filtering.
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Fig. 5.11 The filtered inhalation and exhalation by the constructed IIR high-pass filter
Fig. 5.12 The filtered result in frequency domain
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Fig. 5.13 The filtered result in frequency domain (log)
The frequency response of the constructed high-pass filter is depicted in Fig. 5.14. From the
change of gain (output/input), it is clarified that the 50% attenuation occurs around 600Hz
and the -3dB (0.707) frequency is 875 Hz.
As the low-frequency noises were high in amplitude and energy, the decreased volume of the
filtered noise resulted in an evident decline of STMD and STE. The SNR of the filtered result
had been improved in the low-frequency region. Thus, the effect from circuitry artefact and
airflow vibration would both get mostly eliminated with the simple constructed-in-code filter,
improving the performance of the recognition system.
5.5.3 Real-time processing on the prototype
The size of the framing window is limited to fit the finite 1KB RAM and achieve quick
real-time processing. The size of processing window can be pre-set as any value from 200
to 600. At the initial stages, a segment of 200 samples is defined as one processing set and
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Fig. 5.14 The frequency response of the IIR filter
the size of each set can be adjusted. As the sampling rate is 5578 sample-per-second (SPS)
and it is calculated by the SPI clock (357 kHz) divided by 64 bits per conversion transaction,
one processing window of 200-samples takes 0.036 seconds. The size of processing window
can be pre-set as any value from 200 to 600, which takes 0.1 second. The SPI clock has
been defined and limited by the timer source clock, which is 1.5 Mhz. The identification of
inhalation begins when 200 samples have been processed and the segments whose features
are within pre-set threshold value are considered as a forming part of a clip of inhalation.
In Fig. 5.15, the developed inhalation identification in limited-size windows is depicted.
The chosen features are calculated by samples, stored in buffers, and discerned based on
segments. The buffer to store an audio sample of a single transaction is a 64-byte array
of unsigned 16-bit integers, and the filtered audio samples will be stored in another 64-
byte array. The buffers will be renewed by the latest audio signals. A counter is used for
measuring segments, the maximum value of it refers to the size of the processing window.
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Fig. 5.15 The fast inhalation identification in limited-size windows
The data are not saved on segment-based and there is no real buffer to store the 200-sample
segment. Respectively, the STMD and ZCR are calculated by comparing the difference and
sign-difference between the two latest samples. The absolute difference of the latest samples
will be added to a signed 32-bit integer. And if the latest two samples have different signs,
an unsigned 8-bit integer to store ZCR will be added by one. The processed audio buffered
are discarded and renewed immediately after feature extraction and no raw audio file will be
saved without continuously occupying memory.
When a byte is read from the filtered buffer, the counter adds one and it returns to 0 when
it reaches 200, which means 200 samples have been read and the feature extraction of the
segment is finished. The integers of stored STMD and ZCR will be compared to the pre-set
threshold value to decide whether the 200-sample segment belongs to inhalation or not.
In Fig. 5.16, the flowchart of detection is presented. The inhalation_counter is the sign-
variable of inhalation segments, and inactive_counter presents non-inhalation segments.
To achieve a duration measurement, the start of inhalation will be detected initially. When a
non-inhalation occurs and is detected, the start of the latest segment is marked as the end
of the inhalation. The length and the time of occurrence will be recorded into the FeRAM.
The duration length itself is considered as the third feature for inhalation determination,
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Fig. 5.16 The logic of detecting algorithm
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alongside with the STMD and the ZCR. Insufficient inhalation will not be marked as a correct
inhalation when the duration length is shorter than 0.6 seconds, which is the pre-set threshold
length according to the trained data. The information of an insufficient inhalation will be
discarded immediately. As there are algorithmic anomalous errors, such as a start without
end, an end before the start, and staggered data in back-to-back events, the restrictions of
inhalation detecting have been introduced to the code. The endpoint can be detected when
there is one and only activated start point to avoid overlapping start-end regions.
As each 0.036-second occurs fast, and there will be around 27 processing windows during
each second, the system is quick-reacted and very sensitive. In an improved inhalation length
measurement, 4 continuous non-inhalations after a valid inhalation are considered as the end
sign to reduce a premature end of detection. A tolerance threshold has also been introduced
into the system to reduce instability from hardware and unstable usages. When the value
of one sample set is not within the inhalation range but in the tolerance range, an end will
not be triggered. 6 continuous non-inhalations cancel out the stored start sign of inhalation,
avoiding overlapping start points.
Without complicated audio signal matrix calculation, the processing provides quick, real-time,
effective inhalation identification with limited access memory.
5.6 The LED feedback system
To reduce incorrect usage cases such as short inhalation or non-inhalation and improve
the quality of medicine administering, feedback system has been introduced into several
designs of inhalers. The Aerochamber [164] is a spacer that helps control delivery of asthma
medication, which consists of a plastic tube, a fitted mouthpiece, a valve, and a soft sealed
end to hold a metered dose inhaler. An inspiratory flow indicator called Flow-Vu has been
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designed to improve the quality of administering. A warning whistle will occur immediately
once the patient is inhaling too strong or too quick, and thus reduces improper inhalation.
The Aerochamber is indicating air-flow physically and not being electronic-involved. With
achieving electronic real-time discrimination, a feedback system that presents the result of
evaluation immediately and directly to users will be beneficial for reducing inadequate in-
halation. In the current version, the feedback is presented through the bi-colour LED flashing.
The flashing system consists of a green LED and a red LED with various combinations of
different lengths and numbers of flashing. The green LED has been used to guide the regular
routine of an administering, whereas the red one is designed as the warning signal to indicate
that the system is off or not has been used properly.
In Table 5.2, the meaning of each flashing style is presented and it can be customised by the
user in the system setting stage. The adopted version indicates the mode changes, a good
inhalation, backing to sleep, faulty usage, and 5-second countdown. When the system is
activated and switches between working modes, the green LED flashes once for 0.5 seconds.
When inhalation is detected and stored in the buffer, the green light flashes once for 1 second.
When the system turns back to the sleep mode from any other modes, the red LED shows a
long 2-second flashing. The environment can be estimated using the simple envelope which
is depicted in Section 3.2.4. For pre-defined faulty usage or noisy environment, multiple
flashing occurs to the red LED. To inform the user when the 5-second pause expires, the
green LED flashes twice.
5.7 Incorrect usage and presented solutions
Incorrect and inadequate administering has been recorded during previous CF treatment
[7]. To use the TOBI Podhaler properly, the medicine should be taken regularly in an exact
dosage. Each dose of 4 capsules should be taken around every 12 hours and should not be
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Table 5.2 The flashing code of LED
Meaning Colour Flashing mode
Mode changes Green Flash once, for 0.5 seconds
Good inhalation Green Flash once, for 1 second
Back to sleep Red Flash once, for 2 seconds
Faulty usage Red Flash twice, for 0.1 second each
Noisy environment Red Keep flashing, for 0.1 second each
5-second count down Green Flash twice, for 0.1 second each
taken less than 6 hours apart [16], which is recommended to be taken during mornings and
evenings. An exhalation to the air is needed before inhalation. The inhalation should be deep
and smooth with a single breath. At least two intakes empty one capsule. After inhalation,
the patient needs to remove the device and hold the breath for around 5 seconds. The possible
types of incorrect administering and developed solutions are presented below:
1. Inadequate inhaled medicine or deficiency in duration
A shallow inhalation may lead to an inadequate medicine administering as the powder
requires airway propulsion to reach the target organ. An event of over-enthusiastic inhalation
with excessive powder may also lead to an administering failure and cause respiratory
problems like coughs. The inhalation needs to be steady and deep enough for a successful
powder delivery. Inadequate duration length of inhalation may also lead to an unsuccessful
administering as the airway may not deliver medicine to the target organ in limited time. The
clinicians have the intention to collect information on duration length for further research
about how long inhalation should take to achieve the best result of medicine administering.
Existing measurements analyse the recorded data and demarcate inhalation in PC or mobile
phones, whereas an on-chip recognition is adopted in this research. For a real-time system,
the measurement requires high-speed recognition. To avoid inadequate administering, the
threshold value of STE and STMD is pre-set to define the range of a moderate inhalation.
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The strength of inhalation shares a positive correlation with energy and variance of received
signals, the exceeded or insufficient measured STMD of a single inhalation indicates high or
low inspiratory flow rate. In the case of reducing breathing deficiency, the threshold range
of duration length has also been set, and inhalation that is shorter than 1 second will be
considered too short and neglected.
2. No breath holding after inhalation
5 seconds of breath holding is required to achieve better performance of antibiotic powder,
whereas the needed pauses between inhalation and exhalation are possible to be forgotten.
Some users found it difficult to estimate 5 seconds accurately. Watching at a watch or a clock
is considered inconvenient during adherence. Besides, there are frequent occasions that the
user has no time-measuring equipment around.
The green LED will flash twice after a good inhalation with in-range features and sufficient
duration length, allowing users to regulate their breathing strength, speed, and duration length
if the taken administering has not triggered the LED. The threshold value can be adjusted
through the PC application to fit different users. The LED flashing system also contains a
5-second countdown reminder with a quick double flashing. The countdown clock starts
after a good inhalation.
3. Missed dose
The treatment requires one dose in every 12 hours and 4 capsules for each dose, whereas it is
reported likely that a patient, especially a young adult who stops receiving assistance from
parents, may forget to take a routine administering in required period [31].
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The RTC is running in an extremely-low-power mode once the system receives power supply.
The date and time of patient registration are stored inside as the time reference. The time
stamp will be recorded with each inhaling event to recognise any possible missed dose.
4. Noisy environment
Noise level affects the capability of identification massively for the audio processing system.
The volume of inhalation is relatively low comparing to natural noises, and the spectrum of
inhalation shares similarities with white noise as they are both broadband signals with high
ZCR, impeding the segmentation of inhalation under noisy environments.
A pre-processing noise level evaluation system has been introduced and applied before the
inhalation detection. When the noise level is high with lower than 5 dB SNR, the surrounding
environment will be considered too noisy by the system and a warning sign will be presented
from the LED. Normal detection will only be available when the noise level is low enough to
detect inhalation accurately.
5.8 Summary
This Chapter has introduced the novel developed prototype of the inhalation detecting device
with a fast real-time reacting feedback system, in order to present a low-cost, low-power,
convenient adherence monitoring methodology with the potential to aid future medical study.
It is an attractive approach as a small-scale energy-effective healthcare monitoring system,
which has been designed with extended durability and low-power working modes. It can
continue functioning with extended durability for several months with one charge to fit in a
long-period treatment. The device has been built on a TI low-power microcontroller with an
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omnidirectional microphone, a bicolour LED, a 3-axis accelerometer, and an NFC chip. The
data were stored in FeRAM with improved non-volatility to avoid unwanted data loss.
The full process of the system includes motion detection and sound recognition. The two-
phase motion detection has been used to wake the device from the pre-set deep sleep mode,
which is consist of the detection of interrupts and the detection of approximate horizontal
alignment. With this early design, the device can be aroused by a mild double-shake. The
system showed an adaptive sensitivity and good specificity in later experiments. The system
has achieved accurate real-time inhalation recognition and duration measurement based on
simple time-domain features to reduce computational complexity and memory cost. With
a LED direct feedback system, the result of the fast evaluation has been presented to the
users. The system also has the ability to assist the inhaling process. It can help to solve some
existing problems during treatment, for instance, inadequate inhaled medicine, insufficient
breath-holding, missed doses, and noisy environments.
The performance of the combined use of optimal feature-set and fast real-time block process-
ing has been introduced, and the performance has been therefore evaluated in the presence of
actual users. Subsequently, with more volunteering participants involved, the performance
of inhalation detection on the constructed prototype with different sensing methods as the
reference will be presented, evaluated, and discussed in chapter 6.
Chapter 6
Result of Preparation Test and Initial
User Testing Experiments
The chapter presents the result of inhalation monitoring using the designed prototype system
in actual medicine administering. The performance of the detection was tested under different
noise levels. A two-phase initial user testing study has been completed. In the first phase,
2000 inhalations have been tested. In the second phase, the inhaling events of 15 volunteering
participants have been collected, detected and evaluated to gauge the performance of the
monitoring system.
6.1 Preparation Test: Detection against added noise
Before actual user testing on the developed prototype, the experiments had been designed to
gauge the performance of the presented methodology and features using MATLAB, which
has been described in Section 3.3.4. The aim of this stage is to define and review the threshold
value of each feature, including the STMD, the ZCR, and the PL. 500 recorded inhalations
have been tested under different levels of SNR. Every sample was noised manually by white
6.1 Preparation Test: Detection against added noise 124
noise in incremental noise level, while white noise was acoustic-characteristically similar to
inhalation with high ZCR. The SNR was from 7 dB to 35 dB, adding to the original 40 dB
noise from the soundproof room and the recording system.


















Non-inhalation Detected As Inhalation
Inhalation Detected Rate
Fig. 6.1 The accuracy of detection against SNR
Fig. 6.1 demonstrates the accuracy of inhalation detection with the concept of TP and FP.
More than 80% of inhalations can be correctly detected when the SNR was higher than 13
dB. When the SNR was 20 dB, 92.8% among the inhaling samples had been identified and
marked correctly. The sensitivity increased when the noise level dropped, and it reached
97.6% when the SNR was 35dB. Under a noisier environment, when the SNR was around 10
dB, the STMD of noises increased and approached the threshold value of inhalation. The
boundaries between inhalations and noises were blurred by the high ZCR and STMD of both
signals and thus lost their detectability.
At a high noise level, a clip of continuous white noise or any type of noise with high ZCR
has a higher probability to be identified as inhalation as high volume leads to an increase of
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STMD. When the SNR was 10 dB, 33% of the tagged inhalations were actually white noise
clips. The incorrectly detected rate was declined to 5.5% with the 15dB as the SNR. Only
0.6% of tagged inhalations were FP result when the SNR was 25dB, and no false detection
when the SNR was higher than 30dB. To reduce the negative effects of the possibility to pick
up similar sounds or noises and mark them as inhalations, the threshold value of inhalation
duration length has been adjusted to improve the specificity.
The duration difference is defined as the time difference between the actual inhalation length
and the measured duration of inhalation. No extra noise has been added to the original
inhalations at this stage. Human perception has been introduced as a comparison to the
computational algorithm. The recorded inhalations were imported into Audacity. A trained
rater identified and demarcated each inhalation based on the visual and aural inspection
by looking at the waveform and listening to audios. Among 500 inhalations, the average
duration difference between rated length and detected length was 93 ± 37 (mean ± standard
deviation) ms.
The same set of samples has been tested against a different type of noises. The clips of
noises were collected under natural environments by the constructed prototype. The recorded
samples, which were WAV files with 5578 as the sampling rate, were transmitted from the
prototype to PC by a C# application through a USB cable. The noises included clips from
loud Rock music, acoustic music, speeches from female and male speakers, and mechanical
noises from working building site. As the natural noises were not non-stationary and the
noise level was difficult to gauge, the minimum and maximum of SNR are presented in
Table 6.1.
From the result presented in Table 6.1, the broadband noises or high-frequency noises with
high ZCR, such as mechanical noises and whistle, showed similar influence as white noise
and the level of obstruction from noises depended on their volume, with accuracy as 54.84%
and 63.24% respectively. The Rock music involved different instruments and contained both
6.2 Preparation Test: Detection test on the developed prototype 126
Table 6.1 The accuracy of detection under different noises
Noise Type Noise Level Sensitivity Specificity Accuracy
Loud music 7 - 25 dB 78.3% 84.6% 66.2%
Acoustic music 10 - 30 dB 94.2% 96.6% 91%
Speech (male) 15 - 35 dB 98.5% 97.9% 96.4%
Speech (female) 17 - 35 dB 96.5% 96.6% 93.2%
Mechanical Noise 10 - 20 dB 78.5% 69.6% 54.84%
whistle 10 - 30 dB 77.5% 81.6% 63.24%
high-frequency and low-frequency elements, which also declined the accuracy to 66.2%.
Regardless of the influence, the used broadband noises were high-volume and rare to be seen
during normal medicine delivery. The user can avoid loud music or mechanical site to reduce
the loss of accuracy. The soft acoustic music or speeches, which were more common during
medication treatment, showed limited influence on the detection.
6.2 Preparation Test: Detection test on the developed pro-
totype
Before more users are taken into account for the user testing experiments, the developed
prototype has been repeatedly tested by the same experimenter to review and confirm the
functionality of the device.
2000 inhaling events had been taken discontinuously during a 2-month period. The 16-bit
solution with the 8-bit compressed inhalation duration and stamped time were used at this
stage. The inhalations were monitored by a developed prototype depicted in chapter 5. Only
the sound of air-flow was tested during the experiment without drug delivery.
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Table 6.2 Performance of initial user testing
Total inhalations TP FP Sensitivity Specificity Accuracy
2000 1912 21 95.6% 98.9% 94.6%
The green LED flashing of good inhalation was monitored as the reference for successful
detection during the test. A flashing after an inhaling event was considered successful and
recorded as TP, and an inhalation without LED flashing was considered as unsuccessful
detection and was recorded as TN. When a non-inhalation was detected by the system, and
the LED flashed without a true event, a case of FP was recorded.
Base on the equations of sensitivity, specificity, and accuracy, the result of the initial testing
experiment is presented in Table 6.2.
95.6% (1912/2000) inhalations had been detected correctly. One external reason for missing
detection was the noisy environment. What was more frequent, the undetected inhalations
were not stable enough or not with the features in the threshold range. A quick and strong
event would shorten the pulse length and its STMD might be higher than the threshold
range. The STMD of inhalation with soft and smooth inhaling habit was lower than normal
inhalation, which indicated inadequate air-flow for effective drug delivery. There was also
potential that the device had not been activated properly.
The TP detected rates of the first three hundred were 97%, 95%, and 96%, and the TP
detected rates of the last three hundred were 97%, 96%, and 98%. The accuracy of detection
has stayed stable without any deterioration of performance during months of usage with
thousands of samples, and the stability of the system was initially guaranteed.
98.9% of 1933 recordings were true inhalations while 21 recordings were redundant noises,
such as air-vibration sound from an exhaust fan, high noise-level continuous mechanical
sound (with lower than 13dB SNR), and the sound of friction when the inhaler or the ring-
shaped protective shelf was scrubbing or rubbing on a hard surface like a wooden table. In
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Table 6.3 Categories of the detected redundant noises
Noise Type Added manually Detected as inhalation Detected rate
Whistle 20 9 45%
Air-vibration - 2 -
Friction 20 4 20%
Mechanical sound - 6 -
Table 6.3, the categories of the 21 detected clips are presented. The sound clips of whistle and
surface friction were caused manually or added intentionally with a certain caused number,
and the rest were natural surrounding sound. From the result, the broadband noises were
depicted to be the main causes of FP. 45% of the whistles affected the system especially
when the duration continued for seconds.
On the basis of event detection, a measurement of inhalation length can present more
comprehensive information to the clinicians. The inhalation length error was defined as the
difference between the recorded time length and the actual time length of each inhalation. The
actual time length was recorded by a reference microphone and an accessorial temperature
sensing system for fidelity. The collected data was transmitted to a PC for further analysis.
Table 6.4 Duration errors of detected length
Duration Errors (second) Sample Amount Proportion
<0.2 396 19.80%
0.2 - 0.4 1119 55.95%
0.4 - 0.6 372 18.6%
0.6 - 0.8 86 4.30%
0.8 - 1.0 22 1.1%
>1.0 5 0.15%
Table 6.4 depicts the result of duration errors (in absolute value). From the duration distribu-
tion, 75.75% of length differences were less than 0.4 seconds. Only 5 among 2,000 samples
(0.15%) involved a measuring fault of longer than 1 second time difference. There was still a
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possibility of activating early endpoints during inhalation, especially when the inhalation was
unstable with low-volume pulses, which was considered as non-inhalation by the system.
6.3 User tests with volunteering participants
After the preparation tests, two groups of volunteering participants have been invited to test
the device. The same prototype from Section 6.2 has been used in the entire user testing
experiment.
The purpose of this testing study was to evaluate the performance of the prototype monitoring
system and to ensure whether it was practical and usable together with assessing its accuracy
of measurement, detection, and recognition. It also informed the development and design
of technology, gathered feedback from users on the device, and solicited user views on
its usability. Instead of a big-group long-term trial, the test was small-scale, low-risk, and
short-time with an immediate response.
The participants used an inert inhaler without any actual drug delivery or propellant. The
usages were under observation during the entire test. Participants were asked to use the
device for 5-8 times during a 20-minute session. The participants were given instructions by
reading the user guide, which was a two-page printed manual with step-by-step description
figures, with auxiliary verbal directions. The evaluation of self-guide ability was considered
as one important part. At the end of the session, the participants were asked about the usages
to solicit their views on the technology.
Two types of adherence reinforcement technology were considered in the user testing ex-
periment. The first design measured and recorded the timings relating to the usage of the
inhaler. The second version provided immediate feedback through the bi-coloured LED by
indicating flashing light indicating the correct usage. The participant tested both versions and
6.3 User tests with volunteering participants 130
solicited their feedback on the LED system, and the detecting accuracy of both technologies
was compared to each other.
The tests were under observation. The behaviour and using habit of participants were
monitored with an accessional record. The direct feedback signals from LED were also
monitored to manifest whether the light flashed before the actual end of the inhalation.
Participants were contacted through the established research volunteering mailing list of
the University of Sheffield after receiving a favourable ethics opinion, reference 016858
(Appendix B). All collected data has been kept strictly confidential. During this user testing,
no drug delivery or propellant was involved. The breathing pattern was monitored during the
usage without inhaling any substance. Each participant used a brand new one-off disposable
3D-printed mouthpiece to avoid any possible cross-infection risks.
During the user testing sessions with volunteers, the thermistor was used with the designed
sound detecting system. The experimental setup is depicted in Fig. 6.2.
Fig. 6.2 The experimental setup for user testing experiments with volunteers. The thermistor
was working along with the sound detecting system.
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6.3.1 The first group of volunteers
The first group consisted of 8 volunteers who had some restriction of lung function, such as
asthma or CF. The duration of each session was around 20 minutes. As the participants had
been using inhalers (pMDI or DPI), each of them had own inhaling habit. The first inhalation
was conducted and recorded following only printed paper instruction without further verbal
instructions to observe their own inhaling habits and whether their inhalations could be
detected by the system. 3 out of 8 participants were able to activate the detection in their first
attempts. When an inhaling event was ignored by the system and did not be recorded, it is
indicated that the inhalation involved soft or unstable inspiratory flow. Subsequently, the
participants were told to inhale stronger or steadier. One participant managed to activate the
device until the third attempt.





Inhalations Recordings inhalations excluded)
51 42 42 82.4% 90.7% 0 100%
According to the result presented in Table 6.5, 82.4% (42/51) of inhalations were detected
in the session. As the first inhalation was not verbally guided and only followed the own
inhaling style of each participant, the detected rate of TP was 90.7% (39/43) when the
first inhaling events were not included. As all the inhaling events were under observation,
it was clarified that the non-detected inhalation could be too short, soft, fast, or unsteady
comparing to the pre-set threshold value. No false-positive result has been recorded during
the sessions. Comparing to the previous study with pre-recording system [60], which presents
the sensitivity of 95%, the specificity of 94% and accuracy of 89%, the sensitivity of the
developed real-time system was 4.3% lower with higher specificity. As an early-stage
prototype, 9.3% as FN indicates that the system has the ability to detect inhalation.
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Subsequent to the sessions, recorded data was analysed against a reference stopwatch and
reference temperature sensor for fidelity and the questionnaires studied in terms of usability
and practicality to inform further device refinement. The duration difference in the stage
was calculated by actual duration minus recorded duration from on-chip storage. It can be
defined as:
DurationDi f f erence = Re f erenceDuration−DetectedDuration (6.1)
The duration difference comparing to the stopwatch
To define the reference true inhalation length, a trained experimenter used a stopwatch to
measure the duration of inhalation during the sessions. Due to the time delay of human
reflection or other external factors, error existed on this methodology. To estimate the
approximate duration difference of using a stopwatch, it was used by the same experimenter
to measure 50 inhalation samples for training before the user testing sessions. The result
was compared on the measured duration using a PC segmentation MATLAB system with
recordings of same inhalations. The duration difference of 50 samples between the PC system
and the stopwatch was 0.34 ± 0.22 seconds (mean ± standard deviation), which should be
considered in the later analysis.
Fig. 6.3 presents the duration difference and missed detection of each participant. The actual
duration was estimated based on the collected data from a stopwatch and a temperature
sensor with an approximate ± 0.4 seconds duration difference.
The duration difference comparing to the thermistor
Besides the stopwatch, a 223Fu5183-63021 thermistor from ATC Semitec Ltd [165] was used
as another reference of duration length. The hardware system was built on the micro-chip






























Fig. 6.3 Duration difference and missed detection of each participant in group 1
ATtiny85 [166] by Dr Tim Good. A novel temperature sensing system for demarcating
inhalation was developed in this research. The selected thermistor was cylindrical with 0.51
mm as the diameter and 2.226 mm as the length. It was very tiny and able to be inserted into
the chamber through the mouthpiece via an air-hole. The inhalation recognising system was
developed based on temperature changing due to airflow. It was designed to be very sensitive
to any temperature changing inside the chamber. An inhalation would usually cause a drop
of temperature due to the air flow in room temperature from outside of the mouthpiece. On
the other hand, exhalation was from the human body with a higher human temperature and
would increase the temperature inside the chamber.
The changes in temperature were monitored by the sensing system and recorded as a text
file. The duration length was then estimated based on the temperature changes. As the
air circulation was limited inside the chamber, the internal temperature changing might be
restively stable with a possible delay added to endpoints.











































Fig. 6.4 The distribution of duration difference against temperature sensing and stopwatch of
Group 1
Fig. 6.4 presents the histogram of duration difference against temperature sensing and
stopwatch. The presented range is a ceiling value, which means each number represents a
range from the former number to the number itself. For instance, in category 0, the duration
difference of samples distributes from -0.2 to 0 seconds. And in category 0.6, samples have
duration difference from 0.4 to 0.6 seconds.
According to the histogram, the duration errors against stopwatch of 42 detected samples
were from -0.6 seconds to 1.6 seconds. 83.3% of detected inhalations were shorter than
the actual duration, which indicated the possibility of early endpoints or delay due to using
stopwatch. The accessional record clarified that during 54.05% of the inhalations, the LED
flashed before the actual end of the inhalation.
For the temperature sensing system, the duration difference distributed from -2 seconds to
1.2 seconds. Comparing to the estimated result of the stopwatch, the temperature sensing
was not significantly biased, which also indicated a possible delay for using the stopwatch.
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From the result, the duration difference of 92.8% (39/42) of samples was limited in 1 second,
and 52.3% was limited in 0.4 seconds.
6.3.2 The second group of volunteers
The second group consists of 7 volunteers. Before the sessions, the threshold value has been
adjusted to avoid early detection. The threshold ranges of the ZCR and the STMD extended
for 10%. Each session took around 18 minutes. The result is depicted in Table 6.6.
Table 6.6 Performance of initial user testing in group 2
Total Total
TP Sensitivity FP Specificity Accuracy
Inhalations Recordings
63 60 58 92.1% 2 96.67% 89.03%
92.1% of inhalations were correctly detected while scant inhalation, which was too mild or
too short, were neglected and discarded by the system. The mild short inhalations generally
continued for less than 2 seconds with less than 1-second effective medicine delivery that
needed strong air-flow to reach the target organ. Undetected inhalations usually occurred
to participants in the specific groups, and the odds of insufficient air-flow related to various
covariates, including gender, age, and other body conditions of participants [19, 31, 18].
Two participants took the sessions in noisy environments (with averagely lower than 13dB
SNR) and the continuous white noise affected the detection. Two FP inhalations have been
tagged as inhalations. It was clarified that the continuous broadband noise would be detected
redundantly, which may also result in a delayed end of detection and caused extended
measured duration data.
Besides air-flow delivery and environment, other covariates have also affected the result
of detection in the second group, including the inexperienced skill of using DPIs and
misunderstanding of instructions.
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Subsequent to the sessions, the result was analysed comparing to a visual and auditory
demarcation using a reference microphone (with a Smartphone recording application) and
the reference thermistor to test the fidelity of the system.
The duration difference comparing to the human demarcation and temperature sens-
ing
As the average error of stopwatch measurement was still considerably high, another method-
ology to define the reference duration had been introduced. During sessions in the second
group, the original inhalations were recorded by a mobile recording application. Only the
sound clips of inhalation had been collected with the consent of each participant. The record-
ings were marked and time-stamped respectively and manually by the experimenter, which
were later transmitted to a PC and analysed on Audacity. The endpoints of segments were
recognised visually by looking at the waveform and auditorily by hearing the recordings.
The system was still based on human demarcation but showed more reliability than the
stopwatch as the segmentation could be repeated to reduce error and it was easier to observe
and demarcate the waveform visually.
Fig. 6.5 depicts the duration difference and the faulty-detection of inhalation. Comparing to
the result before feature adjustment, the number of missed detection has been declined due
to the adjusted threshold value of selected features. It was clearer that missed detection and
redundant detection are more likely to occur in specific cases, getting affected by environment
and individual differences. For participants with a lower vital capacity, their inhalations were
usually shorter and softer, with the higher possibility to be neglected or discarded. On the
other hand, the false positive result is often be detected under noisy environment.
Fig. 6.6 shows the histogram of duration difference against temperature sensing and human
demarcation. The measurement improves from the first test.



























Fig. 6.5 The duration difference and missed detection of each participant in group 2






































Temperature Sensor Manual Demarcation
Fig. 6.6 The distribution of duration difference against temperature sensing and human
demarcation of Group 2
For human demarcation, the errors were from -1.4 seconds to 0.8 seconds. 98.3% (57/58) of
error differences were limited in the 1-second range, and 72.8% (42/58) of measured data
had an error of fewer than 0.4 seconds. The duration difference of the temperature sensing
system distributed from -1.6 seconds to 1.2 seconds. According to the shown result, the
duration difference of 94.8% (55/58) of samples was limited in 1 second, and 62.1% was
limited in 0.4 seconds.
The 8-bit compression used the same coding method of duration as the full 16-bit solution,
and the coded data value of duration stayed the same. The accuracy of the 4-bit solution
dropped slightly with higher compression and the 0.3-second resolution. As the coding
method rounds down and truncates the remainder that exceeded the 0.3-second resolution,
the errors contained a positive increment up to 0.3 seconds.
The duration difference against human demarcation of group 2 with the 4-bit compressed
solution is demonstrated in Fig. 6.7. With the positive increment due to number truncation,































Fig. 6.7 The histogram of duration difference with 4-bit solution against human demarcation
the errors were from -1.2 seconds to 1 second. 98.3% (57/58) of error differences were still
limited in the 1-second range, and 77.6% (45/58) of measured data had an error of fewer than
0.4 seconds. The average duration error increased slightly but remained in the acceptable
range.
6.3.3 The feedback from participants
The size and portability
The participants agreed that the size of the device was small, lightweight, and convenient to
be carried. According to the given information, some existing assistive devices, such as a
chamber, might be cumbersome and not easy to be taken along. The electronic monitoring
system in this research add slight extra weight and take limited space alongside the inhaler.
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They also agreed that the attached electronic chip would not affect medicine delivery or
block air-flow during inhalation, and the usage of inhalers was not affected by the additional
monitoring system.
The functionality
86% of the participants thought the monitoring system would be useful for both asthma
and CF patients while some participants thought it would be useful for CF patients but not
necessary for asthma patients as the inhalers were only used when they were uncomfortable
for easing the symptom in a short time. The mentioned inhalers are actually reliever inhalers,
which delivers medicine directly to the lungs and relaxes the muscles surrounding airways
[167]. However, very few people with asthma only need a reliever inhaler, and most of
them benefit from preventer inhalers [168]. Preventer medicine helps to build up the asthma
protection and should be taken as prescribed every day to prevent symptoms. The preventer
inhalers are the main sources of non-adherence to asthma treatment and need to be monitored.
3 participants informed that their inhalations might not reach the standard of a good inhalation
during their past usage according to the evaluation from clinicians or physicians. In these
cases, the participants were happy with the monitoring system with direct feedback and they
could improve the inhalation immediately without getting professional evaluation after a
long-time gap.
The current version of the feedback system was designed to flash as a confirmation of a good
inhalation. One participant suggested that it would be nice to use it as a sign of enough
duration length and the user would know when to stop inhaling. But using the light as a finish
sign may cut or shorten the inhalation. All participants in group 2 agreed that the feedback
system might aid a good self-evaluation, while some participants pointed out that the users
might ignore the light if they have been using it for a long period.
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Inhalation without LED feedback might be inadequate when the clips were taken at the
beginning of the tests. After looking at the LED, they knew what to do to activate the
LED. During a short-time observed test, they could always follow the direction. The main
target in the future work is to prove that the functionality will not decline during long-term
non-observed tests.
The LED
13% of the participant found the LED was not easy to be observed as it was too small and too
close to eyes, especially for people with limited vision. 2 participants preferred an acoustic
warning signal, such as a loud whistling sound, as they were easier to be noticed.
The 5-second countdown system
93% of the participants found the 5-second breath-holding was difficult to be estimated
without the countdown flashing and they agreed that the reminder was important. Some
participants still pointed out that the flashing might be ignored when the patient was holding
breath.
6.3.4 The comprehensive discussion of user testing experiments
During the user tests, the functionality and portability of the developed prototype were tested
by 15 users (60% female) with feedback solicited. The information of inhalation pulse length
(duration), date and time of each event, and identification information of each participant for
distinguishing were stored in the memory of the monitoring system. The inhalations were
also observed, evaluated, and recorded to an additional document by two members of the
experimental group. The participants were giving direct feedback during the test, the related
information was recorded for the later refinement.
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The tests were conducted under multiple environments with the possibility of being influenced
by surrounding noises. According to the previous analysis of detection against SNR, noisy
environment did affect detection, and broadband signals might obstruct the system especially.
Most user tests (10 of 15) were completed in a quiet room with a noise level of approximate
15-30 dB SNR, with exceptions that were underway under the noisier environment of 0 to 8 dB
SNR in group 2. Sometimes the background noises were even louder than inhalation. Noisy
environment increases the probability of FP result and extends the duration by redundant
detection. The result of detection nevertheless kept its performance with an overall 89.03%
of accuracy.
The result might also be influenced by the differences between personal characteristics, such
as age, body condition, length of adherence, using skills, and inhaling habits, which can
be inherent and not easy to be modified during the short-time experiment. The acoustic
features of their inhalations varied due to the differences in air-way delivery, which was
closely related to their vital capacity.
The participants were not long-time patients with CF and had not received any professional
training with essential instructions for using Podhaler from clinical staff. The instructions
were only told verbally with two pages of diagrams during a 2-minute pre-session, while a
full professional training may be essentially required for a later trial or an actual long-term
treatment. The accuracy of detection is looking for an ascent if necessary training is involved
before the session.
During the preparation tests and the user testing experiments, which contains thousands
of inhalation events, the system keeps its full functionality based on a single charge of the
battery. After the experiments, the voltage from the power supply is still higher than 90% of
the value from a full battery. The low-power processing and system design initially show the
advantages to retain functionality during a long-period treatment with the ability and stability
to handle and process thousands of detection.
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The initial small-scale two-phase user tests focused on short-time functionality, portability,
and accuracy of detection, and the tests were under direct observation with verbal instructions
from trained experimental members. Therefore, practicality and stability during long-term
treatment have not been proved. The potential data loss of medication adherence due to
forgetfulness and unskilled usage as time goes on has not been checked in each 20-minute
session. More information will be gathered in later experiments.
Chapter 7
Conclusions and recommendation of
future work
The chapter summarises the performance of the constructed prototype of the novel adherence
monitoring system. The developed low-cost, low-power, portable technology shows good
performance in inhalation detection, discrimination and duration measurement. It presents
the contribution to knowledge alongside with suggestions for possible future work.
7.1 Summaries and conclusions
The summary of the system
A comprehensive analysis of the treatment of CF requires a reliable adherence monitoring
system to make sure the patient is receiving sufficient doses of prescribed regimen delivered
through effective inhalation, which can be detected and measured during the usage. Therefore
an efficient inhalation detecting system may aid evaluating the inspiratory flow rate of
medicine delivery and providing crucial clinical information of medication dosing. The need
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for a low-cost, low-power, portable technique to monitor adherence remains important. This
research has focused on adherence monitoring of CF for long-term home treatment.
One main target of the thesis is analysing the usage of inhaler and demonstrating whether it
has been used properly for a further study of medication effect. There are several modalities
of incorrect usage such as missing doses, the excessive or scant interval between doses, low
inspiratory flow rate, insufficient inspiratory duration, inhaling too fast, and using inhalers
without a holding-breath pause or with an unnecessarily long pause.
With the self-printed finger-sized prototype rather than a previous RFduino board, the power
consumption and financial cost are declined with a penalty in the reduction of available RAM
being reduced to 1 KB. The memory space is limited for a complex calculation like cepstral
or multi-dimension measurements. The data need to be kept on a small scale, allowing either
the calculation or storage fitting in available resources. With the broadband characteristic of
the target signal, frequency-domain features are not providing sufficient useful information to
justify their high computational expense, whereas simple time-domain features are offering
discernible discriminating information with lower computational effort.
Among candidate features, the ZCR, the STMD, and the pulse length contribute most to
identify inhalation separated from complex background interference. The accuracy of the
combination of ZCR and STMD reached 88.7%, which is the best 2-feature solution. The
accuracy reached 96% when the PL was introduced to avoid interfere from short broadband
noises, and short inhalation, which indicated insufficient airflow, will also be eliminated
when the detected length is scant. The sensitivity of the optimal 3-feature solution is 97.5%,
and the specificity is 98.5%.
The portable ring-shaped device is attached to a TOBI Podhaler, including a lightweight
low-power processing prototype of adherence detection, a flat bendable battery, and the
antenna coil as an external component. The device is a healthcare monitoring equipment
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which can achieve real-time evaluation and record clinical information. The device can
function continuously for a long period before the battery runs out and fit a 28-day treatment
expectantly from the setting date.
The system contains the gesture detection mode, the inhalation detecting mode, the result
storing mode, and the final data transmission mode. It stays in a sleep mode with low power
consumption when the system is idle and saves power in this way. It can go back to the sleep
mode from the other modes if any unexpected situation occurs to avoid faulty functionality.
The data are kept in the small size to fit the limited memory and can be stored inside the
device before it is exported to a terminal. The attached bi-colour LED gives out an immediate
assessment of inhalation and provides the real-time direct feedback of the self-evaluation to
users.
The summary of the result
The noise testing experiments and a two-phase initial user testing experiment evaluated the
functionality, practicality, and applicability of the device with high accuracy of detection
against different levels of noise.
In the noise testing experiments, noises of different volume were added to the recorded
sample. The detected rate was higher than 80% under 13 dB SNR. 92.8% of samples were
detected of 20 dB SNR, and it was 97.6% when the SNR was 35 dB. The duration difference
against reference among 500 samples is 93 ± 37 (mean ± standard deviation) ms.
During the preparation tests, the tests were completed under natural environment, with
random surrounding noises from 0 dB to 35 dB. More than 80% of inhalations can be
correctly detected when the SNR was higher than 13 dB. When the SNR was 20 dB, 92.8%
among the inhaling samples had been identified and marked correctly, and it reached 97.6%
when the SNR was 35dB. Among 500 inhalations, the average duration difference of 500
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inhalations between the reference from human demarcation and the detected length was 93 ±
37 (mean ± standard deviation) ms. The difference is less than 3% when the duration length
is longer than 3 seconds.
2000 inhalations were tested by the same user to test the prototype. With the sensitivity rate
being 95.6% and the specificity rate being 98.9%, the accuracy of the device was calculated
to be 94.6%. Comparing to a previous study with pre-recording system [60], which presents
the accuracy of 89%, the performance of the developed system has been initially proven to
be reliable and ready to be used by different participants.
In the user testing experiments with volunteering participants, two groups of volunteers have
been invited to use the monitoring system during regular inhalation. 82.4% of the inhaling
events have been detected correctly under their own inhaling habit and quality of inspiratory.
The detected rate of TP was 90.7% when the first non-instructed inhalations were not taken
into account. The error duration of 92.8% (39/42) of samples was limited in 1 second, and
52.3% was limited in 0.4 seconds.
The features were slightly adjusted for the second group of participants to adapt to the
inhaling habits of more users. With the sensitivity rate being 92.1% and the specificity rate
being 96.67%, the accuracy of the device was calculated to be 89.03%, which was similar to
the previous study with pre-recording system [60] with 89% as the accuracy. 98.3% of the
error differences are less than 1 second, and 72.8% of them are less than 0.4 seconds. For
a duration that longer than 4 seconds, the duration difference that shorter than 0.4 seconds
presents 90% accuracy, which was adequate enough for the further study about whether the
inhaling habit and inhalation length will affect the performance of medicine.
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7.2 Suggestions for further work
1. The user testing sessions have initially proved the performance of the detection system.
A long-term clinical trial is in need to further prove that the adherence monitoring system
can keep its stability and functionality for a long treatment. The result and feedback will be
used as part of an iterative user-centred design process, and subsequent to this stage of the
research, the technology will be further refined before wider testing with the NHS patients
and healthcare professionals next spring. The coding to meet medical device standards will
be discussed with medical professionals and the manufacturer of devices. The improved 8-bit
coding compression of inhalation length will be used in the medical experiments and trials.
2. The experiment and the processed data are the air-flow inhaling sound without any drug
delivery or propellant. In the next stage, with further cooperation with clinics, the sound of
actual drug delivery will be collected for feature adjustments. An iterative user-centred design
process will analyse the collected data. Subsequent to user testing sessions, the technology
needs to be refined before clinical testing with NHS patients and healthcare professionals.
3. After analysing the result and feedback from the volunteering participants, a self-evaluation
to identify soft inhalation is considered useful. The current version abandons the incorrect
inhalations without clarifying the doses are missed or not being taken properly. Although
counting the left capsules may help to understand how many doses have been taken, a soft
inhalation detector can recognise improper inhalation and presents the habit of users.
4. A double shake is used as the wake-up activating signal for the current version. In
the future design, an automatic wake-up system would be developed to avoid the effect of
forgetfulness.
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[82] H. Bořil and P. Pollák. Direct time domain fundamental frequency estimation of
speech in noisy conditions. In 2004 12th European Signal Processing Conference,
pages 1003–1006, Sept 2004.
[83] F. Jin and F. Sattar. A new automated approach for identification of respiratory sounds.
In 2007 IEEE International Conference on Multimedia and Expo, pages 356–359,
July 2007.
[84] A. Mondal and H. Tang. Respiratory sounds classification using statistical biomarker.
In 2017 39th Annual International Conference of the IEEE Engineering in Medicine
and Biology Society (EMBC), pages 2952–2955, July 2017.
[85] C. D. Papadaniil and L. J. Hadjileontiadis. Efficient heart sound segmentation and
extraction using ensemble empirical mode decomposition and kurtosis features. IEEE
Journal of Biomedical and Health Informatics, 18(4):1138–1152, July 2014.
[86] M. Ross, H. Shaffer, A. Cohen, R. Freudberg, and H. Manley. Average magnitude
difference function pitch extractor. IEEE Transactions on Acoustics, Speech, and
Signal Processing, 22(5):353–362, October 1974.
[87] T. Shimamura and H. Kobayashi. Weighted autocorrelation for pitch extraction of
noisy speech. IEEE Transactions on Speech and Audio Processing, 9(7):727–730, Oct
2001.
[88] T. E. Tremain. The government standard linear predictive coding algorithm: Lpc-10.
Speech Technology Magazine, page 40–49, April 1982.
References 156
[89] W. Zhang, G. Xu, and Y. Wang. Pitch estimation based on circular amdf. In 2002
IEEE International Conference on Acoustics, Speech, and Signal Processing, pages
I–341–I–344, May 2002.
[90] H. Tanaka M. S. Rahman and T. Shimamura. Pitch determination using aligned amdf.
In Proc. INTERSPEECH 2006, pages 1714–1717, 2006.
[91] G. Muhammad. Noise robust pitch detection based on extended amdf. In 2008 IEEE
International Symposium on Signal Processing and Information Technology, pages
133–138, Dec 2008.
[92] Muhammad G Abdullah-Al-Mamun K, Sarker F. A high resolution pitch detection
algorithm based on amdf and acf. Journal of Scientific Research, 1(3):508–515, 2009.
[93] Kobayashi T. Abe, T. and S. Imai. The if spectrogram: A new spectral representation.
Proc. ASVA 97, page 423–430, 1997.
[94] Hugo L. Rufiner Leandro D. Vignolo, Diego H. Milone. Geneticwavelet packets for
speech recognition. Expert Systems with Applications, 40:2350–2359, 2013.
[95] Z. Yessenbayev. Robust segmentation of speech signal using mfcc and acoustic
parameters. In 2012 Sixth Asia Modelling Symposium, pages 103–108, May 2012.
[96] Y. Zhang, K. Wang, and B. Yan. Speech endpoint detection algorithm with low
signal-to-noise based on improved conventional spectral entropy. In 2016 12th World
Congress on Intelligent Control and Automation (WCICA), pages 3307–3311, June
2016.
[97] B. Ayoub, K. Jamal, and Z. Arsalane. Gammatone frequency cepstral coefficients
for speaker identification over voip networks. In 2016 International Conference on
Information Technology for Organizations Development (IT4OD), pages 1–5, March
2016.
[98] A. Kyriakides, C. Pitris, A. Fink, and A. Spanias. Isolated word endpoint detection
using time-frequency variance kernels. In 2011 Conference Record of the Forty
Fifth Asilomar Conference on Signals, Systems and Computers (ASILOMAR), pages
1041–1045, Nov 2011.
[99] Kamil Aida-zade, Cemal Ardil, and Samir Rustamov. Investigation of combined use
of mfcc and lpc features in speech recognition systems. Signal Processing, 01 2007.
[100] J. S. Erkelens and P. M. T. Broersen. On the statistical properties of line spectrum
pairs. In 1995 International Conference on Acoustics, Speech, and Signal Processing,
volume 1, pages 768–771 vol.1, May 1995.
[101] Lie Lu, Hong-Jiang Zhang, and Hao Jiang. Content analysis for audio classification
and segmentation. IEEE Transactions on Speech and Audio Processing, 10(7):504–
516, Oct 2002.
[102] Hermansky H. Perceptual linear predictive (plp) analysis of speech. Acoustic, Soc,
Am., 87(4):1738–1752, 1990.
References 157
[103] K. Kumar, C. Kim, and R. M. Stern. Delta-spectral cepstral coefficients for robust
speech recognition. In 2011 IEEE International Conference on Acoustics, Speech and
Signal Processing (ICASSP), pages 4784–4787, May 2011.
[104] J. Fu, S. W. Wang, X. L. Cao, M. L. Jiang, S. H. Zhang, and X. Zhao. The research on
speech endpoint detection algorithm based on spectrogram row self-correlation. In
Proceedings of 2012 2nd International Conference on Computer Science and Network
Technology, pages 212–216, Dec 2012.
[105] C. Zhang and M. Dong. An improved speech endpoint detection based on adaptive
sub-band selection spectral variance. In 2016 35th Chinese Control Conference (CCC),
pages 5033–5037, July 2016.
[106] Wang K C Wu B F. Robust endpoint detection algorithm based on the adaptive
band-partitioning spectral entropy in adverse environments. IEEE Transactions on
Speech & Audio Processing, 13(5):762 – 775, 2005.
[107] H. Zhiyan and W. Jian. Research on speech endpoint detection under low signal-to-
noise ratios. In The 27th Chinese Control and Decision Conference (2015 CCDC),
pages 3635–3639, May 2015.
[108] M. Sifuzzaman and M Rafiq Islam. Application of wavelet transform and its ad-
vantages compared to fourier transform. Journal of Physical Sciences, 13:121–134,
2009.
[109] C. Yali, L. Dongsheng, J. Shuo, and N. Xuefen. A speech endpoint detection algorithm
based on wavelet transforms. In The 26th Chinese Control and Decision Conference
(2014 CCDC), pages 3010–3012, May 2014.
[110] M. R. K. Mollaei M. Eshaghi. Voice activity detection based on using wavelet packet.
Digital Signal Processing, 20(4):1102–1115, 2010.
[111] Shaohua Feng Yanyan Jiang Jianwei Ma Bin Zhang Lu Liu, Siming Ma. Envelope
extraction of anaesthesia breathing sound signal on hilbert huang transform. Procedia
Engineering, 29:2693–2698, 2012.
[112] V. Rapcan, S. D’Arcy, and R. B. Reilly. Automatic breath sound detection and
removal for cognitive studies of speech and language. In IET Irish Signals and
Systems Conference (ISSC 2009), pages 1–6, June 2009.
[113] Bassi A Vivaldi EA Díaz JA, Arancibia JM. Envelope analysis of the airflow signal to
improve polysomnographic assessment of sleep disordered breathing. Sleep, 37(1):199–
208, 2014.
[114] Richard Lyons. Dsp tricks: Approximate envelope detection.
https://www.embedded.com/design/configurable-systems/4210780/
DSP-Tricks--Approximate-envelope-detection, 2010. [Accessed: 7 June 2017].
[115] P. Delacourt and C.J. Wellekens. Distbic: A speaker-based segmentation for audio
data indexing. Speech Communication, 32(1):111 – 126, 2000. Accessing Information
in Spoken Audio.
References 158
[116] R. Bakis et. al. Transcription of broadcast news shows with the ibm large vocabulary
speech recognition system. in DARPA Speech Recognition Workshop, 1997.
[117] Theodorou T. An overview of automatic audio segmentation. International Journal of
Information Technology & Computer Science, 6(11), 2014.
[118] H. Beigi and S. Maes. Speaker, channel and environment change detection. in World
Congress on Automation. Citeseer, 1998.
[119] B. H. Juang and L. R. Rabiner. Hidden markov models for speech recognition.
Technometrics, 33(3):251–272, 1991.
[120] A. Dufaux, L. Besacier, M. Ansorge, and F. Pellandini. Automatic sound detection
and recognition for noisy environment. In 2000 10th European Signal Processing
Conference, pages 1–4, Sept 2000.
[121] H. Lo, J. Wang, and H. Wang. Homogeneous segmentation and classifier ensemble
for audio tag annotation and retrieval. In 2010 IEEE International Conference on
Multimedia and Expo, pages 304–309, July 2010.
[122] V. Vapnik. An overview of statistical learning theory. IEEE Trans. on Neural Networks,
10(5):988–999, 1999.
[123] T. Takagi and M. Sugeno. Fuzzy identification of systems and its applications to
modeling and control. IEEE Transactions on Systems, Man, and Cybernetics, SMC-
15(1):116–132, Jan 1985.
[124] G. Wu, Z. Zhu, and A. Li. Fuzzy neural networks for speech endpoint detection. In
2012 International conference on Fuzzy Theory and Its Applications (iFUZZY2012),
pages 354–356, Nov 2012.
[125] Yoav Freund and Robert E Schapire. A decision-theoretic generalization of on-line
learning and an application to boosting. Journal of Computer and System Sciences,
55(1):119 – 139, 1997.
[126] J. Li, W. Dai, F. Metze, S. Qu, and S. Das. A comparison of deep learning methods for
environmental sound detection. In 2017 IEEE International Conference on Acoustics,
Speech and Signal Processing (ICASSP), pages 126–130, March 2017.
[127] Jun Huang, Y. Dong, Jiqing Liu, Chengyu Dong, and H. Wang. Sports audio seg-
mentation and classification. In 2009 IEEE International Conference on Network
Infrastructure and Digital Content, pages 379–383, Nov 2009.
[128] Huawen Liu, Jigui Sun, Lei Liu, and Huijie Zhang. Feature selection with dynamic
mutual information. Pattern Recognition, 42(7):1330 – 1339, 2009.
[129] Mathias Lohne. The computational complexity of the fast fourier transform. https:
//folk.uio.no/mathialo/texts/fftcomplexity.pdf, 2017.
[130] Hassan Ghasemzadeh, Navid Amini, and Majid Sarrafzadeh. Energy-efficient signal
processing in wearable embedded systems: An optimal feature selection approach.
Proceedings of the International Symposium on Low Power Electronics and Design,
pages 357–362, 07 2012.
References 159
[131] Audacity. http://www.audacityteam.org/, 2018. [Accessed 25 June 2015].
[132] Inven Sense. Inmp441. https://www.invensense.com/products/digital/inmp441/, 2014.
[Accessed: 7 July 2015].
[133] Isabelle Guyon and André Elisseeff. An introduction to variable and feature selection.
Machine Learning Research, 3:1157–1182, March 2003.
[134] Sigma Plus Statistiek. Pearson correlations - quick introduction. https://www.
spss-tutorials.com/pearson-correlation-coefficient/, 2018. [Accessed: 4 November
2018].
[135] J. L. Rodgers and W. A. Nicewander. Thirteen ways to look at the correlation
coefficient. The American Statistician, 42(1):59–66, 1988.
[136] X. Zhi, S. Yuexin, M. Jin, Z. Lujie, and D. Zijian. Research on the pearson correla-
tion coefficient evaluation method of analog signal in the process of unit peak load
regulation. In 2017 13th IEEE International Conference on Electronic Measurement
Instruments (ICEMI), pages 522–527, Oct 2017.
[137] Patrick Mannion. Comparing low-power wireless technolo-
gies. https://www.digiauthor.co.uk/en/articles/techzone/2017/oct/
comparing-low-power-wireless-technologies, 2017.
[138] Bluetooth SIG Inc. Radio versions. https://www.bluetooth.com/bluetooth-technology/
radio-versions, 2018. [Accessed: 1 August 2018].
[139] 2018 Bluetooth SIG Inc. Topology options. https://www.bluetooth.com/
bluetooth-technology/topology-options, 2018. [Accessed: 1 August 2018].
[140] 2018 Bluetooth SIG Inc. Sig introduces bluetooth low-energy wire-
less technology, the next generation of bluetooth wireless tech-
nology. https://www.bluetooth.com/news/pressreleases/2009/12/17/
sig-introduces-bluetooth-low-energy-wireless-technologythe-next-generation-of-bluetooth-wireless-technology,
note = [Accessed: 1 August 2018], 2018.
[141] Cameron Faulkner. What is nfc? everything you need to know. https://www.techradar.
com/uk/news/what-is-nfc, May 2017. [Accessed: 23 Dec 2017].
[142] Blue Calypso Inc. Near field communication (nfc). http://bluecalypso.com/
what-we-do/activation-methods/nfc, 2018. [Accessed: 20 April 2018].
[143] NFC Forum. Technical specifications. https://nfc-forum.org/
our-work/specifications-and-application-documents/specifications/
nfc-forum-technical-specifications/, 2018. [Accessed: 15 Sep 2018].
[144] Square Inc. Near field communication. http://nearfieldcommunication.org/, 2017.
[Accessed: 2 Jun 2018].
[145] Premier Farnell Limited. Cc2541f128rhat. https://uk.farnell.com/texas-instruments/
cc2541f128rhat/ic-soc-bluetooth-2-4ghz-40vqfn/dp/2281643, 2018. [Accessed: 1 Jun
2018].
References 160
[146] Premier Farnell Limited. M24sr02-ydw6t-2. https://uk.farnell.com/stmicroelectronics/
m24sr02-ydw6t-2/nfc-rfid-tag-2kbit-13-56mhz-tssop/dp/2396467, 2015. [Accessed:
1 Jun 2018].
[147] Square Inc. Near field communication versus bluetooth. http://nearfieldcommunication.
org/bluetooth.html, 2017. [Accessed: 15 Dec 2017].
[148] Henning Siitonen Kortvedt and Stig F. Mjølsnes. Eavesdropping near field communi-
cation. https://www.researchgate.net/publication/265976861_Eavesdropping_Near_
Field_Communication, 02 2019.
[149] Panasonic Industrial Devices. https://industrial.panasonic.com/content/data/SC/ds/
ds4/MN63Y1213_E.pdf, 2015. [Accessed: 7 July 2015].
[150] Identiv Inc. Scl010/scl011 contactless smart card reader. https://support.identiv.com/
scl010-scl011/, 2018. [Accessed: 10 May 2018].
[151] P. Noll. Mpeg digital audio coding. IEEE Signal Processing Magazine, 14(5):59–81,
Sept 1997.
[152] Y. Tarui, Y. Hayashi, and K. Nagai. Electrically reprogrammable nonvolatile semicon-
ductor memory. IEEE Journal of Solid-State Circuits, 7(5):369–375, Oct 1972.
[153] Texas Instruments Incorporated. Msp430fr573x mixed-signal microcontrollers. http:
//www.ti.com/product/msp430fr5736, 2011. [Accessed: 12 May 2015].
[154] Fujitsu Semiconductor America Inc. Non-volatile ferroelectric random access memory
(fram). https://www.fujitsu.com/us/Images/SPBG_FRAM_Overview_BR.pdf, 2015.
[Accessed: 10 Dec 2017].
[155] Panasonic Semiconductor Solutions Co. Ltd. Mn63y1221: Nfc tag
lsis. https://industrial.panasonic.com/tw/products/semiconductors/nfctags/lsis/
nfc-tag-lsis/MN63Y1221, 2016.
[156] RFduino. Rfduino. http://www.rfduino.com/, 2013. [Accessed: 15 April 2015].
[157] STMicroelectronics. Mems digital output motion sensor: ultra low-power high
performance 3-axis “femto” accelerometer. https://www.st.com/resource/en/datasheet/
dm00042751.pdf, 2011. [Accessed: 20 August 2016].
[158] Texas Instruments Incorporated. Msp430fr57xx family user’s guide.
http://www.ti.com/general/docs/lit/getliterature.tsp?baseLiteratureNumber=
slau272&fileType=pdf, 2018. [Accessed: 20 Sept 2018].
[159] West J.E. Sessler, G.M. Self-biased condenser microphone with high capacitance.
Journal of the Acoustical Society of America, 34(11):1787–1788, 1962.
[160] Woon Seob Lee Seung S. Lee. Piezoelectric microphone built on circular diaphragm.
Sensors and Actuators A: Physical, 144(2):367 – 373, 2008.
[161] Analog Devices Inc. Admp401: Omnidirectional microphone with bottom port and
analog output obsolete data sheet. https://www.analog.com/en/products/admp401.html,
2012.
References 161
[162] Invensense. Inmp522: Ultra-low noise, low sensitivity tolerance, pdm digital micro-
phone. https://www.invensense.com/products/digital/inmp522/, 2014.
[163] Jerad Lewis. Analog and digital mems microphone design considerations. Analog
Devices Technical Note MS2472, 2013. [Accessed 18 March 2016].
[164] Allergan. Aerochamber plus flow-vu. http://www.aerochambervhc.com/, 2011. [Ac-
cessed: 10 August 2018].
[165] ATC Semitec. Thermistors. https://atcsemitec.co.uk/, 2018.
[166] Atmel. Atmel 8-bit avr microcontroller in-system programmable flash. https://www.
microchip.com/wwwproducts/en/ATtiny85, 2013.
[167] Asthma UK. Reliever inhalers. https://www.asthma.org.uk/advice/
inhalers-medicines-treatments/inhalers-and-spacers/reliever/, 2019.




Title of research project: Dry powder inhaler adherence monitoring device
Name of lead researcher: Dr Mohammed Benaissa, University of Sheffield
Thank you for your interest in taking part in this study. Before you decide whether to take
part, it is important that you understand why the research is being done and what it will
involve for you. Please read the information provided carefully, and discuss it with others
if you wish. Please ask us if there is anything that is not clear or if you would like more
information.
What is the purpose of this research?
The purpose of this study is to gather feedback on a prototype technology used to assist with
adherence in using dry powder inhalers. Adherence is the term for the success of a patient
to follow the instructions regarding correct therapeutic usage or treatment. The specific
application being focused on is an antibiotic inhaler used in the treatment of cystic fibrosis
(CF). This is the first stage of user testing and the aim is to help us to make a system which is
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practical and usable together with assessing its measurement performance. CF is a relatively
rare condition so initial testing is being carried out with volunteers with any restriction on
lung function.
Why have I been chosen?
You have been asked to take part because you have some restriction of lung function (eg
asthma) and are a member of staff or student registered at the University of Sheffield.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do not want to take part, it will
not affect you in any way. If you agree to take part, we will discuss this information with you
again, and ask you to sign a consent form to show you have agreed to take part. If you agree
to take part but then decide that you do not want to, you can withdraw at any time. This
would not affect any services you may receive.
What will happen to me if I take part?
If you decide to take part, you will be invited to use an inhaler which does not contain any
drug, powder or therapeutic component. The ‘inert’ inhaler has been equipped with a small
device which is being tested to record the presence and duration of the breath-in, hold breath
for a short time and exhale cycles required to use this type of inhaler. There is a second sensor
which is being used as a comparison with the one under development which is wired to a
laptop. The enrolment and experiment can be completed in a single visit to the Electronic and
Electrical Engineering Department (EEE) which should take less than an hour to complete.
The steps involved are:
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1. We will invite you to attend a session at the Electronic and Electrical Engineering
Department (EEE) at the University of Sheffield in July 2018, when we will tell you more
about the study.
2. If you agree to take part, you will be provided with brief instructions on how the inhaler is
expected to be used.
3. We will ask you to inhale and exhale using an inert inhaler (there is no drug present)
through a disposable mouthpiece a few times according to the instructions. The breathing
pattern and period of holding breath will be recorded by the system.
4. You will also be asked to give your feedback as to the via a short questionnaire.
5. This completes your kind involvement with the research project.
What is the technology that you are using in this study?
There are two types of adherence reinforcement technology being considered. The first
measures and records the timings relating to usage of the inhaler. The second version
provides some immediate feedback via a coloured LED (small indicator light) as to the
correct usage. The technology comprises a small package of electronics mounted to an
inhaler which uses a microphone and motion detector to record usage information. The data
can then be downloaded later to confirm adherence.
What will happen if I do not wish to take part?
Participation is completely voluntary and you do not have to take part. This will not affect
the nature or standard of care you receive from any health or social care service in any way.
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What are the possible benefits and risks of taking part?
While there are no immediate benefits in taking part, it is hoped that the information you
will give us will help to improve the design of inhaler adherence monitoring technology for
people with respiratory conditions which require the regular use of dry powder inhalers. We
do not anticipate that there will be any particular risks or disadvantages to taking part in this
study.
Are there any expenses or payments involved?
You will not receive any payment for taking part in this study.
What if I change my mind during the study?
You are free to withdraw from the study at any time. You will not have to give any reasons
for your withdrawal.
Will my taking part in the project be kept confidential?
All information which is collected about you during the course of this study will be kept
strictly confidential. The information you give will not be used in any way that could identify
you. You will be identified by a code rather than by name and the information will be stored
in password-protected encrypted computer files at the University of Sheffield which can only
be accessed by the research team. You will not be able to be identified in any reports or
publications.
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Who will have access to the data and where will it be held?
All the data will be held in confidence at the University of Sheffield. It will be used for the
purpose of this research. The research team will have access to the data. With your consent,
the anonymised data may also be used by other researchers at the University of Sheffield.
What will happen to the results of the study?
We aim to publish results of the study in academic journals and present our findings at
professional conferences. Nobody will be able to identify you in any reports or publications.
What if something goes wrong?
If by participating in this research you have any questions, please contact the project team
(details given at the end). This type of research is not considered to be harmful. If you find
using this technology upsetting, or if you wish to seek advice or reassurance about your own
health, then either contact your GP or the university welfare services.
If you do wish to complain or have any concerns about how you have been approached or
treated in the course of this study you can contact Mike Hounslow, Vice-President & Head of
Faculty (Engineering).
Who is organising and paying for the research?
The research is self-funded at the University of Sheffield. The overall project area relies
on close links with Respiratory Medicine at Sheffield Teaching Hospitals NHS Foundation
Trust.
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Who has reviewed this study?








Electronic and Electrical Engineering
Programme: Dry powder inhaler adherence monitoring device
Dear Fei
PROJECT TITLE: Dry powder inhaler adherence monitoring device: initial user testing
study
APPLICATION: Reference Number 016858
On behalf of the University ethics reviewers who reviewed your project, I am pleased to
inform you that on 12/02/2018 the above-named project was approved on ethics grounds, on
169
the basis that you will adhere to the following documentation that you submitted for ethics
review:
• University research ethics application form 016858 (dated 06/11/2017).
• Participant information sheet 1036960 version 2 (05/03/2018).
• Participant consent form 1036961 version 1 (06/11/2017).
University research ethics application form 016858 (dated 06/11/2017).
The following optional amendments were suggested:
I still didn’t see revision to clarify what inert powder will be used. If inert powder used,
please specify what it is. Need to also assess any issue potentially caused by the powder. for
example irritation?
If during the course of the project you need to deviate significantly from the above-approved
documentation please inform me since written approval will be required.
Yours sincerely
Peter Rockett Ethics Administrator Electronic and Electrical Engineering
Appendix C
Initial Testing Protocol
Dry powder inhaler adherence monitoring device: initial user testing study
1. Purpose
This protocol describes the processes and procedures for a study to gain initial user feedback
on the prototype inhaler adherence monitoring device. The participants will be involved
in the initial stage of testing on the prototype technologies. The technology and will be
developed using the feedback gathered during the initial testing and evaluated with the target
patient population (cystic fibrosis) using an observational study.
2. Introduction
One of the key indicators of success in the treatment of cystic fibrosis (CF) using inhaled
dry powder antibiotic delivery is the adherence to the treatment regime. The treatment is
undertaken regularly by the patient in their home. Correct and regular usage of the inhaler is
needed to maintain the required concentration of antibiotic. One solution to aid adherence
may be the use of technology to provide monitoring and feedback.
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From an engineering and economic perspective, the development of suitably practical, small
and disposable monitoring system would be an appealing solution.
This protocol concerns the initial user testing of prototype systems with a view to obtaining
feedback from people with respiratory conditions. It also provides an opportunity to assess
the relative merits of different ways of presenting instructions and providing automatic
feedback.
3. Technology
The systems being developed is a small package of electronics which can measure the usage
of a dry power inhaler and store this information for later retrieval using a suitable reader.
The device may have a multi-colour LED (indicator light) to provide real-time feedback
to the use as to the correct usage. The technology has been developed by members of the
research team in Electronic and Electrical Engineering (EEE) at the University of Sheffield.
4. Objectives
The objective of this sub-study is to gather usage data and user feedback on the prototype
device to inform the development and refinement of the technology. This is the first stage of
user testing, which will continue during later stages towards testing with CF patients in an
NHS setting.
5. Study Design
It is anticipated to undertake a number of cycles to develop the prototype technology including
its internal testing / validation (to ensure safety and functionality), followed by a period of
volunteers to its usability, gather usage data and solicit their views which will then inform
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the design process to refine the approach. In this sub-study, feedback from participants will
be collated using a short questionnaire completion at the end of the study session.
6. Participants
We will undertake this study with approximately a dozen volunteers.
Subject inclusion criteria:
• A restricted lung function of some description (eg Asthma)
• Aged 18+ years
Subject exclusion criteria:
• Unable to provide informed consent
• Unable to communicate in written & verbal English
7. Recruitment
Participants will be identified through the established research ‘volunteers’ mailing list at the
University of Sheffield. This list is co-ordinated by Corporate Information and Computing
Services (CICS) at the University of Sheffield, and therefore all potential participants are
either students or members of staff.
An invitation email will be distributed through this mailing list to advertise the study and
invite eligible people to participate. Potential participants are required to opt-in to the study
by contacting the research team. If they express an interest, they will be sent a participant
information sheet by email to tell them more about the study. Potential participants are then
invited to contact the research team again if they are interested in taking part at which point
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they will be informed of the date, time and location of the sessions at the EEE department.
These will be in July 2018. We anticipate that the whole recruitment, consent and testing
process will take up to a maximum of one hour.
Written informed consent will be taken from all participants by one of the research staff. All
participants will be free to withdraw at any time without providing any explanation if that is
their wish.
8. Study procedures
Once they have given written informed consent, participants will be given instructions on
how to use the technology and asked to use the inert inhaler a few times whilst usage data
is acquired. This will be from the device under test and a baseline measurement system
connected to a laptop.
The participants will be asked to trial the technology a few times during the session and then
will be encouraged to provide some feedback via a short questionnaire.
8.1 Potential harm to participants
This is a low-risk project. The study requires people to use an inert dry powder inhaler
(no drug, powder or propellant is present). A 3d printed mouthpiece is provided for each
volunteer and discarded after their use. We are not asking them to take any drug or change
their usual care but rather evaluate their experience of using the technology only and the
ability of the technology to accurately measure their usage of the inert inhaler. The breathing
pattern will be monitored without inhaling any substance. There is therefore no potential for
physical harm to any participants.
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9. Confidentiality and anonymity
Personal information (e.g. name, address, email and telephone number) will only be recorded
for purposes of communication between participants and the research team, and will only be
accessed by members of the research team at the University of Sheffield. Their participation
will be confidential and handled anonymously. Participants will be given an explanation
about how the data will be processed, and an understanding that the data gathered in the
study will not be reported, discussed or made available in such a way that will enable them
to be identified. The only intended use of personal identifiable information is as part of the
recruitment and consent process. Consent forms will be achieved for 5 years then destroyed.
The anonymised data will be retained and archived with the project and may be published as
part of a thesis or academic paper.
10. Data handling
All research data will be stored electronically within protected storage on servers belonging
to the University of Sheffield. This will only be accessible by members of the research team
and all information will be kept confidential. Paper copies of questionnaires and consent
forms will be stored in the study master file. All electronic data will be accessed on university
computers that are password protected, and maintained within the university server in an
encrypted database with encrypted off/cross-site backups.
11. Research team
Lead Researcher: Dr Mohammed Benaissa, Senior Lecturer, Department of Electronic and
Electrical Engineering, University of Sheffield
Research Engineer: Dr Tim Good, Research Associate, Department of Electronic and
Electrical Engineering, University of Sheffield
175
PhD Student:Miss Fei He, Department of Electronic and Electrical
Appendix D
Participant consent form
Title of research project: Dry powder inhaler adherence monitoring device
Name of lead researcher: Dr Mohammed Benaissa, University of Sheffield
1. I confirm that I have read and understand the Participant Information Sheet explaining the
above research project and I have had the opportunity to ask questions about the project.
2. I understand that my participation is voluntary and that I am free to withdraw at any time
without giving any reason and without there being any negative consequences. In addition,
should I not wish to answer any particular question or questions, I am free to decline.
3. I understand that my responses will be kept strictly confidential.
I give permission for members of the research team to have access to my anonymised
responses. I understand that my name will not be linked with the research materials, and I
will not be identified or identifiable in the report or reports that result from the research.
4. I agree for the data collected from me to be used in future research.
5. I agree to take part in the above research project.
6. I agree to be contacted about future research.
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Name of participant Date Signature
Name of researcher taking consent Date Signature
Appendix E
Invitation email
Invitation email for Dry powder inhaler adherence monitoring device
Subject Header: Inhaler correct usage monitoring: Volunteers wanted to help developing
monitoring technologies: single session of less than an hour
Dear volunteers,
Do you have any form of restricted lung function? For example, that required the
use of an inhaler. Do you want to take part in research to help us develop better
technologies for self-management?
We are looking for adults with any form of restricted lung function (eg Asthma) to help us to
test our prototype technologies for measuring correct usage of a particular class of inhaler
called a dry powder inhaler.
This study does not involve the delivery of any drug an inert inhaler is used which has been
instrumented to allow its usage to be monitored. Such inhalers are typically used to deliver
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antibiotic therapy for the treatment of cystic fibrosis. This is a relatively rare disorder so
volunteers with any restricted respiratory function are requested.
The research involves a single session which will include the consent process and provide an
opportunity for the volunteer to use the prototype instrumented inhaler a few times following
a brief set of instructions. At the end of the session, the volunteer will be asked to provide
any feedback they wish via a short questionnaire.
This is the initial user testing of the prototype so a second measurement technique is attached
to the inhaler connected to a laptop.
Individual sessions will be organised in the Mappin Street area or other mutually convenient
campus location. Time of day is flexible and some time before the end of June.
The technologies have been developed by researchers in the Electronic and Electrical Engi-
neering Department. The research has been granted ethical approval by the University of
Sheffield.
Please get in touch to express your interest in taking part: fhe3@sheffield.ac.uk
With best wishes,
Fei HE
Department of Electronic & Electrical Engineering, University of Sheffield
Appendix F
User Guide of Initial User Testing
Waking Up
1. Shake the inhaler twice, until the green light flashes for 1 second.
2. Hold the inhaler horizontally until the green light flashes again.
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The Detection of Inhalation
1. To start breathe out (exhale) fully to empty your lungs of air.
2. Place your mouth over the mouthpiece and close your lips tightly around it.
3. Inhale deeply with a single breath. Keep the inhalation at a steady pace. The green light
will flash once during a good inhalation.
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4. Hold your breath for 5 seconds after completing the inhalation. The green light will flash
twice indicating the time has elapsed.
5. Exhale and take a few normal breaths away from the Podhaler device.
6. Place the inhaler back on the table and rest with normal breathing for around 1 - 2 minutes.
Repeat the set of steps for around 5 - 8 times.
